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Abstract 
The incidence of neonatal infections caused by Enterobacteriaceae has been increasing 
in recent years, and they are now recognised as the predominant causative agents in 
neonatal intensive care unit (NICU) outbreaks. Klebsiella spp. and Serratia spp. are the 
most common causative pathogens, and E. coli is one of the leading causes of neonatal 
meningitis and sepsis. The infant intestinal flora is influenced by the feeding regime. 
This study focuses on assessing the risk to neonates from the ingestion of  
the Enterobacteriaceae such as; Enterobacter hormaechei, Enterobacter ludwigii, 
Enterobacter aerogenes, Enterobacter cloacae and Klebsiella oxytoca. The strains under 
study were isolated from two sources; human mastic breast milk (MBM) and neonatal 
nasogastric enteral feeding tubes (EFT). 
The overall aim was to evaluate the risk to neonates posed by the ingestion of these 
organisms either from contaminated breast milk or from infant formula.  
Due to the lack of adequate source information, it was necessary to first confirm the 
identity of the strains under investigation. This was achieved using standard biochemical 
profiles (phenotyping) and where necessary 16S rDNA sequence analysis. Secondly, it 
was necessary to determine whether all strains were unique or if any were multiple 
isolations of the same strain. This was achieved using Pulsed-Field Gel Electrophoresis 
(PFGE).  To determine the potential exposure of neonates to these organisms, a range of 
physiological and virulence related assays were undertaken; heat tolerance to 55°C, 
biofilm formation, capsule formation and acidic pH survival (pH 3.5).  
The potential virulence of the strains was assessed using attachment-invasion assays of 
human Caco-2 intestinal cells, human brain microvascular endothelial cells (HBMEC) 
and rat brain capillary endothelial cell line (rBCEC4); and also persistence of bacteria in 
macrophages by using U937 cells. Patterns of adherence of Enterobacteriaceae to  
Caco-2 cells was investigated. The presence of the virulence factors of strains was 
determined by identifying haemolytic activity, serum resistance, siderophore production 
and antimicrobial susceptibility. The iron uptake genes were also investigated.  
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The results by PFGE showed that neonatal enteral feeding tubes and mastic  
human breast milk were contaminated by twenty-one and three pulsotypes of 
Enterobacteriaceae, respectively. Furthermore, the same pulsotypes were spread among 
enteral feeding tubes of infants in the same NICUs; indicating the same origins, such as: 
environment, milk or carer. Similarly, the MBM strains were isolated from the same 
mother. The identification of strains by using 16S rDNA sequence analysis (genotyping) 
was more accurate than phenotyping (API technique) and the clustering of strains by 
PFGE is a suitable technique for strains relatedness. 
The physiological features of the strains in the current study were investigated. The 
ability of strains to survive at 55ºC was studied and most of the strains were able to 
survive at 55ºC for >30 minutes. Biofilm formation was investigated as this may be a 
factor of organism persistence in the neonatal intensive care unit (via milk, environment 
or workers) and attachment to enteral feeding tubes.  All strains formed biofilms and this 
was, in general, enhanced at 37°C compared with room temperature (20ºC) in all types 
of formula. The highest levels of biofilm were in casein-based infant formula. Most 
strains produced capsular material at 37ºC on all types of formula. However, capsular 
material was produced by all strains in soya infant formula. All strains were able to 
survive at pH 3.5 for up to 2 hours. 
All strains were able to attach to Caco-2, HBMEC and rBCEC4 cells lines, while there 
was variation between strains ability to invade mammalian cells. In particular, most of  
Ent. hormaechei strains were able to invade the three types of cells lines and one  
Ent. ludwigii strain 1439 was only able to invade the rBCEC4 cell line. Ent. ludwigii 
strain 1439 was isolated from a case of neonatal meningitis. Three out of eight strains of  
Ent. hormaechei and two strains of Ent. cloacae strains survived within macrophages. 
Haemolysin production, serum resistance and siderophore production were also studied 
and  all strains were positive. 
Genes encoding for iron uptake irp1, irp2 and fyuA were detected whereas irp1, irp2 
genes were absent in all strains while fyuA was present in 4/6 of Ent. ludwigii strains, 1/8 
of Ent. hormaechei, 2 of  Ent. cloacae, 1 of Ent. aerogenes and 3/6 of K. oxytoca. Three 
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out of eight strains of Ent. hormaechei showed resistance to even the 3
rd
 generation 
cephalosporins, ceftazidime and cefotaxime and were ESBL-positive. 
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1.1 INTRODUCTION 
 
The Enterobacteriaceae is a family of Gram-negative bacilli, some of which are motile, 
and have capsules. Most species are facultative anaerobic, oxidase-negative and  
catalase-positive rods. The Enterobacteriaceae which most commonly produce  
extended-spectrum β-lactamases (ESBLs) are Klebsiella pneumoniae and Escherichia 
coli (Romero et al., 2007). Some members are found in soil, water, plants and animals. 
The Enterobacteriaceae group is comprised of more than 100 species of bacteria that 
normally inhabit the intestines of humans and animals. Many Enterobacteriaceae species 
are lactose fermenting and are commonly referred to as “coliforms”. Exotoxins are 
produced by some pathogenic strains, whereas others produce enterotoxins which affect 
the intestinal tract, causing diarrhoea and body fluid loss. Some Enterobacteriaceae (i.e. 
K. pneumoniae) are able to cause pneumonia and urinary tract infections. Wound 
infections and other nosocomial (hospital acquired) infections are caused by 
Enterobacteriaceae. They are also recognized as a major cause of bacteraemia and 
meningitis. 
In recent years, the incidence of neonatal infections due to Enterobacteriaceae has been 
increasing and they are now recognised as the predominant causative agents of infection 
in neonatal intensive care unit (NICU) outbreaks (Gastmeier et al., 2007; McGuire et al., 
2004; Kaufman et al., 2004). The most common neonatal Enterobacteriaceae pathogens 
reported are Klebsiella spp. and Serratia spp.; 23.4% and 13.8% cases respectively 
(Gastmeier et al., 2007). There are also other pathogenic species which, although they 
occur less frequently, have a high severity following infection.  For example, pathogenic 
strains of E. coli are a leading cause of neonatal meningitis and sepsis (Stoll et al., 2005), 
and Cronobacter sakazakii can cause necrotizing enterocolitis and meningitis. Neonates 
may be particularly prone to Gram negative infection (i.e. Enterobacteriaceae) as their 
innate immune cells have lower responses to lipopolysaccharide (LPS), the outer portion 
of the bacterial cell wall (Townsend et al., 2007). However, Nanthakumar et al. (2000) 
reported that the human colonic carcinoma epithelial (Caco-2) cells secrete less IL8 
(LPS, 8-fold; IL-1b, 20-fold) than fetal cells after inflammatory stimulation. 
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1.2  Impact of Enterobacteriaceae on neonates 
Enterobacteriaceae are the most common opportunistic pathogens particularly E. coli, 
Enterobacter spp., Klebsiella spp., Serratia spp., and Salmonella. They are significantly 
implicated with morbidity and mortality (Friedland et al., 2003; Adamson et al., 2012). 
Many different types of infections can be caused by these organisms, such as sepsis, 
brain meningitis, pneumonia, and urinary tract infections particularly in intensive care 
units (ICUs) (Kollef et al., 1999; Ibrahim et al., 2000). Enterobacteriaceae such as E. 
coli, Klebsiella, Proteus, Serratia and Citrobacter spp. are able to cause nosocomial 
infections. Most of these strains are members of normal flora such as E. coli and Ent. 
cloacae, and probably cause infections through selection following an empiric 
antimicrobial regime (Iversen et al., 2004a; Stoll et al., 2005). The most common human 
diseases which are caused by a family of Enterobacteriaceae are presented in Table 1.1 
(Liu et al., 2012; Podschun and Ullmann, 1998; Pazhani et al., 2005; Fraser and Arnett, 
2006; Chaudhry et al., 2007; Hammerum and Heuer, 2009; Bisi-Johnson et al., 2011). 
Table ‎1.1: Most common species Enterobaceriaceae causing clinical infectious disease. 
 
1.3 Enterobacter spp. as a cause of neonatal infection 
The Enterobacter genus belongs to the family of Enterobacteriaceae and are known as 
facultative anaerobic Gram-negative strains. This genus are saprophytic bacteria which 
Clinical species Clinical Infection Presentation
Cit. freundii
Pneumonia, meningitis, septicaemia, wound and 
urinary tract infections 
Ent. aerogenes, Ent. cloacae
Pneumonia, septicaemia, wound and urinary 
tract infections 
E. coli
Diarrhoea, meningitis, septicaemia and urinary 
tract infections 
K.oxytoca, K. pneumoniae
Pneumonia, septicaemia and urinary tract 
infections 
Mo. morganii Septicaemia and urinary tract infections
Pl. shigelloides Diarrhoea and septicaemia
Pr. rettgeri, Pr. stuartii Urinary tract infections
Sal. enteritica
Diarrhoea, typhoid fever, septicaemia, 
osteomyelitis and urinary tract infections 
Se. marcescens, Se. liquefaciens
Pneumonia, septicaemia, wound and urinary 
tract infections 
Sh. sonnei, Sh. flexneri Diarrhoea 
Y. pestis, Y. enterocolitica Diarrhoea, septicaemia plague and enteritis
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are widely encountered in nature, such as in soil and sewage and are commensal  
in the enteric flora in the human gastrointestinal tract (Mazari-Hiriart et al., 2008; 
Quintanilha et al., 2007). There are 14 known species of Enterobacter, some of these  
have been implicated as causes of diseases in humans and the most commonly  
encountered species are Ent. aerogenes, Ent. cloacae, Ent. agglomerans, and  
C. sakazakii (Andresen et al., 1994; Burchard et al., 1986; Chow et al., 1991; Gallagher 
1990; Gaston 1988; Haddy et al., 1991; Hawkins et al., 1991; Stenhouse et al., 1992). 
Ent. aerogenes and Ent. cloacae are considered the most frequently encountered human 
pathogens within the genus Enterobacter (Andresen, et al., 1994; Burchard et al., 1986; 
Haddy et al., 1991;  Burchard et al., 1994; Karnad et al., 1987; Weischer and Kolmos, 
1992). The major nosocomial pathogens often found in intensive care settings are 
Enterobacter species. From 1976 to 1989 in the United States of America (USA), the 
National Nosocomial Infections Surveillance System (NNIS) reported data on 
nosocomial bacteremia. In 2008 the National Healthcare Safety Network reported that 
Enterobacter spp. accounted for approximately 5% of nosocomial bacteremia cases, 
between 1995 and 2002, a study by Wisplinghoff et al. (2004) from different states in 
USA demonstrated the most commonly isolated nosocomial pathogens with a higher rate 
in intensive care unit wards was Enterobacter species (Wisplinghoff et al., 2004). 
Previous studies by v Dijk et al. (2002) and van den Berg et al. (2000) reported that 
neonatal intensive care units (NICUs) have outbreaks of Enterobacter spp. 
1.3.1  Ent. cloacae 
Ent. cloacae are members of the genus Enterobacter. As other Enterobacteriacae, they 
are saprophytic microorganisms of the normal digestive flora in humans and are the most 
commonly isolated clinical species (Thomas et al., 1993; Wang et al., 1991). Recently, 
six species have been classified in the Ent. cloacae complex, including Ent. cloacae,  
Ent. asburiae,  Ent. hormaechei, Ent. kobei, Ent. ludwigii and Ent. nimipressuralis. The 
biochemical and molecular studies on E. cloacae have shown genomic heterogeneity, 
comprising six species. Species of the Ent. cloacae complex are widely encountered in 
nature, but they can act as pathogens (Mezzatesta et al., 2012). 
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Ent. cloacae has emerged as an alarming pathogen for healthcare institutions globally. It 
accounts for up to 5% of hospital-acquired sepsis, 5% of nosocomial pneumonias,  
4% of nosocomial urinary tract infections and 10% of postsurgical peritonitis cases 
(Paauw et al., 2008a and Hoffmann and Roggenkamp, 2003). In different clinical 
settings, including neonatal NICUs, outbreaks due to exogenous Ent. cloacae infection 
have been reported. In 1998, van Nierop et al. reported an outbreak of Ent. cloacae in a 
NICUs that caused nine deaths. Also, Kuboyama et al. (2003) reported an overall 34% 
mortality rate associated with Ent. cloacae in unrecognized outbreaks in NICU. This 
bacterium was possibly transmitted to neonates by contaminated intravenous fluids, 
whole parenteral nutrition solutions and medical equipment.  
The healthcare workers may play a role in cross-transmission of many single-clone 
outbreaks and inpatients may also act as a reservoir (Dalben et al., 2008). In hospitalized 
neonates, Ent. cloacae can cause a range of infections such as urinary tract infection, 
bloodstream infection, pneumonia and bronchopulmonary dysplasia (Grattard  et al., 
1994; Modi et al., 1987). Enterobacteriaceae has been isolated from powder infant 
formula (PIF), such as Ent. cloacae, K. pneumoniae, K. oxytoca, Ent. hormaechei, Cit. 
freundii, and E. coli (Muytjens et al., 1988; Townsend et al., 2008a). 
Only a few of the studies have reported enteral feeding tubes (EFT) as a site of the 
bacterial colonisations. Bacterial contamination of the EFT with >10
3
cfu/ml in 71/125 
EFTs was reported by Mehall et al. (2002a) from infants over four months of age. 
Staphylococcus epidermidis, S. aureus, Enterococcus faecalis, Ent. cloacae and K. 
pneumoniae were detected in their study. They also showed that seven infants older than 
four months who were fed with tubes containing >10
5
cfu/ml developed necrotizing 
enterocolitis. Their study also identified methicillin-resistant Staphylococcus aureus 
(MRSA) contamination in the EFT (Mehall et al., 2002b).  
1.3.2  Ent. hormaechei 
Ent. hormaechei is a Gram-negative rod in the Ent. cloacae complex, and is most 
frequently isolated from clinical sources (Townsend et al., 2008a). The species have 
been defined within the Ent. cloacae complex via deoxyribonucleic acid (DNA) cross-
Chapter 1 
 
6 
 
hybridization, naming three new subspecies of Ent. hormaechei: Ent. hormaechei subsp. 
steigerwalti, Ent. hormaechei subsp. hormaechei and Ent. hormaechei subsp. oharae 
(Hoffmann et al., 2005a).  
Using biochemical identification, Ent. hormaechei strains are catalase positive, oxidase 
and deoxyribonuclease (DNase) negative and fermentative.  Ent. hormaechei form non-
pigmented colonies after 18 to 24 hours at 15 to 42°C, with an optimum for growth at 
36°C, on all non-selective media, such as Colombia agar with 5% sheep blood, chocolate 
agar, tryptic soy agar (TSA), Luria-Bertani agar (LBA), and brain heart infusion agar, as 
well as on semi-selective media such as MacConkey and ENDO agar (Hoffmann and 
Roggenkamp, 2003). 
Ent. hormaechei is the most commonly isolated nosocomial pathogen (Paauw et al., 
2008a). It has been a cause of septicaemia in an outbreak occurring in six NICUs in five 
hospitals in Brazil, and due to contamination of parental nutrition solutions which all 
originated from the same manufacturer (Campos et al., 2007). Ciprofloxacin resistance 
was closely associated with the prior use of fluoroquinolones and broad-spectrum 
cephalosporin in Enterobacter species isolates causing bacteremia (Kang et al., 2005). 
A previous study conducted by the Post-doctoral researcher Dr Stacy Townsend at 
Nottingham Trent University (NTU) identified Ent. hormaechei from isolates received  
from a United States (US) hospital that had been misidentified as ‘Cronobacter’ strains. 
Further analysis, with Pulsed Field Gel Electrophoresis (PFGE) and 16S rDNA 
sequencing revealed that the strains were clonal and were from an NICU outbreak which 
the hospital had not detected (Townsend et al., 2008a). Hence, the hospital had not only 
failed recognising that they had an outbreak, but had also misidentified the organisms.  
Muytjens et al. (1988) identified Cronobacter strains from PIF using biochemical 
profiling.  However, by using 16S rDNA sequence analysis some of the strains were 
reidentified as Ent. hormaechei. This organism has been reported to be resistant to 
quinolone highlighting the difficulty of treatment (Townsend et al., 2008a). The study of 
this organism is significant in the clinical setting as it is difficult to treat and identify. 
Enterobacteriaceae isolates identified from EFT from the Nottingham Queen's Medical 
Chapter 1 
 
7 
 
Centre (QMC) and Nottingham City Hospital (NCH) included Ent. hormaechei (Hurrell 
et al., 2009b).  Many of these strains were resistant to the 3
rd
 generation cephalosporins, 
ceftazidime and cefotaxime, and ESBLs were detected. This demonstrates that neonates 
are directly exposed to antibiotic resistant strains in NICUs during feeding. 
Comparative bacterial thermal death rates of Enterobacteriaceae revealed that an  
Ent. hormaechei strain isolated from a neonatal enteral feeding tube was more heat 
resistant that Sal. seftenberg. This latter organism is recognised as the most heat resistant 
Enterobacteriaceae and its detection is used by industry to ensure their heat treatment 
processes are efficient (Forsythe, 2009). This shows that Ent. hormaechei has a greater 
chance of surviving during the reconstitution of infant formula than other organisms, and 
that preparation may need to be modified to take this into account. 
1.3.3  Ent. aerogenes 
Ent. aerogenes is known as part of the normal flora of the human gastrointestinal tract 
that is in most cases endogenously acquired (Flynn et al., 1987). In addition,  
Ent. aerogenes is an opportunistic colonizing pathogen which can cause infection in 
hospitalized patients (Sanders  and Sanders, 1997). This organism is one of the more 
commonly described Gram-negative bacteria causes of nosocomial respiratory tract 
infections (Arpin et al., 1996; Davin-Regli et al., 1996a). Recently, Ent. aerogenes  
has emerged as a significant hospital pathogen (de Champs et al., 1991; Flynn et al., 
1987; Mellencamp et al., 1990;  Meyers et al., 1988). Because of the widespread 
prescription of broad-spectrum antibiotics, especially extended-spectrum cephalosporins,  
Ent. aerogenes has emerged as a pathogen (Shlaes, 1993).  
The presence of medical devices such as endotracheal tubes or central venous catheters 
are associated with multiresistant Ent. aerogenes, which facilitate colonization (Chow et 
al., 1991; Weinstein, 1986). 
Ent. aerogenes has been associated with nosocomial infections during the last 5 years. 
Several outbreaks linked with multiresistant strains of Ent. aerogenes have been reported 
in ICUs in France (Arpin et al., 1996; Davin-Regli et al., 1996 a and b; Grattard et al., 
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1995; Neuwirth et al., 1996), Belgium (De Gheldre et al., 1997; Jalaluddin et al., 1998), 
Austria (Allerberger et al., 1996) and the United States (Georghiou et al., 1995).  
Ent. aerogenes species are not commonly isolated in NICUs however, a previous study 
by Gallagher (1990) reported that in a pediatric population during a 5 year period, 22 
episodes of nosocomially acquired Enterobacter bacteria were identified: 17 were  
Ent. cloacae, three were Ent. aerogenes and two were Ent. agglomerans. Another study 
also reported that Ent. aerogenes was isolated in a NICU from the blood culture of a 5 
day old neonate; and 12 more episodes were found 10 weeks later which caused 
nosocomial outbreaks of septicemia in the NICU (Loiwal et al., 1999). 
1.3.4  Ent. ludwigii 
Ent. ludwigii is a Gram-negative rod, belonging to the Enterobacteriaceae family, and is 
motile, catalase positive, oxidase and DNase negative, fermentative, and non-pigmented. 
Ent. ludwigii has the ability to ferment 3-0-methyl-D-gluco-pyranose and myo-inositol. 
Ent. ludwigii has been reported to produce a Bush class 1 beta-lactamase rendering 
resistance to ampicillin, amoxicillin plus clavulanic acid and cefoxitin in the disk 
diffusion tests. In addition, Ent. ludwigii is susceptible to cefepime, trimethoprim plus 
sulphamethoxazole, gentamicin, and resistant to piperacillin, piperacillin plus 
tazobactam, cefoxitin, cefotaxime, ceftazidime (Hoffmann et al., 2005b). 
There have been few studies of this organism, possibly due to the lack of a reliable 
identification scheme. However, during the second year of this project, we received an 
additional Ent. ludwigii strain (NTU1439) from Nottingham QMC hospital which had 
been isolated from a case of neonatal meningitis. This strain was included in the project 
as it reinforced the importance of evaluating the risk of neonatal infection by Ent. 
ludwigii.  
In previous studies, Ent. ludwigii has been isolated from various sources such as clinical 
specimens (Hoffmann et al., 2005b), and from plants (Shoebitz et al.,2009). Delgado  
et al. (2008) isolated Ent. ludwigii from human milk. However, as will be reported here, 
it was originally identified as K. oxytoca using classical tests. By using 16S rDNA 
sequence analysis, the Delgado K. oxytoca isolates were reidentified as Ent. ludwigii at 
Chapter 1 
 
9 
 
NTU. By coincidence, NTU already had an Ent. ludwigii strain in its collection which 
was initially identified as Cronobacter; this strain isolated from a case of neonatal 
meningitis in Nottingham QMC hospital. 
1.4 Klebsiella spp. as a cause of neonatal infection 
The most commonly isolated members of the genus Klebsiella (family 
Enterobacteriaceae) are K. pneumoniae and K. oxytoca which consist of Gram-negative, 
non-motile, encapsulated rods (Green et al., 2009), and the colonies of Klebsiella have a 
characteristic mucoid appearance because they produce polysaccharide capsules 
(Podschun and Ullmann, 1998). Klebsiella spp. are opportunistic pathogens that can 
cause a variety of illnesses including pneumonia, urinary tract infections, septicaemia, 
soft tissue, intravenous, meningitis, liver abscess, and gastrointestinal disease common in 
immunocompromised or those with underlying conditions (Green et al., 2009). 
To cause infection, microorganisms must adhere to the mucosal surfaces in order to 
reach host cells and can use surface appendages to achieve this (Podschun and Ullmann, 
1998). Klebsiella is abundant in the environment (e.g., soil and water) but can also be 
isolated from skin, mucous membranes, and the intestines of humans and animals 
(Podschun and Ullmann, 1998). In a study of bacterial colonisation in a NICU, there was 
a higher risk of the acquisition of Klebsiella spp., and Enterobacter spp., in infants 
receiving antibiotics for more than 3 days and associated with an increased duration of 
NICU stay. Klebsiella spp. is recognised to survive on the skin and is more resistant to 
desiccation than other Enterobacteriaceae (Gastmeier et al., 2007). 
 
1.5 Influence of the existing gut microbiome on neonates health 
Colonization of the human gut with microbes begins during birth by microbes from the 
environment. In the first few hours of life, usually the most important source of 
inoculum is the mother’s vaginal and fecal microbiomes (Gueimonde et al., 2006 and 
Vaishampayan et al., 2010). However, some data reported that infants delivered by C-
section-delivered have lower gut microbial richness and variety at 4 months of age, 
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compared to vaginally delivered infants (Azad et al., 2013). The great functional and 
phylogenetic difference observed between infant gut microbiomes possibly because of 
random colonization happenings, variances in immune responses to the colonizing 
microbes, alterations in host behaviour, or other features of host lifestyle (Palmer et al., 
2007; Dethlefsen et al., 2006). 
The previous studies report that the microbiome is implicated in human health 
(Turnbaugh et al., 2007). Gut microbiotas can contribute to excess host adiposity 
(Turnbaugh and Gordon 2009; Turnbaugh et al., 2006), protect against the improvement 
of type 1 diabetes (Wen et al., 2008), and induce colitis (Garrett et al., 2007) and 
metabolic syndrome (Stockman, 2012). Hence, the microbiota has been proposed as a 
target for therapeutic intervention for numerous chronic diseases (Turnbaugh et al., 2007; 
Zaneveld et al., 2008).  
The microbiotas of adult are assumed to be relatively stable over time which imparts 
resilience to disturbance, confirming continued gut function (Turnbaugh and Gordon 
2009; Ley et al., 2006; Dethlefsen et al., 2008). In contrast, in the infant (full-term 2-5 
years old) the chaotic shifts in the microbiome are affected with life events, such as 
drastic diet changes or antibiotic treatments, which result in large changes in the relative 
large quantity of taxonomic groups.  Moreover, they found that the 2.5 years old human 
gut microbiome has several of the functional features of the adult microbiome (Koenig et 
al., 2010). 
 
1.6  Potential sources of infection to neonate in NICU 
Neonates characterise a unique and highly exposed patient population. Improvements in 
medical technology that have occurred over the last few decades have developed the 
survival and quality of life for neonates, particularly those infants born with extreme 
prematurity or with congenital defects. However, infants hospitalized in the NICU can 
be exposed and acquire health care-associated infections from both human and inanimate 
sources (Brady, 2005). Evidence supporting each of these ways is given below (Figure 
1.1): 
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Figure ‎1.1: Sources of transmission of bacteria within a NICU setting. 
1.6.1 Bacterial exposure of neonates human breast milk 
Nutrition is necessary to the health and growth of infants and children. Breastfeeding is 
the best nutritional choice for infants, superior to infant formula feeding, as breast milk 
possesses immune factors that are effective for long term protection against infections, 
diseases and influences metabolism later in life (Oddy, 2001). In the NICU, most 
mothers are providing their breast milk to feed their premature infants (Morales and 
Schanler, 2007). However, breast milk has been recognized as the source of numerous 
bacterial infections in neonates (Qutaishat et al., 2003; Revathi et al., 1995), including 
Salmonella (Anonymous, 1978; Ryder et al., 1977). Several clinicians request bacterial 
cultures of milk from the mother for screening before allowing the milk to be fed to 
neonates (Ng et al., 2004). A previous in-vitro study by Lenati et al. (2008) found that 
Cronobacter spp. was resistant to the antimicrobial properties of breast milk, for more 
details see Figure 1. 11. 
In the last few years, there have been many studies which have demonstrated that breast 
milk is a prevalent source of bacteria to the infant gut and plays a role in the initiation 
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and growth of gut microbiota. Staphylococci, streptococci, lactococci, lactobacilli and 
enterococci were isolated more frequently from this biological fluid in healthy women 
(Heikkila et al., 2003; Martín et al., 2003).  
Sometimes transmission of serious bacterial diseases to the neonate can occur through 
breast milk, for example, Salmonella species (Qutaishat et al., 2003), group B 
streptococcus (Kotiw et al., 2003), Listeria species (Svabic-Vlahovic et al., 1988), 
methicillin-resistant St. aureus (Gastelum et al., 2005), and Mycobacterium tuberculosis 
(Pronczuk et al., 2002), which is the most common species documented in cases of 
infection by this route, Figure 1.1  
The report by Widger et al. (2010) states that three cases of late onset neonatal 
septicaemia were investigated in their unit, including one that resulted in death, which 
were more likely to be caused by contaminated expressed breast milk. Another report 
demonstrated that the contamination of breast milk has been causing fatality in neonates, 
but these have been related to concurrent mastitis (Gastelum et al., 2005; Kotiw et al., 
2003). Recent study by Urbaniak et al. (2014) informed that Enterobacteriaceae were 
isolated from breast tissue of women with and without cancer in Canada and Ireland. The 
women were not had any symptoms of infection, however the viable of bacteria was 
confirmed in some samples by culture. 
1.6.2  Bacterial exposure of neonates through powdered infant formula 
Recently, the Food and Agriculture Organization/World Health Organization (FAO/ 
WHO, 2004 and 2006) have focused attention on the microbiological safety of PIF. The 
considerable concern for PIF was due to neonatal infections through Cronobacter and 
Salmonella that were associated with contaminated PIF (Caubilla-Barron et al., 2007; 
Iversen et al., 2008). PIF are not sterile however, they comply with the international 
microbiological standards (Codex Alimentarius Commission 2008). Furthermore, the 
report by US Centers for Disease Control and Prevention (CDC) report that in a NICU, 
an outbreak of C. sakazakii infection was associated with the use of powdered infant 
formula (CDC, 2002). The report also emphasised that infection through this organism 
often leads to a fatal disease, highlighting the significance of careful preparation, 
handling and use of infant formula products in the health care setting, Figure 1.1 
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Many types of bacteria have been isolated from PIF and the most common organisms 
isolated from PIF were Clostridium perfringens, St. aureus, Bacillus cereus and 
Enterobacteriaceae (Forsythe, 2005). Enterobacteriaceae including Ent. cloacae,  
K. pneumoniae, K. oxytoca, Ent. hormaechei, Cit. freundii, and E. coli  have been 
isolated from PIF (Muytjens et al., 1988; Townsend et al., 2008a). These organisms have 
been categorised by the FAO/WHO (2004 and 2006) as category B which is 'causality 
plausible, but not yet demonstrated' with consideration of their potential  
to cause neonatal infections via the ingestion of reconstituted PIF. Though  
these organisms are opportunistic pathogens, there was no evidence to confirm any 
outbreaks in NICUs associated with their presence in contaminated PIF. The most 
common organisms isolated from PIF were Cl. perfringens, St. aureus, Bacillus cereus 
and Enterobacteriaceae (Forsythe, 2005). 
There are approximately 2,000 serovars of the Salmonella bacterium that can cause 
disease in humans, and symptoms include diarrhoea, fever and vomiting which can cause 
serious infection in infants (Crawley and Westland, 2012). A previous study by 
Rodríguez-Urrego et al. (2010) in 2008 in Spain reported that 31 cases of Salmonella 
infection in infants occurred because of infant formula contamination, and 10 of these 
infants needed hospitalisation.  
Powdered infant formula is made from pasteurized liquid and then spray dried. However, 
it is more likely that, the contamination of formula occurs from the preparer or 
preparation environment than from the manufacturing procedure (FAO/WHO 2004). The 
previous study by Weir (2002) recommended that in NICUs, the preparation of PIF 
should be carried out following the manufacturer’s instructions by trained people under 
clean and aseptic conditions in a designated area. The FAO/WHO (2004) recommended 
that reconstitution of powdered infant formula with water >70°C, decreasing the time 
between reconstitution and feeding (< 2 hours), and not storing reconstituted feed at 
ambient temperature could reduce the risk of bacterial infection. 
1.6.3  Bacterial exposure through neonatal feeding tube 
In NICUs, enteral feeding tubes are commonly used to feed infants who are unable to 
swallow milk or formula. As per other medical inserting devices, EFT have to be clean 
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and sterile. Recent studies at NTU in collaboration with local NICUs revealed that 
organisms are present in EFT from neonates on non-formula feeding regimes (Hurrell et 
al., 2009b).  This indicates that neonate exposure to Cronobacter may not be exclusively 
through reconstituted formula, and that increased exposure to bacterial pathogens may be 
linked to more general feeding practices, Figure 1.1. 
Hurrell et al. (2009a and b) studied 129 neonatal enteral feeding tubes from two local 
NICUs. They found that irrespective of feeding regime, neonatal enteral feeding tubes 
can act as loci for the bacterial attachment and multiplication of a wide range of 
Enterobacteriaceae and, hence, revealed a potentially greater risk to neonatal health  
than Cronobacter alone.  The organisms frequently isolated included E. coli,  
Ent. cancerogenus, Ent. hormaechei, K. pneumoniae, K. oxytoca, Raoutella spp.,  
Se. liquefaciens and S. marcescens. Additionally, Cronobacter spp. and Yersinia 
enterocolitica were recovered. All S. marcescens strains were resistant to amoxillin and 
co-amoxiclav.  
Of additional importance was that a quarter of Ent. hormaechei isolates were resistant to 
the 3
rd
 generation cephalosporins ceftazidime and cefotaxime. During the period of the 
study, K. pneumoniae and S. marcescens caused infections in the two NICUs and ESBLs 
were detected in two of these strains (Hurrell et al., 2009b).   
Hurrell et al. (2009b) isolated bacteria from EFT used by infants on two NICUs. The 
infants had received different feeding regimes: reconstituted PIF, breast milk, fortified 
breast milk, ready to feed formula and a mixed feeding regime. A nil by mouth group 
was selected as a control cohort. Enterobacteriaceae was isolated from 76% of the 
enteral feeding tubes.  The highest Enterobacteriaceae biofilm was isolated from infants 
fed reconstituted PIF; an average 4.2 log10 cfu/tube. In fact, the PIF was reconstituted at 
room temperature and not with water at >70°C, as recommended by FAO/WHO. These 
bacteria could multiply while feeding on the formula during the time the tube was in 
place (48 hours) and because, unlike breast milk, PIF contains no antibacterial agents. 
The study found that the lowest levels of bacteria were obtained from the EFT of infants 
fed breast milk 52%, whereas the others ranged from 78 to 88% for mixed feeding 
regime and reconstituted PIF. Bacteria were obtained from the EFT of infants fed breast 
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milk (maximum of 5.3 log10cfu/tube) and infants that were nil by mouth had a maximum 
value of 2.7 log10 cfu/tube. The maximum value of breast milk was higher than the other 
neonates in the group and may be due to the high near neutral gastric pH (6.0). 
Enterobacteriaceae biofilms were recovered from 81% of neonates fed with sterile 
ready-to-feed formula.  It is thought that the bacteria may have originated from the throat 
due to gastroesophageal reflux. 
In parallel studies, Hurrell et al. (2009a) showed in situ that bacteria can grow in the 
nasogastric tubes to cell densities of 10
7
 colony forming units/tube within 8 h, and 
10
9
cfu/tube within 24 hours.  It is plausible that in vivo the biofilm will both inoculate 
subsequent routine feeds (every 2-3 hours) and as the biofilm ages, clumps of cells will 
detach and survive passage through the neonate’s stomach. Subsequently, these 
organisms will enter the stomach as a bolus with each feed.  
A major conclusion of this study was that the microbiological safety of neonatal feeds 
should not exclusively focus on reconstituted infant formula, and Cronobacter spp., but 
also on the general preparation and practices of enteric feeding to reduce the risk of 
exposure to other Enterobacteriaceae some of which may carry antibiotic resistance 
factors.  Therefore, the practice of prolonged placement of EFT in neonates needs to be 
considered with respect to the increased risk of exposure to bacterial pathogens.  Hence, 
biofilm formation on EFT is an important risk factor to consider with respect to neonatal 
infections (Hurrell et al., 2009a and b). The sources of these potentially pathogenic 
Enterobacteriaceae need to be evaluated.   
1.6.4 Bacterial exposure of neonates health-care workers or immediate 
environment 
As Shown in Figure 1.1, healthcare workers and patients are the most possible sources of 
infectious agents and are also the most common susceptible hosts. Residents in NICU 
can also become infected with health care-associated infections by horizontal 
transmission of microorganisms spread through aerosol or contact (direct or indirect) 
transmission. Despite at the present time,  the enhanced safety of blood products 
administered in hospitals, the frequent use of blood products in the stabilization of 
critically ill newborns allows for the potential transmission of bloodborne pathogens, 
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currently identified and those yet to be identified (Yeager, 1974 and Saulsbury et al., 
1987).  Likewise, Transmission of infections on contaminated medical devices is also 
potential and outbreaks of hospital-acquired infections have been associated to devices 
such as electronic thermometers, blood pressure cuffs, stethoscopes, latex gloves, masks, 
neckties, pens, badges and lanyards, and white coats (WHO, 2009; Uneke et al., 2008; 
Treakle et al., 2009). 
Some studies have found that pathogens bacteria can be transmitted from out-of-hospital 
sources to patients through health-care workers’ hands. For instance, an outbreak of 
postoperative Se. marcescens wound infections was refer to a contaminated jar of 
exfoliant cream in a nurse’s home. An investigation suggested that the bacterial was 
transmitted to patients by the hands of the nurse who wore artificial fingernails (Passaro 
et al., 1997). Se. marcescens was transferred from contaminated soap to patients through 
health-care wokers’hands (Sartor et al., 2000). 
Multidrug-resistant bacteria cause a important ratio of hospital-associated infections  
(Hidron  et al., 2008; Morgan et al., 2010). These organisms are generally transmitted 
from patient-to-patient in the healthcare system via transiently contaminated healthcare 
workers, equipment, and the environment (Siegel et al., 2007). An outbreak of 
multidrug-resistant Acinetobacter baumannii, strains from patients, healthcare workers’ 
hands, and the environment were identical (El Shafie et al., 2004). 
Health-care waste is considered as a source of pathogenic microorganisms, that can 
cause contamination and give increase to infection. These microorganisms can be 
transmitted by direct contact, in the air, or through a diversity of vectors (Pr ss,     ). 
1.7 Commonly used infant formula 
The World Health Organization (WHO, 2003) and health departments across the 
developed and developing world recommend breastfeeding for feeding infants in the first 
six months of life as the best feeding method (Crawley and Westland, 2012). Infant 
formulas as breast milk substitutes are available for mothers who cannot or choose not to 
breastfeed. However, infant formulas are an artificial substitute for breast milk having 
inherent differences (Renfrew et al., 2012) such as the exact chemical makeup of breast 
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milk is still unknown and cannot be manufactured. Breast milk contains mother’s 
antibodies and numerous other defensive factors. These mature factors from the mother’s 
immune system help the baby’s immature immune system to fight against infection. In 
addition, infant formula requires industrial storage and delivery systems with important 
quality control problems. Furthermore, infant formula has no positive influence on 
maternal health (Crawley and Westland, 2012) whereas breast feeding leaves a life-long 
impact on the mother’s health. 
The essential components of any infant milk, irrespective of the format (powder or 
ready-to feed), are proteins, fats, carbohydrates, vitamins and minerals. The major infant 
formula manufacturers improve their own brands with a combination of each of these 
components. The essential nutritional properties of the majority of infant formula are 
very similar. Most infant formula are based on modified cows’ milk (skimmed or full-fat, 
liquid or powder, or using whey protein concentrates) by adding lactose or other 
carbohydrates, vegetable and other oils, vitamins and minerals (Crawley and Westland, 
2012). 
Infant formula manufacturers have modified cow’s milk protein (whey based) or first 
milks by adjusting the casein to whey ratio which is similar to breast milk (40:60). Infant 
formula are suitable from birth which can be either 'whey-based' or 'casein-based'. The 
whey-based infant formula may also have a relatively poor mineral content, specifically 
sodium and potassium which are required for new-born babies who have immature 
kidneys.  
In addition, whey-based infant formula are usually the first choice if a mother does not 
breast-feed. While in casein-based infant formula the ratio of casein to whey is the same 
as cows' milk (80:20), casein-based infant formula are normally used if the baby seems 
not to be satisfied on a whey based product. Also, it can be helpful to delay the 
introduction of solids before the recommended age up to 4 to 6 months (Forsythe, 2009). 
Other infant formula are based on soy protein from soya beans which is nutritionally 
similar to cows' milk formula. Soya infant formula is formulated for infants who cannot 
tolerate cows' milk because they have an allergy to the proteins in cow’s milk and/or are 
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unable to digest the lactose in cows' milk. Usually, glucose syrups are used in soya infant 
formulas as a source of carbohydrates. This type of formula is used by parents who wish 
to feed their baby with a vegetarian product (Forsythe, 2009). The compositions of based 
infant formula are given in Table (1.2). 
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Table ‎1.2: The compositions of based infant formula. 
 
Nutrition Whey Casein Soya
Lactose Lactose Glucose syrup
Vegtable oils (contains soya lecituin) Vegtable oils Vegetable oils
skimmed milk skimmed milk _
Demineralised water water _
_ Emulsifier (monoglycerides of fatty 
acids and soya lecithin)
Emulsifler (soya lecithin)
Whey protin concentrate _ Soya protein
Galacto-oligosaccharids (GOS) _ _
Fructo-olgosaccharids (FOS) _ _
Fish oil _ _
Gluconate _ _
Thiamin (B1) Thiamin (B1) Thiamin (B1)
L-carnitine L-cysteine L- carnitine
Niacin (B3) Niacin (B3) Niacin (B3)
Taurine Taurine Taurin
Biotin Biotin Biotin
Folic acid Folic acid Folic acid
Riboflavin (B2) Riboflavin (B2) Riboflavin (B2)
Vitamin A Vitamin A Vitamin A
Vitamin B6 Vitamin B6 Vitamin B6
Vitamin B12 Vitamin B12 Vitamin B12
Vitamin C Vitamin C Vitamin C
Vitamin D3 Vitamin D Vitamin D3
Vitamin E Vitamin E Vitamin E
Vitamin K1 Vitamin K Vitamin K1
Pantothenic acid Pantothenic acid Pantothenic acid
Potassium Chloride Potassium chloride Potassium chloride
Copper Copper sulphate Copper sulphate
Magnesium Carbonate Magnesium Carbonate Magnesium hydrogen phosphate
Zinc sulphate Zinc sulphate Zinc sulphate
Maganese sulphate Manganese sulphate Manganese sulphate
Choline chloride Choline Chloride Choline Chloride
Potassium iodide Potassium iodide Potassium iodide
Sodium selenite Sodium selenite Sodium selenite
Inositol Inositol Inositol
Cytidine -5`-monophosphate Cytidine- 5`-monophosphate _
Guanosine -5`-monophosphate 
disodium salt
Guanosine-5`-monophosphate 
disodium 
_
Uridine -5`-monophosphate disodium 
salt 
Uridine -5`-monophosphate disodium 
_
Adenosine -5`-monophosphate 
disodium salt 
Adenosine -5`-monophosphate 
_
Inosine -5`-monophosphate disodium 
salt 
Inosine -5`-monophosphate disodium  
_
Sodium Chloride Sodium bicarbonate _
Potassium hydroxide Potassium hydroxide _
Calcium Citrate Sodium citrate Sodium Citrate
_ Ferrous sulphate _
Calcium hydroxide _ Calcium Carbonate
Iron lactate _ Iron Sulphate
Calcium Phosphate _ Calcium phosphate
Potassium Citrate _ Potassium citrate
Acid regulator (Citric acid) _ _
Minerals
Ingredients of based infant formula
Major nutrients
Vitamins
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1.8  Conditions and concerns in the NICU 
Premature babies are those born before 37 weeks of gestation (or before the 37th week of 
pregnancy). They are at risk for a variety of problems such as breathing, feeding, 
difficulties or both, and infections. Thus, they need special medical care that only exists 
within NICUs or Special Care Nurseries (SCNs) (American Academy of Pediatrics, 
2014). Furthermore,  for premature infants, feeding by mouth is not safe and sometimes 
not possible because of neurological immaturity or respiratory problems. Milk in such 
infants is usually given through a nasogastric feeding tube. Enteral feeding is generally 
preferred over parenteral nutrition in the ﬁrst few days of life and it helps promote 
endocrine adaptation and the maturation of bowel motility (McGuire et al., 2004). 
The WHO guidelines for hygienic preparation of PIF plan to decrease the number of 
bacteria in the reconstituted product by using hot water for preparation and a short time 
storage for any surviving organisms to grow (Codex Alimentarius Commission, 2008). 
However, a broader perspective is that neonates are frequently fed by using enteral 
feeding tubes. These tubes are commonly placed for long periods of time (more than 
several days) to decrease distress to the neonate by gag reflexes (Holý and Forsythe, 
2014).  
However, Enterobacteriaceae can adhere to and colonize tubes at 37°C receiving fresh 
feeds at regular intervals (Hurrell et al. 2009a). This is related to all neonates with 
inserted nasogastric tubes, and not only for those who are receiving reconstituted PIF. In 
fact, Enterobacteriaceae have been isolated from nasogastric tubes from neonates 
receiving breast milk and other feeding regimes at a rate ≥ 107 cfu/tube (Hurrell et al. 
2009a). Thus, regardless of the type of feed the hygienic practices and avoidance of 
temperature abuse are important and vital (Holý and Forsythe, 2014). 
The recommendation for reconstitution of PIF with hot water (>70°C) by the FAO/WHO 
is not followed in all countries (e.g. USA). To avoid the contamination problems when 
dipping a thermometer into the reconstituted formula, the advice in the UK is to use the 
water that has been boiled in a kettle and left to cool for 30 minutes. With consideration 
of the difference in cooling curves depending on the volume of water and kind of kettle, 
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this is impractical for premature babies who only need small volumes of formula, and are 
fed at 2-hourly intervals.  
The PIF includes breast milk fortifiers which are added to complement the nutritional 
value of breast milk. These products are not reconstituted with water and cannot be 
exposed to heat treatment to kill intrinsic bacteria (Holý and Forsythe, 2014). 
Recently, specific UK national guidelines (under consultation) on the prevention and 
management of Gram-negative sepsis in neonates were developed because of a NICU 
outbreak in the UK (Wise, 2012). 
1.9 Bacterial mechanisms of pathogenicity 
Pathogenic bacteria are able to cause disease in human hosts using a number of 
mechanisms. Bacterial pathogens have numerous molecules that facilitate attachment to 
host cell targets, causing a diversity of different host responses. The molecular 
mechanisms through which bacteria can interact with the host can be unique to specific 
pathogens or conserved across several different species. The identification and 
characterisation of all these different strategies is the key to fighting bacterial diseases. 
This study focuses on mechanisms used by pathogenic bacteria to cause infectious 
disease. 
1.9.1  The interaction of bacteria with mammalian cells 
The colonisation of intestinal bacteria on the surface of intestinal walls is one of the 
basic ways bacteria are able to interact with mammalian cells. The intestinal walls of 
newborn babies are sterile, but are quickly colonised by bacteria entering the body with 
food and from the environment. E. coli is one of the first microorganisms which 
colonises the surface of intestinal walls of newborn babies (Grajek and Olejnik, 2004). 
Nevertheless, the microorganisms on the host epithelium can be affected by diverse 
factors, for instance, nutrition, antibiotic treatment, environmental exposure to 
microorganisms, and microbial colonization in the neonatal period (Lindhorst and 
Oscarson, 2009; Abraham and Medzhitov, 2011).  
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The gastrointestinal tract also has innate defence mechanisms that act against microbial 
survival and dissemination inside the host by washing microbes from surfaces, 
consisting of epithelial integrity, the rapid regeneration of old epithelial cells, fast 
propulsion of infected cells, autophagy, and innate immune responses (Kim et al., 2010). 
However, bacteria can invade epithelial cells and cause infections (Townsend et al., 
2008b; Kim et al., 2010). Besides that, the organisms are able to form biofilms which 
possibly protect cells from environmental stresses and antimicrobial agents (Kim et al., 
2008). 
The preterm babies have a stratum corneum which is immature and thin as compared to 
that found in full term babies, children or adults. The mature stratum corneum consists of 
between 10 and 20 layers of cells, whereas the stratum corneum of preterm babies less 
than 30 weeks may have only 2 to 3 layers, which could increase the chance of invasion 
by harmful microbes (Evans and Rutter, 1986 and Hoeger, 2006). However, many 
diverse bacterial pathogens have the ability to adhere, invade, and cause damage to host 
cells and tissues, in addition to surviving the host defences and causing an infection 
(Wilson et al., 2002). Furthermore, several bacterial pathogens are able to secrete 
various components and toxins to avoid the defences of immune systems (Kim et al., 
2010). To avoid these factors, pathogenic bacteria are also capable of creating an 
antiphagocytic surface layer which consists of polysaccharides or by secreting their 
adhesins on polymeric structures which extend out from the cell surface (Kline et al., 
2009). 
The infection of the human intestine by enteropathogenic bacteria such as E. coli,  
Sal. enterica, Shigella flexneri, and Y. enterocolitica is based on the capability of 
bacteria to adhere, invade and colonize the intestinal epithelium, survive intracellularly 
and be transmitted from cell to cell (Reis and Horn, 2010).Two different strategies are 
used by these bacteria to cause an infection in the host; firstly these bacteria are able to 
resist the host attack through macrophages by releasing the T3SS system proteins. 
Secondly they are able to survive within macrophages because of their ability to induce 
changes within the intracellular environment of the cell (Reis and Horn, 2010; 
Sansonetti, 2002). 
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Bacteria can interact with the host cells in two ways: attachment to the host cell without 
any modification to the membrane or by using the surface appendages such as microvilli 
(Greiffenberg et al., 2000). In Gram-negative bacteria, the outer membrane is an 
important factor which helps in the attachment of the bacteria with the external 
environment (Mogensen and Otzen, 2005). 
  Adhesion to mammalian cells 1.9.1.1
The expression of adhesive molecules on the surfaces of bacteria is an essential virulence 
factor. Most bacterial pathogens use adhesion to facilitate their interaction with host 
tissue cells. These surfaces include skin, mucous membranes, such as oral cavity, 
nasopharynx, urogenital tract, and deeper tissues; lymphoid tissue, gastric and intestinal 
epithelia, alveolar lining, endothelial tissue. The host acts to wash microbes from these 
surfaces by producing various mechanical forces, such as saliva secretion, coughing, 
sneezing, mucous flow, peristalsis, and blood flow (Wilson et al., 2002).  
Microbial adherence factors can be produced from polypeptides (proteins) or 
polysaccharides (carbohydrates or sugars) which form the capsule. Protein adhesins are 
divided into two categories: fimbrial and afimbrial. Fimbriae (pili) are appendages that 
protrude from the bacterial surface and consist of proteins that are tightly packed into an 
array as a helical cylinder. In particular, Gram-negative bacterial pathogens depend  
on fimbriae for adherence such as E. coli (for both urinary tract infections and 
gastroenteritis), Vibrio cholerae, Pseudomonas aeruginosa, and Neisseria species 
(Donnenberg, 2000; Hahn, 1997). 
In afimbrial adhesins made of proteins that are known as adherence factors, the contact 
of afimbrial adhesins with the host cell is more intimate and occur over a shorter domain 
than with fimbriae. Gram-negative (Y. pseudotuberculosis, enteropathogenic E coli, 
Neisseria spp.), Gram-positive (Staphylococcus spp. and Streptococcus spp.) and 
mycobacterial pathogens express afimbrial adhesins (Donnenberg, 2000; Merz and So, 
2000; Joh et al., 1999; Bermudez and Sangari, 2000). The interactions between bacterial 
and the mucosa host such as adherence and invasion are commonly the cause of bacterial 
disease in the gut (Hu and Kopecko, 2008). 
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  Invading mammalian cells 1.9.1.2
Adhesion of bacteria to host surfaces is the first step in the pathogenesis of most 
infections in man and animals. Some pathogens have deeper access into the host to 
continue the infection cycle. This pathogenic strategy can be divided into two categories: 
extracellular and intracellular (Wilson et al., 2002). 
Extracellular invasion happens when a microbe breaks down the barriers of a tissue to 
distribute enzymes inside the host and the microbe remains outside of host cells. This is 
a strategy used by several pathogenic bacteria such as group A β-haemolytic 
Streptococcus and St. aureus which produce toxins such as haemolysin (Walker, 1998). 
Haemolysin are divided into three different types, α-hemolysin, β-hemolysin and γ-
hemolysin.  Clinical isolates, such as E. coli and Serratia spp. are able to secrete α-
hemolysin (König et al., 1987; Welch, 1987; Schmidt et al., 1995). The haemolysins 
expressed by these species have the capability to destruct cells however, other cell types 
may also contribute to their spread in host tissues (Wilson et al., 2002). 
The ability of microbes to penetrate the cells of a host tissue and survive within this 
situation is known as intracellular invasion. Numerous Gram-negative, Gram-positive, 
and mycobacterial pathogens have the capability to invade host cells (Finlay and Falkow, 
1997; Cleary and Cue, 2000; Bermudez and Sangari, 2000; Dehio et al., 2000). 
Cronobacter strains have the ability to attach and invade Caco-2 human epithelial cells, 
and invade rat brain capillary endothelial cells (Townsend et al., 2008b). 
  Intracellular lifestyles 1.9.1.3
After invasion, many bacterial pathogens have the ability to survive and replicate within 
host cells which survive invasion such as epithelial, endothelial and macrophages. The 
host cells have mechanisms to damage ingested bacteria which include the creation of 
reactive oxidative intermediates, the decrease of pH vacuoles that contain bacteria, and 
the activation of destruction proteases. However, bacteria have the ability to avoid these 
killing mechanisms, such as survival in low acidity (Wilson et al., 2002). For example, 
Adherent-invasive E. coli (AIEC) isolated from Crohn's disease patients was able to 
replicate within macrophages in large vacuoles (Bringer et al., 2006). Bacteria that 
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survive intracellularly are possibly able to replicate and transmit between cells in the 
same area of infection or transfer to other areas of the body (Wilson et al., 2002). 
1.10 Biofilm formation 
The biofilm was defined as "an assemblage of microbial cells that adhere to abiotic or 
biotic surfaces. Also, biofilm known as irreversibly associated (not removed by gentle 
rinsing) with a surface and enclosed in a matrix of primarily polysaccharide material" 
(Donlan, 2002; Davey and O’Toole  2000). In Gram-negative bacteria, several of the 
polysaccharides are neutral or polyanionic. The existence of ketal-linked pyruvates or 
uronic acids enhances their anionic properties, thus it allows association of divalent 
cations such as calcium and magnesium to increase the binding force in a developed 
biofilm (Donlan, 2002; Sutherland, 2001a). 
Biofilm protect microorganisms from shear forces and low pH environments such as in 
the stomach. Inside the host, biofilm gives microorganisms a competitive advantage due 
to its protects biofilm bacteria from exposure to innate immune defences (such as 
opsonization and phagocytosis) and antibiotic treatments antibiotics (Scher et al., 2005). 
The process of biofilm formation is characterized by several stages that have been 
identified include  in Figure 1.2. 
The adhesion surface is pre-conditioned by the macromolecules which are present in the 
bulk liquid, 2. The planktonic cells in the bulk liquid are transferred to the surface, 3. 
Cells are adsorbed on the surface, 4. Those cells which are adsorbed reversibly are 
described, 5. Some bacterial cells adsorb irreversibly on the surface, 6. Cell-cell 
signalling molecules are produced, 7. Transfer of substrate to and within the biofilm, 8. 
Cells bound to the biofilm metabolise the substrate and transfer the products out of the 
biofilm, 9. All of these processes occur in parallel with EPS production, replication and 
cell growth (Simo˜es et al., 2010). 
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Adapted from (Simo˜es et al., 2010). 
Figure ‎1.2: The processes governing biofilm formation. 
The attachment of bacteria will occur most readily on surfaces that are rougher, more 
hydrophobic, and coated by surface conditioning films (Chae et al., 2006; Donlan, 2002; 
Millsap et al.,1997; Oulahal et al., 2008; Patel et al., 2007; Simo˜es et al., 2008). The 
ability of bacteria to form biofilm is related to properties of the cell surface, particularly 
the presence of extracellular appendages, the interactions involved in cell–cell 
communication and EPS production are important for biofilm formation and 
development (Allison, 2003; Davies et al., 1998; Donlan, 2002; Parsek and Greenberg, 
2005; Sauer and Camper, 2001). The appendages are allowing bacterial to attach the 
surfaces and make the biofilm more resistant to environmental stress. The biological 
aspects regulating biofilm formation, which will be covered in the following sections: 
1.10.1 Specialized attachment structures/surface properties of the cell  
The presence of extracellular filamentous appendages and cell surface hydrophobicity 
may affect the rate and the extent of microbial attachment. The hydrophobicity of the 
cell surface is important in adhesion since hydrophobic interactions lead to a rise with an 
increasing non-polar nature of one or both surfaces involved, i.e., the bacterial cell and 
the adhesion surface (Donlan, 2002). According to Drenkard and Ausubel (2002), the 
ability of bacteria to attach to another bacteria and to surfaces is based partly on the 
interaction of hydrophobic domains.  
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Numerous cells are able to produce extracellular filamentous appendages, which may 
play a role in the attachment process. In fact, many of such structures are known to 
present – flagella, pili or fimbriae, prothecae, stalks and hold-fast (Harbron and Kent, 
1988). 
Flagella are responsible for the motility of bacteria. Numerous types of bacteria have 
flagella. It is probable that the flagellum itself may form an adhesive bond with the 
adhesion surface (Harbron and Kent, 1988). 
The primary function of flagella in biofilm formation is supposed to be in transport and 
in initial cell–surface interactions (Sauer and Camper, 2001). Flagella-mediated motility 
is assumed to overcome repulsive forces at the surface of the substratum and, as a result, 
a monolayer of cells forms on the adhesion surface (Daniels et al., 2004). 
Pili or fimbriae are found on several Gram-negative bacteria including Pseudomonas 
species. They are fine, filamentous appendages ranging in width from 4–35 nm and in 
length up to several micrometers (Harbron and Kent, 1988). These two structures are 
usually straight, and are not involved in motility. Their function is only known to make 
cells more adhesive, because bacteria with pili can adhere strongly to other bacterial 
cells and inorganic particles (Harbron and Kent, 1988). According to Sauer and Camper 
(2001), pili and pilus-associated structures have been appeared to be significant for the 
adhesion to and colonization of surfaces, possibly by overcoming the initial electrostatic 
repulsion barrier that are present between the cell and the substratum. 
The expression of fimbria is variable between pathogenic and environmental isolates. 
(Gerstel and Römling 2001) establish that phosphate and nitrogen depletion are signals 
which able to switch on the agfD promoters in the stationary phase in Salmonella 
typhimurium. Fimbria expression has been correlated with strain pathogenicity. It was 
discovered in 100% of E. coli responsible for sudden infant death syndrome, and also 55% 
of bovine mastitis isolates, and 38% of E. coli non O157 STEC (Olsén et al., 1989; 
Goldwater and Bettelheim, 2002; Cookson et al., 2002). Zogaj and researchers detected 
the production and genes responsible for cellulose and fimbria using Citrobacter spp. 
Enterobacter species and Klebsiella species. Their results also display that Citrobacter 
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species are capable to produce curli fibers but Enterobacter and Klebsiella species are 
unable to do. On the other hand, they discovered that genes responsible for curli fibers 
production were existent in Citrobacter species and Enterobacter species but not in 
Klebsiella species (Zogaj et al., 2003). Ten fimbrial related genes were present in all C. 
sakazakii and 38% of C. malonaticus, but were absent in other Cronobacter species 
(Healy et al., 2009).  
A number of genes have been detected as requirements for the formation of curli fibers. 
The previous study by Zogaj et al (2003) has isolated csg genes from some species 
belong to Enterobacteriaceae such as Citrobacter, Cronobacter and Klebsiella spp. 
Furthermore, Sakellaris et al. (2000) isolated them from Shigella spp. The expression of 
csg genes is not only associated with curli expression but they are connected also with 
bacterial resistance to environmental factors such as desiccation. The csg genes were 
detected in strains which were unable to express curli fimbria; also not all Salmonella 
strains and E. coli are capable to express curli fimbria even under suitable environmental 
conditions (Zogaj et al., 2003). 
 The essential regulator of csgBAC is possibly the transcriptional regulator csgD. The 
increase of biofilm formation, invasion and bacterial virulence factors have been 
associated with the rise of csgD gene activity, being strongly controlled with genetic and 
environmental factors (Uhlich et al., 2002). It has been determined that csgD operon is 
being influenced by regulators that are grouped as csgDEFG and csgBA as divergent 
operons (Hammar et al., 1995). Gualdi and researchers (2008) found that overexpression 
of csgD can overcome temperature dependent control of curli encoding csgBA operon 
1.10.2  Extracellular polymeric substances (EPS) 
EPS are responsible to bind cells and other particulate materials together (cohesion) and 
to the surface (adhesion) (Allison, 2003; Sutherland, 2001b). The EPS comprises of 
polysaccharides, proteins, nucleic acids, lipids, phospholipids and humic substances 
(Jahn and Nielsen, 1998; Sutherland, 2001b; Wingender et al., 1999). Proteins and 
polysaccharides amount for 75–89% of the biofilm EPS composition, indicating that 
they are the predominant components (Tsuneda et al., 2003).  
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Biofilms form a gel phase around microorganisms which live inside it (Sutherland, 
2001a; Wingender et al., 1999). The EPS matrix functions as a barrier in which diffusive 
transport prevails over convective transport (Sutherland, 2001b). EPS has general 
protective effect on biofilm forming microorganisms against adverse conditions, for 
example, it has frequently been shown that biofilm cells can tolerate high concentrations 
of biocides (Mah and O’Toole, 200 ; Simo˜es and Vieira, 200 ; Simo˜es et al., 2005). 
The EPS matrix acts to delay or prevent antimicrobials from reaching target bacteria 
within the biofilm by diffusion limitation and/or chemical interaction with the 
extracellular proteins and polysaccharides (Heinzel,    8; Mah and O’Toole, 200 ). 
Furthermore, inside the EPS matrix the molecules necessary for cell–cell communication 
and community behaviour may accumulate at concentrations high enough to be effective 
(Pearson et al., 1999; Sutherland, 2001b). 
Lipids and nucleic acids might have important effect on the rheological properties and 
thus the stability of biofilms (Neu, 1996). The extracellular DNA is required for the 
initial formation of biofilms by Pseudomonas aeruginosa and probably for biofilms 
formed by other bacteria that specifically release DNA (Whitchurch et al., 2002). 
Colonic acid and cellulose are essential EPS components to form biofilm and have a 
similar influence on bacterial attachment to mammalian cells. Matthysse et al. (2008) 
reported that the ability of E. coli O157:H7 to attach to plastic surfaces as well as alfalfa 
sprouts and Caco-2 cell lines based on EPS. They used E. coli O157:H7 with deletions of 
pgaC, yhjN and wcaD the genes encoding for poly-ß-1,6-N-acetylglucosamine, cellulose 
and colonic acid respectively. Their result reported that the attachment of E. coli 
O157:H7 to alfalfa sprouts was blocked in the pgac mutant; the attachment was 
decreased 100 and 10 fold compared to the wild type strain for yhjN mutants and was 
reduced 1,000 and 100 fold for wcaD mutants. The attachment to Caco-2 cell line was 
significantly reduced for pgaC and yhjN mutants but not for wcaD mutant. The E. coli 
O157:H7 strains were not capable to form significant biofilm on PVC in LB agar. 
Mutation in the polysaccharides genes pgaC, wacaD and yhjO were capable to form 
third of the amount of biofilm compared to the wild type (Matthysse et al., 2008). 
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1.10.3 Cell–cell communication 
Cell–cell signalling plays an important role in cell attachment and detachment from 
biofilms (Daniels et al., 2004; Donlan, 2002). Bacteria are considered to be colonial by 
nature and exploit elaborate systems of intercellular interactions and communications to 
enable their adaptation to altering environments (Davies et al., 1998; Fuqua and 
Greenberg, 2002; Sauer and Camper, 2001). Accordingly to Daniels et al. 2004 the 
successful adaptation of bacteria to changing natural conditions is based on their 
capability to sense and respond to the external environment and modify gene expression.  
Quorum sensing is a process of cell–cell communication that based on the process of 
autoinduction (Eberhard et al., 1981). The process of quorum sensing acts to provide a 
mechanism for self-organization and regulation of microbial cells (Parsek and Greenberg, 
2005). It includes an environmental sensing system that allows bacteria to monitor and 
respond to their behaviour according to population density. 
1.11 Siderophores 
Bacterial pathogens require iron for survival and a diverse range of metabolic processes 
including amino acid synthesis, oxygen transport, respiration, nitrogen fixation, 
methanogenesis, the citric acid cycle and DNA biosynthesis (Sandy and Butler, 2009). 
The iron in human cells is very low and is bound by lactoferrin, transferrin, and ferritin 
(Brooks et al., 2004). Pathogenic bacteria synthesize and secrete small organic 
molecules called siderophores, which are low-molecular-weight chelators that solubilize 
and acquire iron from eukaryotic iron-binding proteins such as lactoferrin and transferrin 
(Ratledge and Dover, 2001). Thus, siderophores are considered as major virulence 
factors in the pathogenicity of organisms (Eijkelkamp et al., 2011).  
The majority of aerobic and facultative anaerobic microorganisms produce at least one 
siderophore (Neil, 1995). So far nearly 500 siderophores have been found from selected 
microorganisms and several important siderophores produced by bacteria are presented 
in Table 1.3 (Balagurunathan and Radhakrishnan, 2007). 
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  Table ‎1.3: The important siderophores produced by bacteria. 
Organisms Siderophores 
A. calcoacaticus Acinetobactin 
Ae. aerogenes Aerobacin 
Aer. hydrophila Amonabsactin 
E. coli Enterobactin 
Klebsiella spp. Aerobactin 
My. tuberculosis Mycobactin 
Salmonella Aerobactin 
St. aureus Aureochelin 
P. aeruginosa Pyoverdin and pyochelin 
V. cholerae Vibriobactin 
Y. pestis Yersniabactin 
          
Yersiniabactin is part of  an iron-uptake system discovered in several species of the 
family Enterobacteriaceae (Bach et al., 2000; Schubert et al., 2000) and was first 
described in Yersinia spp., where the genes are located on a high-pathogenicity island 
(HPI) (Carniel, 2002). Several previous studies have reported that Yersinia spp., E. coli 
and possible K. pneumoniae strains having the HPI are more virulent than strains lacking 
this island (Bearden et al., 1997; Carniel et al., 1992; Lin et al., 2008). 
There are many  studies that have demonstrated that pathogenic strains of Yersinia;  
Y. pestis (Fetherston et al., 1992),  Y. pseudotuberculosis (Buchrieser et al.,1998) and  
Y. enterocolitica (Carniel et al., 1996)  carry a pathogenicity island known as the HPI 
(Carniel et al., 1996) for the reason that its existence is essential for the expression of a 
high-virulence phenotype. The HPI of Y. pestis is known as the pgm locus, which 
consists of about 102 kb of chromosomal DNA and comprises the irp1 and irp2 and fyuA 
or psn genes included in iron storage and uptake the hemein storage (hms) locus (Perry 
et al., 1990), see Figure 1.3 . 
The irp1 and irp2 genes code for the two iron-repressible high-molecular-weight 
proteins HMWP1 and HMWP2, which apparently are involved in the production of 
yersiniabactin (Lucier et al., 1996); and the fyuA or psn gene  plays a significant role for 
ferric yersiniabactin uptake or pesticin sensitivity as it serves as coding for the 
yersiniabactin receptor. FyuA also acts as a receptor for pesticin (Carniel et al., 1992; 
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Carniel et al., 1989;  Heesemann et al., 1993; Rakin et al., 1994). HMWP1 and HMWP2 
are found only in pathogenic strains of Yersinia and are associated with virulence 
(Carniel et al., 1987 and 1989). 
In the Netherlands, a nationwide outbreak was caused by multidrug resistance  
Ent. hormaechei outbreaks (EHOS). These organisms appeared to possess mechanisms 
to acquire iron from their environment by producing yersniabactin which were found on 
the HPI. The HPI was transferred to other Enterobacter spp. in vivo which possibly 
played a role in the epidemic behaviour (EHOS) (Paauw, 2008b).   
 
Adapted from (Tang et al., 2014) 
 
Figure  1.3: Genetic and structure organization of the high pathogenicity island of Y. 
enterocolitica. 
 
1.12 Diversity of antibiotics resistance in Enterobacteriaceae 
Over the past several decades, the widespread use of antibiotics has led to the appearance 
of antibiotic resistant strains of many bacteria which then become a serious clinical and 
public health problem (Wilson et al., 2002). Antibiotic resistance among nosocomial 
pathogens is a cause of concern (Wood et al., 1996; Goldmann et al., 1996). Gram-
negative and Gram-positive bacteria have acquired resistance to many types of 
antimicrobial drugs (Wilson et al., 2002). Many antibiotic resistant bacterial strains have 
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acquired multidrug resistance, which represents a cause for significant concern, 
including diarrhoeal pathogens, for example, Shigella, Salmonella, E. coli, and 
Enterococcus faecium; respiratory pathogens such as K. pneumoniae and P. aeruginosa; 
urinary tract pathogens like E. coli, and M. tuberculosis, which remains the leading cause 
of death from a single infectious disease worldwide (Mazel and Davies, 1999; Wood et 
al., 1996). 
Enterobacteriaceae with E. coli are by far the most important pathogens for humans and 
have been known as the most common source of community and hospital-acquired 
infections. They have the facility to spread easily among humans by hand carriage and 
contaminated food and water and have the ability to acquire genetic material by 
horizontal gene transfer, mediated mostly by plasmids and transposons (Partridge, 2011; 
Stokes and Gillings, 2011; Toleman and Walsh, 2011). For these reasons, the emerging 
multidrug resistance in Enterobacteriaceae is of most importance for clinical therapy. 
The β-lactams are different antibiotic molecules that are composed of four groups: 
penicillins, cephalosporins, monobactam, and carbapenems, according to their chemical 
structures. The latest developed molecules that have the broadest spectrum of activity are 
carbapenems (imipenem, ertapenem, meropenem, and doripenem) (Nordmann et al., 
2012). Multidrug-resistant Enterobacteriaceae produce ESBLs which are the most 
important contributing factor to β-lactam resistance (Livermore, 2003). β-lactamases are 
enzymes produced by bacteria that act to inactivate β-lactam antibiotics by hydrolysis. 
These enzymes are divided into four groups based on their activity profile as shown in 
Table 1.4 (Nordmann et al., 2012). 
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Table ‎1.4: Diversity of β-lactam resistance in Enterobacteriaceae. 
 
The ESBLs are β-lactamases which have the capability to hydrolyse and cause resistance 
to different types of the β-lactam antibiotics, such as the expanded-spectrum (or third-
generation) cephalosporins and monobactams, but not the cephamycins and carbapenems 
(Bradford, 2001). Bacteria that are able to produce ESBLs are still an important reason 
for therapy failure with cephalosporins and have serious effects on infection control 
(Paterson and Bonomo, 2005). 
The majority of ESBLs have been divided into three groups: TEM, SHV, and CTX-M 
types (Paterson and Bonomo, 2005). Members of the family Enterobacteriaceae  
are most commonly express plasmid-encoded β-lactamases such as TEM-1, TEM-2,  
and SHV-1  that confer resistance to penicillins but not to expanded-spectrum 
cephalosporins (Leverstein-van Hall et al., 2002). The majority of ESBL-producing 
organisms isolated worldwide are K. pneumoniae and E. coli, but these enzymes have 
also been discovered in many other members of the Enterobacteriaceae family and, in 
particular, non-fermentors (Jacoby and Munoz-Price, 2005).  
The Infectious Diseases Society of America reported that ESBL-producing Klebsiella 
spp. and E.coli are together one of the six drug-resistant microbes against which new 
therapies are urgently needed (Talbot et al., 2006). ESBLs have continued to increase in 
diversity and spread and are now a global health concern (Serefhanoglu et al., 2009; 
Martinez et al., 2012; Lautenbach et al., 2001). A recent trend is the emergence of 
inactivate no affect
Penicillinases penicillins
cephalosporins, aztreonam, or 
carbapenems
Cephalosporinases 
cephalosporins and 
aminopenicillins
other penicillins (carboxy- and 
ureido-penicillins), aztreonam, 
and carbapenems
Extended-spectrum β-
lactamases (ESβLs)
all β-lactams carbapenems 
Carbapenemases 
carbapenems and may also 
deactivate other types of β-
lactam molecules, 
depending on the enzyme
-
enzyme‎of‎β-
lactamases
β-lactam‎antibiotics
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community-onset bloodstream infections caused by ESBL-producing bacteria, 
particularly CTX-M producing E. coli. These infections are now rare, but it is possible 
that, in the near future  possible  the clinicians will be regularly confronted with hospital 
varieties of bacteria causing infections in patients from the community (Thenmozhi et al., 
2014). 
Mostly phenotypic methods are used in clinical diagnostic laboratories because these 
tests are easy to do, are cost effective, and have been included in most automated 
sensitivity systems, making them widely accessible (Wiegand et al., 2007). However, 
phenotypic techniques are not able to differentiate between the specific enzymes 
responsible for ESBL production types (SHV, TEM, and CTX-M). Numerous research 
or reference laboratories are using genotypic methods to identify the specific gene 
responsible for the production of the ESBL (Woodford and Sundsfjord, 2005). 
Since 2000, many surveys from different European countries, including Spain 
(Rodríguez-Baño et al., 2004), Italy (Mugnaioli et al., 2006), Greece (Pournaras et al., 
2004), the UK (Woodford et al., 2004) and Canada (Pitout et al., 2007) have reported an 
alarming increase in resistance of bacteria to other classes of antimicrobial agents 
between ESBL-producing bacteria isolated from community sites. These surveys 
exhibited co-resistance to co-trimoxazole, tetracycline, gentamicin, and ciprofloxacin. 
For example, in Canada more than 66% of isolates were resistant to ciprofloxacin (Pitout 
et al., 2007). These studies also presented that strains producing CTX-M enzymes were 
significantly more resistant to ciprofloxacin than strains missing polymerase chain 
reaction (PCR) evidence for blaCTX-M genes (Pitout et al., 2007; Pitout et al., 2004). 
Hurrell et al. (2009b) determined the antibiograms for the Enterobacteriaceae strains 
isolated from EFT in NICU and they found that all the S. marcescens strains were 
resistant to amoxillin and co-amoxiclav. Also, a quarter of Ent. hormaechei isolates were 
resistant to the 3
rd
 generation cephalosporins, ceftazidime and cefotaxime. During the 
study period K. pneumoniae and S. marcescens caused infections in the two NICUs. In 
addition, ESBLs were discovered in three of these strains (Hurrell et al., 2009b). 
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The infant intestinal flora is influenced by the feeding regime. Enterobacteriaceae are 
present in neonatal nasogastric enteral feeding tubes in NICU, but there is no study 
determined the risk of these strains.  This study focuses on assessing the risk to neonates 
from opportunistic bacterial pathogens  (Enterobacteriaceae) which have been isolated 
from two sources; human mastic breast milk and also neonatal nasogastric enteral 
feeding tubes. The overall purpose of the current study was to evaluate the risk to 
neonates posed by ingestion of specified Enterobacteriaceae either from contaminated 
milk or from infant formula.  
1.13 Objectives 
The initial studies used PFGE to genetically fingerprint the strains isolated from the 
NICUs by other researchers. This was determined by the prevalence and persistence of 
particular Enterobacteriaceae species, for example, whether certain strains persist in the 
NICUs, and verified whether they colonise the tubes of unrelated neonates over 
prolonged periods of time.  The second part of the project was to focus on the virulence 
potential of K. oxytoca, Ent. hormaechei and Ent. ludwigii.  
To extend the earlier studies by Hurrell et al. (2009a and b) of Enterobacteriaceae from 
EFT, additional strains from mastic breast milk (MBM) were included. These were 
obtained from a study by Delgado et al. (2008). Klebsiella strains have been selected as 
they are both a common cause of neonatal infections and were frequently isolated from 
the EFT. An additional reason is that when Delgado et al. (2008) examined the bacterial 
diversity of MBM, they isolated a number of Klebsiella strains, and these have been 
made available to us for comparative studies.  Despite common expectation, breast milk 
is not sterile and can contain a range of bacteria.  
There was additional merit for a study to include Klebsiella as it has been isolated from 
similar sources from two separate countries (UK and Spain) and this has considerable 
comparative value. The second organism of interest, Ent. hormaechei, was isolated from 
both the previous Nottingham NICU studies of Hurrell et al. (2009b). This organism had 
come to our attention through a series of semi-related studies, as follows: 
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1. Dr Stacy Townsend (former NTU post-doctoral researcher) acquired ‘Cronobacter’ 
strains from a hospital for further analysis.  Further studies using PFGE revealed that 
they were clonal, and were from a NICU outbreak which the hospital was not aware of.  
Subsequent 16S rDNA sequencing reidentified the strains as Ent. hormaechei 
(Townsend et al., 2008a). Hence, the hospital had not only not recognised an outbreak 
but had also misidentified the organisms. 
2. NTU acquired a quinolone resistant ‘Cronobacter’ from Poirel et al. (2007) as it is an 
unusual trait for the organism. However, 16S rDNA sequencing showed the strain was 
Ent. hormaechei and this indicates the difficulty in treatment of infections due to this 
organism as well as its identification in the clinical setting.   
3. Muytjens et al. (1988) highlighted the incidence of Cronobacter spp. in powdered 
infant formula. This paper has been highly cited to date as a key primary study on the 
topic. However, the strains were identified in 1988 using biochemical profiling, whereas 
NTU used 16S rDNA sequence analysis to reidentify the strains, some of which were 
Ent. hormaechei (Townsend et al., 2008a). Hence, this indicates powdered formula as a 
source of neonate exposure. 
4. Enterobacteriaceae isolates from EFT from QMC and NCH hospitals included  
Ent. hormaechei (Hurrell et al., 2009b).  Many of these strains were resistant to the 3
rd
 
generation cephalosporins, ceftazidime and cefotaxime, and ESBLs were detected. This 
demonstrates that neonates are directly exposed to antibiotic resistant strains in NICUs 
during feeding. 
5. Comparative bacterial death rates of Enterobacteriaceae revealed that the  
Ent. hormaechei strain isolated from neonatal enteral feeding tube (4 above) was more 
heat resistant than Sal. Seftenberg. This later organism is normally recognised as the 
most heat resistant Enterobacteriaceae and heat treatment processes in industry use this 
later organism to ensure their processes are efficient (Forsythe; FSA report 2009).  This 
shows that the organism has a greater chance of surviving during the reconstitution of 
infant formula than other organisms, and that procedures may need to be modified to 
take this into account. 
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In addition to Ent. ludwigii obtained from a study by Delgado et al. (2008), we also 
received Ent. ludwigii strain (NTU1439) from Nottingham QMC hospital that was 
isolated from a case of neonatal meningitis. This organism was included in the project as 
it reinforced the importance of evaluating the risk of neonatal infection by Ent. ludwigii. 
Ent. aerogenes and Ent. cloacae were not included in this study because, at the time this 
study was initiated, these strains were considered as K. oxytoca. However, later we 
identified these strains as Ent. aerogenes and Ent. cloacae using 16S rDNA sequence 
analysis.  
This study compares the physiological and virulence traits between bacterial species 
which neonates are exposed to from MBM and EFT. Only a limited comparison was 
made according to the source of strains. However, this was not possible for Ent. ludwigii 
and Ent. hormaechei as these were not isolated from MBM and EFT respectively. 
Finally, K. pneumoniae strains obtained from Jordan which have been isolated from EFT 
were also analysed, but only for PFGE profile due to time constraints.  
1.14  Project Aims 
In particular, the specific aims are: 
1. Characterise Ent. ludwigii, Ent. hormaechei and Klebsiella spp. strains according to 
standard phenotyping methods and compare with genotyping. 
2. Determine physiological attributes of the strains with respect to heat tolerance, biofilm 
formation, cell capsule production and acidic pH survival (pH 3.5).  
3. Determine the virulence potential of strains isolated from MBM and EFT using tissue 
culture technique and by identifying the presence of virulence factors. 
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2.1 GENERAL MATERIALS 
2.1.1  Bacterial strains 
A total of 228 strains of Enterobacteriaceae from different sources were used in this 
study. One hundred thirty-three strains had been isolated from neonatal EFT from two 
local Nottingham hospitals (QMC and NCH), (Table 2.1- 2.3) and reported in a previous 
Nottingham NICU study by Hurrell et al. (2009b). Twenty strains had been isolated from 
MBM by the lactation consultants at different primary health-care centres in Spain 
(Delgado et al., 2008) (Table 2.4). Seventy five EFT and flushed milk isolates of K. 
pneumoniae from Jordan were also analysed, but only for PFGE profile due to time 
constraints (Table 2.5 part 1 and 2). 
 
The following studies were carried out on the three sets of strains: 
 Initial experiments used strains from two different sources, EFT and MBM, to 
determine their relatedness by using PFGE technique (Tables 2.1-2.4). PFGE 
subtyping of EFT isolates from QMC and NCH was by Alkeskas in our research 
group as part of his PhD project (Table 2.1- 2.3). 
 Further experiments used strains from MBM (Table 2.4) and EFT isolates from 
QMC and NCH (Table 2.6). These strains were used to determine their 
physiological traits, such as heat tolerance, biofilm formation, capsule formation 
and acid tolerance at pH 3.5. In addition, these organisms were used to 
investigate their ability to attach and invade Caco-2 cell line. 
 Twenty three strains were chosen for virulence factors determination, as shown 
in (Table 2.7). This part of the project focused on the virulence potential of  
Ent. ludwigii, Ent. hormaechei, Ent. cloacae, Ent. aerogenes and K. oxytoca 
isolated from two different sources. 
 Ent. hormaechei, and Ent. ludwigii strains from the MBM and EFT isolates 
(QMC and NCH) collection were used for determining attachment and invasion 
HBMEC and rBCEC4 cell lines (Table 2.8). 
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      Table ‎2.1: Description of Ent. hormaechei and Ent. aerogenes strains isolated  
from enteral feeding tubes at neonatal intensive care units in Nottingham. 
  
NCH indicates Nottingham City Hospital and QMC indicates Queen’s Medical Centre. 
 
 
 
Species Strain number Date of isolation Source Neonate
Ent. cloacae 779 2
Ent.hormaechei 790 4
Ent. cloacae 789 23/01/2007 12
" 795 17
" 797 17
" 798 18
" 799 18
" 800 19
" 801 20
" 802 21
" 803 22
" 979 36
" 980 36
" 981 36
" 983 36
" 986 36
" 987 36
" 993 36
" 997 36
" 856 50
" 859 51
" 860 52
" 861 52
" 862 52
" 863 52
" 960 23/05/2007 83
Ent. cloacae 1028 108
Ent.hormaechei 1044 115
" 1052 117
" 1033 110
" 1034 110
" 1035 110
" 1074 117
" 1032 110
" 1053 117
" 1075 117
" 1027 108
Ent. aerogenes 1058 118
" 1056 119
Ent.hormaechei 1038 113
" 1039 113
" 1040 113
" 1066 126
" 1067 126
" 1081 126
" 1084 126
" 1068 128
" 1069 128
" 1089 128
16/01/2007
NCH
17/04/2007
16/02/2007
30/01/2007
16/10/2007
22/10/2007
12/11/2007
QMC
19/11/2007
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     Table ‎2.2: Description of Ent. cancerogenus strains isolated from enteral feeding    
tubes at neonatal intensive care units in Nottingham. 
 
           NCH indicates Nottingham City Hospital and QMC indicates Queen’s Medical Centre. 
Species Strain number Date of isolation Source Neonate
Ent. cancerogenus 782 7
" 783 8
" 781 17/01/2007 6
" 784 23/01/2007 9
" 806 24
" 807 24
" 808 24
" 810 26
" 814 27
" 815 27
" 816 27
" 817 27
" 818 13/02/2007 28
" 824 36
" 982 36
" 985 36
" 988 36
" 989 36
" 992 36
" 994 36
" 996 36
" 998 36
" 990 37
" 991 37
" 825 37
" 826 37
" 827 33
" 828 33
" 829 33
" 831 33
" 834 35
" 957 81
" 966 86
" 969 87
" 972 87
" 842 20/03/2007 42
" 845 45
" 847 45
" 848 48
" 850 48
" 851 48
" 907 58
" 908 58
" 909 58
" 1059 119
" 1071 108
" 1037 112
" 1042 128
" 1054 118
" 1077 31/10/2007 120
" 1088 19/11/2007 120
NCH
20/02/2007
16/10/2007
QMC
22/10/2007
06/02/2007
16/02/2007
11/02/2007
17/02/2007
16/01/2007
24/04/2007
10/04/2007
02/04/2007
22/05/2007
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Table ‎2.3: Description of Klebsiella spp. strains isolated from enteral feeding tubes at 
neonatal intensive care units in Nottingham.  
 
                 NCH indicates Nottingham City Hospital and QMC indicates Queen’s Medical Centre. 
 
Species Strain number Date of isolation Source Neonate
K. pneumoniae 778 1
" 785 9
" 787 10
" 788 11
" 792 13
" 794 14
K. oxytoca 832 36
" 833 36
" 830 20/02/2007 33
K. pneumoniae 839 39
" 841 39
" 976 89
" 977 89
" 999 94
" 1004 94
" 1006 94
" 1000 95
" 1002 95
" 1005 95
" 1001 96
" 1003 96
" 1012 103
" 1013 103
" 1014 103
K. pneumoniae 1046 116
" 1048 116
" 1049 116
K. oxytoca 1078 120
" 1079 121
K. pneumoniae 1090 129
" 1091 129
" 1092 129
" 1093 129
16/02/2007
05/06/2007
30/05/2007
28/02/2007
19/11/2007
22/10/2007
31/10/2007
12/06/2007
QMC
23/01/2007
NCH
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Table ‎2.4: Description of strains isolated from Spain from MBM. All strains in this table 
were used for the characterisation and identiﬁcation of bacterial isolates; chapter 3 and 
determining physiological traits; chapter 4. 
 
HCM indicates Hospital Clinico of Madrid and MBM indicates mastic human breast milk. 
 
 
 
 
 
 
 
 
 
Species Strain Location Source of isolation
Ent. ludwigii 1349 HCM MBM
" 1351 " "
" 1352 " "
" 1348 " "
" 1366 " "
Ent. cancerogenus 1350 HCM MBM
" 1357 " "
" 1358 " "
" 1359 " "
" 1360 " "
" 1361 " "
" 1362 " "
" 1363 " "
" 1364 " "
" 1365 " "
" 1367 " "
" 1355 " "
K. oxytoca 1353 HCM MBM
" 1354 " "
" 1356 " "
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Table ‎2.5: Description of K. pneumoniae strains isolated from neonatal EFT used in 
Jordan, part 1. 
 
PRH indicates Princesses Rahma Hospital, KAH indicates King Abdulla Hospital and the letters or numbers after the 
abbreviations (KAH or PRH) are indicating code of infant information. Flushed milk indicates lumen liquid from 
enteral feeding tube. 
 
Species Strains Location Source of isolates  Feeding regime Age of infant Neonatal Number Date of isolation
K. pneumoniae 1681 PRH P Flushed milk
" 1682 " "
" 1683 PRH J Tube
" 1684 " "
" 1685 " "
" 1713 " Flushed milk
" 1714 " "
" 1686 PRH A "
" 1687 " "
" 1688 " Tube
" 1689 " "
" 1690 PRH B "
" 1691 " "
" 1692 " Flushed milk
" 1693 PRH C Tube
" 1694 " "
" 1695 " Flushed milk
" 1696 " "
" 1697 PRH D Tube
" 1698 " "
" 1699 KAH 17 Flushed milk
" 1700 " "
" 1701 KAH16 Tube
" 1702 " "
" 1703 " Flushed milk
" 1704 " "
" 1705 KAH1 15 Tube
" 1706 " "
" 1707 " Flushed milk
" 1708 " "
" 1709 PRH H Tube
" 1710 " "
" 1711 " Flushed milk
" 1712 " "
" 1715 PRH L "
" 1716 " "
" 1717 PRH F Tube 35 days old 12 07/07/2011
06/07/2011
bebelac
9 days old 11 23/07/2011
S26
15 days old 9
16 days old 10
31/05/2011
23/07/2011
24 days old 8
04/07//2011
09/07/2011
04/07//2011
neosure 
26 days old 7
bebelac
21 days old 1
9 days old 2
21 days old 3
12 days old 4
37 days old 5
23 days old 6
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Table ‎2.5: Description of of K. pneumoniae strains isolated from neonatal EFT used in 
Jordan, part 2. 
 
PRH indicates Princesses Rahma Hospital,  KAH indicates King Abdulla Hospital and the letters or numbers after the 
abbreviations (KAH or PRH) are indicating code of infant information. Flushed milk indicates lumen liquid from 
enteral feeding tube. 
Species Strains Location Source of isolates Feeding regime Age of infant Neonatal No. Date of isolation
K. pneumoniae 1718 PRH O Tube 12
" 1719 " "
" 1720 " Flushed milk
" 1721 " "
" 1722 PRH I "
" 1723 " "
" 1724 " Tube
" 1725 PRH G Flushed milk
" 1726 " "
" 1727 KAH 6 Tube
" 1728 " "
1729 PRH N Flushed milk 14 days old 17 15/07/2011
" 1730 PRH E Tube
" 1731 " "
" 1732 " Flushed milk
" 1733 " "
" 1734 KAH 34 Tube
" 1735 " "
" 1736 " Flushed milk
" 1738 PRH T " 15 days old 20
" 1737 PRH S tube
" 1739 " Flushed milk
" 1740 " "
" 1741 PRH Q "
" 1742 " Tube
" 1743 " "
" 1744 PRH AD Tube
" 1745 " Flushed milk
" 1746 PRH AE "
" 1747 " "
" 1748 PRH AT Tube
" 1749 " "
" 1750 PRH AI Flushed milk
" 1751 " Tube
" 1752 PRH Y "
" 1753 " "
" 1754 PRH W Flushed milk
" 1756 " "
12/12/2011
09/07/2011
25
24 days old 26
7 days old
24
S26
10/12/2011
36 days old 21
8 days old 22
13 days old 23
11 days old 28 20/12/2011
15/12/2011
10 days old 27
neosure 18 days old 19 07/12/2011
bebelac
9 days old 23/07/2011
39 days old 14
06/07/2011
15 days old 15
5 days old 16 22/05/2011
19 days old 18
13
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Table ‎2.6: Summary table of selected Ent. hormaechei, Ent. cloacae, Ent. aerogenes, 
Ent.  cancerogenus and K. oxytoca strains from EFT isolates (QMC and NCH) collection, 
used for determining physiological  traits; chapter 4. 
 
(a) NCH Nottingham City Hospital, (b) QMC Queen’s Medical Centre. 
 
 
 
 
Species Strain Location
Source of 
isolates
Neonate 
Number
Date of isolation Age of infant  Feeding regime
Ent. hormaechei 790 NCH
a EFT 4 16/01/2007 breast milk
" 795 " " 17
breast milk & powder infant 
formula
" 798 " " 18 nil by mouth
" 860 " " 52 17/04/2007 breast milk with fortifier
" 1034 QMC
b " 110 16/10/2007 1-2 weeks breast milk & pre-made formula
" 1038 " " 113 22/10/2007 > 4 weeks pre-made formula
" 1053 " " 117
" 1075 " " 117
Ent. cloacae 779 NCH
a EFT 1 16/01/2007 pre-made formula
" 789 " " 12 23/01/2007 breast milk with fortifier
Ent. aerogenes 1056 QMC
b " 118 22/10/2007 < one week breast milk
Ent. cancerogenus 806 NCH
a EFT 24 06/02/2007 > 4 weeks breast milk with fortifier
" 824 " " 36 16/02/2007 3-4 weeks breast milk
" 845 " " 45 02/04/2007 2-3 weeks pre-made formula
" 848 " " 48 10/04/2007 > 4 weeks infant formula
" 909 " " 58 24/04/2007 2-3 weeks pre-made formula
" 957 " " 81 22/05/2007 3-4 weeks breast milk with fortifier
" 1037 QMC
b " 112 16/10/2007 1-2 weeks
" 1042 " " 128 22/10/2007 > 4 weeks breast milk with fortifier
" 1077 " " 120 31/10/2007 1-2 weeks
K. oxytoca 832 QMC
b EFT 36 16/02/2007 3-4 weeks breast milk
" 1078 " " 120 1-2 weeks breast milk with fortifier
" 1079 " " 121 < one week pre-made formula
breast milk & pre-made formula
> 4weeks
2-3weeks
16/10/2007 2-3 weeks
30/01/2007
31/10/2007
> 4 weeks
Chapter 2 
 
48 
 
Table ‎2.7: Summary table of selected Ent. hormaechei, Ent. cloacae, Ent. 
aerogenes, Ent. ludwigii and K. oxytoca strains from the MBM and EFT isolates 
(QMC and NCH) collection, used for determining virulence factors; chapter 5. 
 
(a) NCH Nottingham City Hospital, (b) QMC Queen’s Medical Centre, (c) HCM Hospital Clinico of Madrid. 
EFT: Indicates Enteral feeding tube, MBM: Indicates human mastic breast milk and CSF: indicates 
cerebrospinal fluid. Pulsotype for MBM and CSF strains is detailed in this study (chapter 3) whereas PFGE 
pulsetype for EFT isolates were by Alkeskas in our research group as part of his project.  
 
 
 
 
Species Strain Source of isolates Source
Ent. hormaechei 790 EFT NCH
a
" 795 " "
" 798 " "
" 860 " "
" 1034 " QMC
b
" 1038 " "
" 1053 " "
" 1075 " "
Ent. cloacae 779 EFT NCHa
" 789 " "
Ent. aerogenes 1056 EFT QMC
b
Ent. ludwigii 1349 MBM HCM
c
" 1351 " "
" 1352 " "
" 1348 " "
" 1366 " "
" 1439 CSF QMC
b
K. oxytoca 832 EFT QMC
b
" 1078 " "
" 1079 " "
" 1353 MBM HCM
c
" 1354 " "
" 1356 " "
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Table ‎2.8: Table of selected Ent. hormaechei, and Ent. ludwigii strains from the MBM 
and EFT isolates (QMC and NCH) collection, used for determining attachment and 
invasion HBMEC and rBCEC4 cell lines; chapter 5. 
 
  (a) NCH Nottingham City Hospital, (b)QMC Queen’s Medical Centre, (c) HCM Hospital Clinico of Madrid. EFT: 
Indicates Enteral feeding tube, MBM: Indicates human mastic breast milk and CSF: indicates Cerebrospinal fluid. 
Pulsotype for MBM and CSF strains is details in this study (chapter 3) whereas PFGE pulsetype of EFT isolates were 
by Alkeskas in our research group as part of his project.  
 
 
 
 
 
 
 
 
 
 
Species Strain Source of isolates Location
Ent. hormaechei 790 EFT NCH
a
" 795 " "
" 798 " "
" 860 " "
" 1034 " QMC
b
" 1038 " "
" 1053 " "
" 1075 " "
Ent. ludwigii 1349 MBM HCM
c
" 1351 " "
" 1352 " "
" 1348 " "
" 1366 " "
" 1439 CSF QMC
b
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2.1.2  Bacterial cultivation 
 Tryptone soya agar (TSA) 2.1.2.1
Tryptone soya agar (CM131B, Oxoid Thermo Fisher Scientific) was prepared according 
to the manufacturer’s instructions. Briefly, 40g of Tryptone soya agar was suspended in 
1 litre of distilled water, and sterilised at 121°C for 15 minutes. After cooling to 45-50°C 
it was mixed gently and dispensed into sterile Petri dishes. These were stored in the 
fridge at 4ºC until required. 
  Tryptone soya broth (TSB) 2.1.2.2
Tryptone soya broth (CM0989B, Oxoid Thermo Fisher Scientific) was prepared by 
dissolving 30g of TSB in 1 litre of distilled water, and autoclaving at 121°C for 15 
minutes. The media was stored in a cool and dark place until required. 
  Milk agar 2.1.2.3
To prepare milk agar media, 3g of agar (LP001, Oxoid Thermo Fisher Scientific) and  
0.4g of ammonium sulphate were dissolved in 40ml of distilled water, and autoclaved at 
121ºC for 15 minutes. 200ml of milk based ready to use formula whey (Cow and Gate 
First Infant Milk), casein (SMA Extra Hungry Ready to use) and soy-based (Cow and 
Gate infasoy) infant formula was warmed at 55ºC and mixed with the autoclaved agar. 
The medium was dispensed into Petri dishes, and stored in a cooled place until required. 
 Saline distilled water 2.1.2.4
One saline tablet (BR0053G, Oxoid Thermo Fisher Scientific) was dissolved in 500ml 
distilled water to prepare 0.85% saline that was autoclaved at 121°C for 15 minutes.  
 Luria-Bertani broth (LB) 2.1.2.5
Luria-Bertani Broth (L3022, Sigma Aldrich; USA) was prepared by dissolving 25g of 
Luria-Bertani in 1 litre distilled water. It was dispensed in the required volumes and 
autoclaved at 121ºC for 15 minutes. The media was stored in a cool and dark place until 
required. 
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  Iso-Sensitest agar (ISO) 2.1.2.6
Distilled water (1 litre) was mixed with 31.4g ISO agar (CM0471, Oxoid Thermo Fisher 
Scientific), brought to boil to dissolve the medium completely and then sterilised by 
autoclaving at 121°C for 15 minutes. The plates were stored in a cool place until 
required. 
 Long term storage of strains 2.1.2.7
In a 2ml Eppendorf tube 800µl of TSB broth was mixed with one colony from the TSA 
plate and 200µl of 80 % glycerol was added and stored in a -80°C freezer.  
2.1.3 Mammalian cell lines 
In this study, four mammalian cell lines (Caco-2, HMBEC, rBCEC4 and U937) were 
used to determine Enterobacteriaceae virulence towards host cells. The cell lines were 
stored in liquid nitrogen, with the date, cell line type and passage numbers clearly 
labelled. 
  Human colonic carcinoma epithelial (Caco-2) cell line 2.1.3.1
Human colonic carcinoma epithelial cell line (Caco-2) was received from the European 
Collection of Cell Cultures (ECACC# 86010202). The cell line was originally from a 
human colon adenocarcinoma. The cell lines are able to form a well-differentiated cell 
monolayer and are similar to small intestinal enterocytes. Therefore, it is widely utilized 
in studies of pathogen-host cell interaction (Szymanski et al., 1995). Cells were used 
between passages seven and twelve.  
 Human brain microvascular endothelial cells (HBMEC) 2.1.3.2
The human brain microvascular endothelial HBMEC cell line was obtained from Dr M. 
Rittig (University of Nottingham). Cells were used between passages sixty six and 
seventy.  
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  Rat brain capillary endothelial cell line (rBCEC4) 2.1.3.3
The rat brain capillary endothelial cell line rBCEC4 was obtained from I. E. Blasig 
(Forschungsinstitut für Molekulare Pharmakologie, Berlin; Germany). Cell line rBCEC4 
was used between passages twenty and twenty five. 
 Macrophage cell line (U937) 2.1.3.4
Macrophages cell line (U937) was received from the American Type Culture Collection 
(ATCC) (CRL-1593.2). Cells were used between passages seven and eleven. 
 
2.1.4 Medium of tissue culture experiments 
 
 Growth medium for human colonic carcinoma epithelial (Caco-2) cell line 2.1.4.1
The growth medium was prepared by using 500ml minimum essential medium (M4655, 
Sigma) mixed with 10% fetal calf serum (F7524, Sigma), 1% non-essential amino acid 
solution (100x, M7145, Sigma) and 1% penicillin-streptomycin mixture (10.000 units 
penicillin and 10mg streptomycin/ml) (P4333, Sigma). 
 Infection medium for Caco-2 cell line 2.1.4.2
To prepare the Infection media, 500ml minimum essential medium (M4655, Sigma), was 
mixed with 10% fetal calf serum and 1% non-essential amino acid solution (100x, 
M7145, Sigma). 
  Growth medium for human brain microvascularendothelial cells (HBMEC) 2.1.4.3
and rat brain capillary endothelial cell line (rBCEC4) 
Dulbecco’s modified Eagle’s medium-high glucose DMEM (D6429, Sigma) 500ml was 
prepared and supplied with 10% fetal calf serum (F7524, Sigma), 1% non-essential 
amino acid solution (100x, M7145, Sigma) and 1% penicillin-streptomycin mixture 
(10.000 units penicillin and 10mg streptomycin/ml) (P4333, Sigma). 
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 Infection medium for HBMEC and rBCEC4 2.1.4.4
500ml Dulbecco’s modified Eagle’s medium-high glucose DMEM (D6429, Sigma) was 
mixed with 10% fetal calf serum and 1% non-essential amino acid solution (100x, 
M7145, Sigma). 
  Growth medium for macrophage cell line (U937) 2.1.4.5
The growth medium was prepared by using 500ml RPMI-1640 medium (R8758, Sigma) 
supplied with 10% fetal calf serum (F7524, Sigma), 1% non-essential amino acid 
solution (100x, M7145, Sigma) and 1% penicillin-streptomycin mixture (10.000 units 
penicillin and 10mg streptomycin/ml) (P4333, Sigma). 
  Infection medium for macrophage cell line (U937) 2.1.4.6
500ml RPMI-1640 Medium (R8758, Sigma) was mixed with 10% fetal calf serum and 
1% non-essential amino acid solution (100x, M7145, Sigma). 
2.1.5  Buffers and detergents 
 Dulbecco’s‎Phosphate‎Buffered‎Saline (PBS) 2.1.5.1
Phosphate buffered saline containing sodium and magnesium chloride solution (D8662, 
Sigma) was used to wash cells during preparation. The phosphate buffered saline was 
used for all cell lines used in this study.  
 Triton- X 0.5% 2.1.5.2
The solution of 0.5 % Triton-X was prepared by adding 500µl of Triton-X (Fisher 
BP151-100 Canada) to 99.5ml of sterile distilled water. 
 TE Buffer 2.1.5.3
The TE Buffer solution was prepared by using  5ml of 1M Tris base (BP152-500, 
Thermo Fisher Scientific), with 1ml of 0.5M EDTA , and 494ml distilled water. This 
buffer was used to prepare the plug agarose and to wash PFGE plugs. 
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  Tris base- Boric acid – EDTA (TBE) Buffer 10X preparation (1 Litre 2.1.5.4
distilled water) 
The mixture was prepared using 108g Tris base (BP152-500, Thermo Fisher Scientific), 
55g boric acid (B/3750/53), 40ml 0.5M EDTA pH 8.0 and autoclaved for 20 minutes. 
  TAE 1X 2.1.5.5
To make up TAE 1X 20ml of TAE 50X (2.0M Tris Acetate + 100 mM Na2EDTA) were 
mixed with 980ml of distilled water. 
  Cell Suspension Buffer  2.1.5.6
To prepare a cell suspension buffer total volume = 3ml* n, Buffer needed as follows: 
Tris pH 8.0 = 0.3ml* n  
EDTA pH 8.0 = 0.6ml* n  
VdH2O = 3ml* n – (V add Tris +V add EDTA)  
n indicates the number of samples and V indicates Volume. 
 Cell lysis buffer 2.1.5.7
To prepare the cell lysis buffer (50 mM Tris:50 mM EDTA, pH 8.0 + 1% Sarcosyl); 
1% Sarkosyl NL (N-Dodecanoyl-N-methylglycine sodium salt) Sigma Aldrich, UK  
(L-5125), proteinase K 20mg/ml Sigma Aldrich, UK (P2308) and Calculate the  
total volume of cell lysis buffer/Proteinase K Buffer needed as follows:  
total volume = 5ml *n  
Tris, pH 8.0 = 0.25ml * n  
EDTA, pH 8.0 = 0.5ml * n 
Sarkosyl NL = 0.05g *n 
proteinase k = 25µl * n and  
VdH2O = 5ml * n – (V Tris + V EDTA + V proteinase k) 
 (n indicates the  number of samples and V indicates Volume). 
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 Iron III solution 2.1.5.8
To prepare iron III solution, 9ml of HCl (100ml of distilled water added to 830µl HCl) 
was mixed with 1ml of FeCl3 6H2O solution (1L distilled water mixed with 2.73g of 
FeCl3 6H2O). 
 Chrome azurol sulphate (CAS) solution 2.1.5.9
ChromeazurolS (199532, Sigma) was prepared by mixing 100ml of sterile distilled water 
with 0.0121g of CAS. 
 Hexadecyltrimethylammonium bromide (HDTMA) 2.1.5.10
Distilled water (80ml) was mixed with 0.1458g of HDTMA (H6268, Sigma). 
 Sodium hydroxide solution 2.1.5.11
Ten grams of 50% w/v NaOH was added to distilled water (20ml). 
2.1.6 Molecular studies 
 Genomic DNA extraction  2.1.6.1
Each bacterial strain was grown aerobically in TSB broth with shaking, at 37°C 
incubator. The DNA was carried out with the GenElute™ Bacterial Genomic DNA Kit 
(Sigma) for each strain. Nanodrop 2000 (Thermo Scientific, UK) was used to check the 
concentration and purity of the eluted DNA.  
 PCR product purification 2.1.6.2
MinElute PCR Purification Kits (Qiagen, UK) were used to purify the amplified 
products by following the manufacturer's protocol. Nanodrop 2000 (Thermo Scientific, 
UK) was used to check the concentration and purity of the samples. The final elution 
step was conceded out in 20µl of molecular biology grade water (Fisher Scientific, UK). 
The sequencing machines were by Accugenix, Delaware (USA), Eurofins MWG Operon 
(London, UK) and Source Bioscience (Nottingham, UK). The data was analysed by 
Ribosomal Database Project (http://rdp.cme.msu.edu/seqmatch/seqmatch_intro.jsp). 
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 Agarose gel electrophoresis 2.1.6.3
The amplified PCR products were checked by visualisation on a 1% agarose gel (Life 
Science ® Company, UK, BIO-41025). The gel, 1% (w/v) agarose was mixed in 1X 
Tris-acetate-EDTA (TAE) buffer (Geneflow, UK) and microwaved until melted. From 
SYBR® Safe DNA gel stain (Life Technologies–Invitrogen, UK) 0.1µ/ml (v/v) was 
added to the molten gel and then poured in a tray and allowed to set. The gel was loaded 
with 5µl of sample and 100 bp DNA ladder (Promega, Southampton, UK) was used as a 
marker. The gel was run for 45 minutes at 90V in 1X TAE buffer. Under ultraviolet 
(UV) light, the gel was viewed to observe the DNA bands, using the InGenius® gel 
documentation system (Syngene; UK). 
2.1.7  Safety considerations 
Health and safety codes of practice were followed for all experiments. All materials used 
in the protocols were risk assessed using the suitable control of substances hazardous to 
health (COSHH) forms. Good laboratory practices were carried out for microbes, media 
and chemicals, as well as for operating laboratory devices. The Hepatitis B vaccination 
was received before commencement of tissue culture experiments. 
2.2 Characterisation experiments 
2.2.1  Phenotypic characterisation 
The identification of the strains was initially determined using the ID32E (bioMérieux) 
phenotyping kit, according to manufacturers' recommendations, and the apiweb database 
(www.apiweb.biomerieux.com). 
2.2.2 Genotypic characterisation 
Pulsed-field gel electrophoresis (PFGE) was used as a technique for differentiating 
strains at the DNA level. The isolates were streaked on TSA and incubated at 37ºC  
for 14-18 hours. Each strain was suspended in 3ml cell suspension buffer (0.3ml Tris, 
0.6ml EDTA and 2.1ml H2O); section 2.1.5.6. The cell concentrations were adjusted to 
an optical density (OD) of 1.35 ± 0.05 at 610nm. The TE buffer was prepared and added 
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to 1% agarose and 1% SDS and kept at 55°C until required. Bacterial cell suspension 
(300µl) was mixed with 300µl of TEB agarose and 15µl of Proteinase K (20mg/ml, 
Sigma, P2308) and dispensed in 100µl volumes into each plug.  
The plugs were placed in 50ml polypropylene tubes containing 5ml of cell lysis buffer/ 
Proteinase K (0.25 Tris, 0.50µl EDTA, 1% Sarcosyl and 25µl of Proteinase K); section 
2.1.5.7 and left in a water bath shaker at 54ºC for 1.5-2 hours with vigorous shaking at 
150-175 rpm. The lysis buffer was removed and 15ml of sterile ultra-pure water was 
added to wash the agarose plugs, and incubated in the water bath with shaking at 50°C 
for 15 minutes. This was repeated three times. The TE buffer (5ml) was added to the 
plugs and incubated in the shaking water bath at 50°C for 15 minutes. The TE buffer was 
poured off and the previous step repeated three times. The plugs were stored at 4°C in  
5-10ml sterile TE buffer until required.  
For restriction digestion of the DNA, 2mm of the plug was cut off and placed it in an 
Eppendorff tube containing 135µl of sterile water and 15µl of buffer for 30 minutes at 
room temperature. The mixture was removed and 150µl of restriction enzyme mixture 
(131.25µl sterilised water, 15µl TB buffer and 3.75µl enzyme Xba1) was added and 
incubated at 37°C for 1.5-2 hours. Each plug was put in order in the comb and 100ml of 
0.5 TBE buffer (95ml H2O, 5ml TBE and 1g agarose) were poured into the gel support 
tray.  
Two litres prepared from the TBE buffer 0.5x (1900ml H2O, 100ml TBE) was added to 
the running tank. The gel was run at 14°C with pulse times of 2.2 to 63.8 second for 20 
hours at 6 V. After the electrophoresis run was over, the gel was stained by 20μl of 
ethidium bromide (Sigma, E1510) stock solution (10mg/ml) with 400ml of distilled 
water for 20-30 minutes in a covered container. The InGenius® gel documentation 
system (Syngene; UK) was used to photograph the gels. The electronic images of the 
PFGE patterns were saved in TIFF file format and analysed with Bionumerics software 
version 3.5, dice coefficient and unweight pair group method with arithmetic mean 
(UPGMA) for cluster analysis. The Salmonella serotype Braenderup reference standard 
(H9812) strain 732 was used as the marker. 
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The tolerance value is expressed as a percentage of the total normalized gel length. Two 
bands on different PFGE patterns are considered to be the same if the difference in the 
position of the bands is less than the tolerance percentage. If the difference in the 
positions of the bands is greater than the tolerance percentage, then the bands are 
considered to be two different bands. A low tolerance (0.5%) allows for a minimal 
amount of shifting of the bands when comparing bands of different PFGE patterns. In 
this study different tolerance values were used when analyzing the PFGE patterns 
however the optimum band similarities were obtained at the tolerance values of 1.50%, 
1.75% and 1.60% for EFT, MBM and Jordan strains respectively.  
2.3 Identification of strains by using 16S rDNA sequence analysis 
2.3.1 Preparation of FTA® Elute cards 
The FTA Elute card was labelled with the sample code, and 5ml of sterile water was 
dispensed into a labelled tube. The suspension of bacteria was equal to 0.5 McFarland 
standard and 40µl of the suspension distributed in concentric circular motion within each 
circle. The dry cards were placed in an envelope and shipped to Accugenix, 
Inc.Delaware, USA. 
2.3.2 AccuPRO-ID Bacterial Identification 
Cultures were 24-48 hours old on TSA after incubation at 37°C as according to the 
recommended methodology from AccuPRO-ID bacterial proteotypic identification 
service. Each sterile Eppendorf tube (1.5ml) was labelled for each sample and 300µl of 
sterile, nuclease free water was placed in it. Each Eppendorf tube was inoculated with  
1 µl loop of bacteria from culture (24-48 hours old). Pure ethanol (900µl) was added to 
each suspension and the cap secured in preparation for shipment.  
2.3.3 PCR 16S rDNA sequence analysis 
Genomic DNA extraction was prepared as described above in section 2.1.6.1. The partial 
sequencing of the 16S rDNA loci (528 bp) was performed using primers described  
by Iversen et al. (2006). The PCR reaction mixture contained 5µl buffer, 2µl MgCl2,  1µl 
2’-deoxynucleoside 5’-triphosphate (dNTP), forward (TGGAGAGTTTGATCCTGGC- 
Chapter 2 
 
59 
 
 TCAG) primer and  reverse (TACCGCGGCTGCTGGCAC) primer (2.5µl each), 0.25µl 
TAQ polymerase, 1µl DNA and 10.75µl distilled water. PCR conditions were as follows: 
initial denaturation at 95°C for 10 minutes; 30 cycles of denaturation at 95°C for 30 
second, primer annealing at 62.6°C for 30 second, extension at 72°C for 45 second; 
followed by a final extension step of 72°C for 10 minutes.                                                                        
2.4 Physiological experiments 
2.4.1  Heat tolerance 
Overnight cultures were inoculated into whey-based ready to use formula (Cow and Gate 
First Infant Milk) and casein (SMA Extra Hungry Ready to use) and incubated at 37°C 
overnight.  Infant milk was warmed to 55°C for 30 minutes in a water bath. Bacterial 
suspensions (1ml) were inoculated into 9ml warmed milk. At zero time 100µl  of 
suspension were transferred to one well of the 96 well plates. This was repeated every  
5 minutes for 30 minutes. Serial dilutions of the bacterial suspension (15µl) were diluted in 
saline to 10
-7
. The Miles and Misra enumeration technique on TSA plates was used to 
determine the number of cells surviving exposure to 55ºC. The plates were incubated at 
37ºC overnight. The viable count was plotted against time, and D-values calculated on the 
time required for a 1 log10 reduction  in the viable count. 
2.4.2  Biofilm formation 
Bacteria production was determined according to the method described by Stepanović et 
al. (2004), with a slight modification. In brief, bacteria were grown at 37°C overnight 
without shaking for 24 hours in TSB and then diluted to 10
4
 cfu/ml in sterile saline and 
used to inoculate reconstituted formula (casein, whey and soya). Serial dilution of each 
type of inoculated formula milk was carried out into saline in the wells of a 96-well flat 
bottomed polystyrene microplate. The microplates were incubated aerobically for 24 
hours and 48 hours at 20ºC and for 24 hours at 37ºC. The contents of each well were 
removed using a vacuum and the remaining biofilm was washed two times with 300µl of 
sterile saline and shaken for 15 minutes at 200 rpm. Crystal violet 0.01% (250µl) was 
added to the wells for 5 minutes, and then the microplates were washed two times with 
250µl sterile distilled water per well. The residual attached bacteria were extracted with 
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200µl of ethanol (70% v/v) per well, and after 15 minutes 150µl was transferred to new 
plates. 
 The absorbance of each well was measured at 540nm using a GEN5 program, the 
triplicate results were averaged and divided by the negative control.  The relative 
increase in biofilm formation level for each strain was obtained from dividing the OD of 
the strain retained by the isolates. The OD of tested strains was determined according to 
the method described by Stepanovic et al. (2004) where the threshold for positive 
bacterial biofilm OD was defined as three standard fold increase above the mean OD. of 
the negative control. Strains were categorised as follows: No biofilm formation: OD 
strain = OD control, low biofilm formation: OD strain ≤ 2x OD control, moderate 
biofilm formation: OD strain ≤ 4 x OD control and high biofilm formation: OD strain >4 
x OD control. 
2.4.3 Capsule formation 
The preparation of milk agar media was described in section 2.1.2.3. Capsule production 
on milk agar by tested strains was determined by colony appearance on milk agar at  
20ºC (after 24 hours and 48 hours) and 37ºC (after 24 hours). 
2.4.4 Acid tolerance of organisms to pH 3.5 (HCl acidified formula) 
Bacteria resistance to pH 3.5 was studied according to the method as already used by 
Edelson-Mammel et al. (2006), with some modification. A single colony of the test 
organism was inoculated into 5ml of TSB and incubated for 18 hours at 37°C. Two types 
of formula were used in this study (whey and casein-based formulas). The milk was 
adjusted to pH 3.5 with 1mM of sterile HCl (sterilised by filtration using 0.2µm filters). 
Two sterile tubes containing 9ml of pH adjusted formula were placed in a water bath at 
37°C to avoid the heat shocking of the inoculated cells.  
The pH adjusted infant formula was inoculated with 1ml of the bacterial cell suspension 
into the water bath to maintain the temperature. From each tube 100µl of adjusted infant 
formula was taken at each time point (0, 5, 10, 15, 20, 30, 45, 60, 90 and 120 minutes) 
and then were serially diluted in normal saline and plated on TSA agar plates by using 
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the Miles and Misra technique to determine the number of viable cells. The plates were 
incubated for 18 hours at 37°C and the number of colonies was enumerated as colony 
forming units (cfu). The number of colonies was transformed to log (cfu/ml) values for 
presentation on the log curve graph. 
2.5 Virulence factors 
2.5.1 Bacterial attachment and invasion of host cells 
 Preparation of bacterial inoculum 2.5.1.1
The strains were grown overnight on TSB at 37°C, The overnight culture were then 
pelleted by centrifugation for 3 minutes at 1200 rpm. The supernatant was then discarded 
and the pellet was re-suspended in 1ml of infection medium. Each strain was added at  
~ 10
6 
cfu per well to obtain the multiplicity of infection of 1:100 and incubated with 5% 
CO2 at 37°C for 3 hours. 
 Mammalian cell culture 2.5.1.2
All cell lines were taken from the liquid nitrogen that was used for each of the tissue 
culture studies. The frozen ampoule was melted and quickly seeded into 10ml of the 
suitable growth medium, and 100µg/ml gentamicin was added to the initial passage. 
Bacterial attachment and invasion of host cells were determined by the method of 
Townsend et al. (2008b). The seeded cells were incubated at 37°C with 5% CO2. The 
cells were centrifuged for 5 minutes at 1500 rpm by using CENTAUR2 centrifuge (MES, 
UK). The pellet was re-suspended in 25ml of growth medium and seeded into 75ml 
tissue culture flasks. The seeded cells were incubated at 37°C in 5% (v/v) CO2, for 24 
hours for rBCEC4 and HBMEC for 48 hours for Caco-2 and U937 to obtain the 
confluent layer (70-80%). Mammalian cells were then seeded in 24-well microplate for 
48 hours and the concentration in each well was 2 x 10
4
 cells/ml. Five millilitres of 
trypsin-EDTA solution was used to detach the confluent monolayer. 
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 Attachment assay 2.5.1.3
The attachment and invasion assay was used to determine the ability of the bacterial 
strains to adhere Caco-2, rBCEC4, and HBMEC cell lines. To obtain less variation 
between the two assays, the determination of attachment was carried out at the same time 
using the same cell line passage of mammalian cell line and same inoculum of bacterial 
suspension. Cultivation of the Caco-2, rBCEC4, and HBMEC cell lines was described 
 in section 2.1.3. The mammalian cells were washed three times using Dulbecco’s 
phosphate buffered saline (PBS) (D8662, Sigma) and were infected with each isolate at  
~ 10
6 
cfu per well (MOI of 1:100) and incubated with 5% CO2 at 37°C for 3 hours. After 
incubation, the cells were washed three times with PBS, and then 100µl 0.5% Triton-
X100 was added to the wells and diluted with PBS to determine the viable count using 
the Miles and Misra method.  
This assay enumerated the total number of bacteria associated with the mammalian cells 
after a 3 hours incubation period. These cells may be either attached to the surface or 
located intracellularly. Therefore, the number of attached bacteria was determined by 
subtracting the number of intracellular bacteria following invasion using the gentamicin 
protection assay. The average number of bacterial cfu/well was used to present data, 
given that each well contained 2 × 10
4
 mammalian cells. The attachment efficiency of 
the tested isolates was determined by the number of bacteria attached per well/inoculum 
size ×100. The experiment was repeated twice in triplicate. Error bars in Figures indicate 
the standard deviation value. 
The attachment and invasion assays were performed with the breast milk and nasogastric 
EFT isolates as listed in Table 2.5. E. coli 1230 and Sal. Enteritidis strain 358 were used 
as negative control and positive control respectively for Caco-2 cell line, whereas  
Cit. koseri strain 48 was used as positive control for rBCEC4 and HMBEC cell lines. 
  Gentamicin protection invasion assay 2.5.1.4
For the invasion assay, the mammalian cell lines Caco-2, rBCEC4, and HBMEC were 
used as described in section 2.1.4. These cells were washed three times with PBS and 
were infected with the organism at 2 x 10
6 
cfu per well (MOI of 1:100) and incubated 
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with 5% CO2 at 37°C for 3 hours. After incubation, the cells were washed three times 
with PBS and then 500µl of warm tissue culture media with 125µg/ml gentamicin 
(G1397, Sigma) were added to each well and incubated for 1 hour. Triton-X100 solution 
(100µl) was added to each well after removing the liquid and washing three times with 
PBS. Serial dilutions were carried out of each sample for enumeration following the 
Miles and Misra method on TSA plates. The invasion efficiency of tested strains was 
calculated by dividing the number of the internalised bacteria per well (cfu) by the initial 
bacterial cell number (cfu) and multiplying by 100. The experiment was repeated twice 
in triplicate. Error bars in figures indicate the standard deviation. 
  Gentamicin protection assay for U937 macrophage uptake and persistence 2.5.1.5
The ability of bacterial strains to internalise and persist in human macrophages was 
studied. The macrophage cells were cultivated in RPMI 1640 medium with 2mM L-
glutamine, and modified to contain 10mM HEPES, 1mM sodium pyruvate, 4.5g/L 
glucose, 1.5g/L sodium bicarbonate, and supplemented with 10% foetal bovine serum. 
At 37°C and under 5% CO2, the cells were treated with 0.1μg/ml of phorbol  2-myristate 
13-acetate (PMA; Sigma) and placed in tissue culture plates to adhere and become 
activated. The period before infection was at least 24 hours.  
RPMI medium was added prior to infection for washing the cells to remove residual 
PMA. The strains were grown overnight in TSB, and then 120µl was transferred to 5ml 
of fresh RPMI 1640 medium. The suspension was incubated for 2 hours at 37ºC in a 
shaking incubator at 160 rpm. The OD was measured by using a spectrophotometer 
(JENWAH, UK) and adjusted at 600nm to between 0.3-0.5nm. Bijoux bottles containing 
3ml of tissue culture media were inoculated with bacteria with a final OD of 0.005nm. 
The bacteria were inoculated at ~ 10
5
 cfu per well and U937 human macrophages were 
seeded at  
2 x 10
4
 cells per well to obtain the multiplicity of infection of 1:10 for 45 minutes at 
37°C in 5% CO2 (v/v) incubator. The cells were then washed three times with PBS.   
The persistence of bacterial cells in macrophages up to 48 hours was investigated by the 
maintenance of two sets that were infected for 45 minutes. After the incubation period, 
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the macrophages were resuspended in U937 medium supplemented with  00μg/ml and 
10μg/ml of gentamicin for 24 hours and 48 hours respectively and incubated at 37°C in 5% 
CO2. Macrophages were washed three times with PBS and then lysed with 0.5% Triton-
X100, pipetted to homogenise, decimally-diluted and then plated on TSA to determine 
the number of intracellular bacteria by using the Miles and Misra technique. The uptake 
and persistence efficiency of bacterial strains was calculated by using the number of the 
internalised bacteria per well (cfu) divided by the total of bacterial cells (cfu) in the 
inoculum and multiplying by 100.  
The U937 macrophage uptake and persistence assays were performed with the MBM 
and nasogastric EFT isolates as listed in Table 2.5. E. coli strain 1230 and Cit. koseri 
strain 48 were used as negative control and positive control respectively. The standard 
deviation is indicated by the mean of uptake and persistence efficiency of each isolate 
for two independent experiments in triplicates. 
 
  The adhesion patterns of bacteria with Caco-2 human epithelial cells 2.5.1.6
Six well microplates were seeded with 2 x 10
4 
Caco-2 cells and then incubated at 37°C 
with 5% CO2 for 48 hours and checked for adherence and confluent growth. Overnight 
bacterial cultures were centrifuged and resuspended in 8ml of appropriate complete 
medium DMEM. The tissue culture cells were infected with ~ 10
8
 bacteria per well (4ml) 
giving a MOI 1:10000. The infected Caco-2 cells were incubated at 37°C with 5% CO2 
for 3 hours. The medium was aspirated after the incubation period and the cells washed 
three times with sterile PBS. The coverslip for control slide was prepared by removing 
the medium immediately from the chamber slide, then the coverslip was removed and 
the cells washed three times with 5ml sterile PBS.  
Absolute methanol was used for 5 minutes to fix the slides, and these were air-dried. 
Giemsa staining was performed following a modified method described by Mange et al. 
(2006). The Giemsa stain was diluted 1: 20 (5%) with distilled water, then the cells were 
stained for 15 minutes, then washed with distilled water and allowed to air dry. The 
slides were viewed using light microscopy under oil immersion.  
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2.5.2 Haemolysin production 
Tryptic soy agar (500ml) was prepared according to the manufacturer’s instructions and 
sterilised at 121°C for 15 minutes. After cooling to 45-50°C, 25ml of sterile sheep blood 
defibrinated (Oxoid, SR0051) or horse blood (Oxoid, SR0050) were added to create  
a 5% suspension of sheep or horse blood and mixed gently and dispensed into sterile 
Petri dishes. A single colony was harvested from a TSA plate and streaked onto blood 
agar plate, and incubated for 18 hours at 37°C. Following the haemolytic reaction on a 
blood agar plate, strains were categorised as follows: α-partial haemolysis as greenish 
colour around the colonies, ß-indicated by clearing around colonies on blood agar and  
γ - indicated by a lack of clearing or another change around colonies on blood agar.  
S. pyogenes NCTC 9994 was used as positive control. 
2.5.3 Serum sensitivity determination 
Serum resistance was determined according to the method described by Hughes et al. 
(1982), with a slight modification. Serum was obtained from human male AB plasma 
(Sigma, H4522). The strains were grown overnight in LB Broth and were centrifuged 
(1500g for 5 minutes), the pellet was diluted to l0
6
 cfu/ml in 5ml of phosphate buffered 
saline. An inoculum (0.5ml) of suspension cells was added to 1.5ml of undiluted serum, 
equal volumes (0.2ml) of this suspended and human serum were mixed before 
incubation at 37°C.  
Viable counts were obtained at the beginning and after 1, 2, 3 and 4 hours of incubation 
at 37°C. Serially diluted cells were plated on TSA agar plates using the Miles and Misra 
technique and incubated aerobically at 37°C for 18 hours before the number of colonies 
was counted. The experiment was in duplicate. E. coli strain 1230 and Salm. Enteritidis 
strains 358 were used as negative control and positive control respectively. 
2.5.4  Siderophore production 
For siderophore production the method of Gundogan et al. (2011) was used with slight 
modification. Chrome azurolsulphate (CAS) agar was prepared by using two solutions. 
The first solution (dark blue liquid) was prepared by using 50ml of CAS solution (see 
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section 2.1.5.9), 10ml of iron III solution (section 2.1.5.8) and 40ml of HDTMA before 
autoclaving at 121°C for 15 minutes (100ml in total of dark solution). The second 
solution was prepared by mixing 900ml of distilled water, 15g agar, 30.24g pipes and  
12g NaOH and then autoclaving at 121°C for 15 minutes. After autoclaving, the first 
solution was mixed with the second solution and then the media was poured into the 
plates.  
Immediately before use, 5mm diameter holes were punched into the agar. To prepare the 
bacterial suspension, five colonies were taken from TSA and inoculated into LB broth 
containing 200µM of 2,2´-dipyridyl (31.236mg in 1L of LB broth) and incubated with 
shaking (170 rpm) at 37°C overnight. After incubation, the sample was centrifuged  
at 5000 rpm for 10 minutes and 70µl of the supernatant was added into the holes. The  
agar was incubated at 37ºC for 4-8 hours. The observance of an orange zone  
around the hole indicated that the strain was positive for siderophore production.  
Y. enterocolitica  strain 8081 was used as a positive control. 
2.5.5 Determination of high pathogenicity island 
Each bacterial strain was grown aerobically in TSB broth with shaking, at 37°C 
incubator. The DNA was carried out with the GenElute™ Bacterial Genomic DNA Kit 
(Sigma) for each strain. Amplifications were done in a 25µl reaction 2 mM MgCl2, 1µl 
Deoxyribonucleotide Triphosphate (dNTPs) mix, 1µl of each primer, and 0.25 U of Taq 
Flexi DNA polymerase (Promega, UK). The method was as previously described  
by Schubert et al. (2000). The initial denaturation step (94°C, 5 minutes) was followed  
by 30 cycles of denaturation (94ºC,  1 minute), annealing (annealing temperature,  
1 minute), and extension (72ºC, 1 minute) with 1 final extension step (72ºC, 8 minutes). 
The sequences of the forward primers and reverse primers, the annealing temperature, 
and the size of the amplified fragment are presented as follows:  
 irp1 primer forward TGAATCGCGGGTGTCTTATGC and reverse 
TCCCTCAATAAAGCCCGCT (product size 238 bp; temperature, 57ºC). 
 irp2 primer forward AAGGATTCGCTGTTACCGGAC and reverse 
TCGTCGGGCAGCGTTTCTTCT, (product size 287 bp; temperature, 57ºC) and;  
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 fyuA primer forward GCGACGGGAAGCGATGATTTA and reverse 
TAAATGCCAGGTCAGGTCACT (product size 547 bp; temperature, 56ºC). 
 Samples were electrophoresed in 1.5% agarose gels which were stained with SYBR® 
Safe DNA Gel Stain, and a 100 bp DNA ladder (Promega, UK) to determine product size 
[Appendix 2].  The running tank was filled with 1X TAE buffers and gels were run for 
45 minutes at 90 volts. Under the UV light, using the InGenius® gel documentation 
system (Syngene; UK), DNA samples were visualized. Y. enterocolitica strain 8081 was 
used as positive control.  
2.5.6  Antimicrobial susceptibility testing and ESBLs detection  
The disk diffusion method was used to determine bacterial susceptibility in accordance 
with standardised HPA (2006) and BSAC methods (2008) for the following antibiotics: 
amikacin (30µg), ampicillin (10µg), cefotaxime (30µg), ceftazidime (30µg), cephalothin 
(30µg), ciprofloxacin (1µg), gentamicin (10µg), imipenem (10µg), cefuroxime (30µg), 
chloramphenicol (30µg), streptomycin (10µg), ceftriaxone (30µg), cefoperazone (30µg), 
doxycycline (30µg), cefotetan (30µg), cefpodoxime (10µg), co-amoxiclav (20+10µg; 
zone diameter based on a 2:1 ratio of amoxicillin:clavulanate) and trimethoprim (2.5µg). 
ESBLs production was determined by the combination of cefpodoxime (CPD) kit (30-μg) 
(Oxoid, DD0029) and cefpodoxime-plus-clavulanate (CD CV) (30- plus 10-μg) disks, 
ceftazidime (CAZ) (30-μg) and ceftazidime-plus-clavulanate (CAZ CV) (30- plus 10-μg) 
disks and cefotaxime (CTX) (30-μg) and cefotaxime-plus-clavulanate (CTX CV) (30- 
plus 10-μg) disks. From overnight cultures, 4-5 colonies were transferred into a tube 
containing 5ml of a sterile saline and mixed thoroughly via vortex to give just visible 
turbidity. The suspension was adjusted to the density of the 0.5 McFarland standards. 
ISO-sensitest agar (Oxoid, CM0471) was streaked by adjusted suspension of organisms. 
The disk tests were performed with confluent growth on ISO-sensitest agar (Oxoid, 
CM0471). After incubation for 18 hours at 37°C, a zone of inhibition can be observed.  E. 
coli NCTC 10418 was used as a control organism as it is sensitive to all antimicrobial 
drugs. An ESBL was detected by measuring a difference of ≥ 5mm between the zones of 
combination disc compared to that of the individual antibiotic cefpodoxime/ceftazidime 
and cefotaxime. 
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2.5.7 Data analysis 
In this study, two comparisons were analysed using ANOVA one way (Tukey method) 
analysis test and a P value of less than 0.05 (p < 0.05) was considered to indicate 
statistical significance. The first comparison was between biofilm levels in each type of 
infant formula (whey, casein and soya) at two temperatures 20°C and 37°C by each 
strain.  Additionally, ANOVA one way (Tukey methods) analysis test was used in order 
to compare between levels of biofilm for the species in different types of formula and 
different temperatures. Furthermore, one way ANOVA also was used to find the 
consistence of the independent experiments for the strains to adhere Caco-2, rBCEC4, 
and HBMEC cell lines, the significance was set at p < 0.05. All experiments were 
formed in triplicate except for experiments of acid tolerance of organisms at pH 3.5 
which were performed in duplicate. Data are presented as the average of two 
independent experiments. Error bars in figures represent the standard deviation.   
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3.1 INTRODUCTION 
There are a variety of phenotypic and genotypic methods to determine if isolates are 
indistinguishable or closely related. These tests include PFGE and multilocus enzyme 
electrophoresis, as described by Tenover et al. (1995). The most common technique, 
which is still considered the gold standard, for bacterial strain characterisation is PFGE. 
The PFGE technique is used by many laboratories to determine strain relatedness to 
identify the source of a strain or outbreak, and to confirm an outbreak of a bacterial 
disease (Agasan et al., 2002; Bender et al., 2001). This technique relies on its ability to 
separate and visualise DNA molecules based on their size. In addition, PFGE has shown 
an excellent ability to separate DNA molecules ranging in size from a few kilobases (kb) 
to greater than 10 megabase pairs (Mb) (Steward et al., 1988; Burmeister et al., 1992). 
PFGE technique is able to separate large of DNA molecules by the use of an alternating 
electrical field, such that greater size resolution can be obtained when compared to 
normal agarose gel electrophoresis. PFGE is often employed to track pathogens, such as 
Salmonella, Shigella, E. coli (including O157) ( Peters, 2009). However, current 
technology has been certain that whole-genome sequencing to be a highly discriminating 
and efficient method for strain typing of outbreak samples. it has been recently applied to 
subtyping analysis, and it bridges the gap between PFGE and whole-genome sequencing. 
Whole-genome sequencing uses restriction site analysis arranges 200 to 500 bands in the 
order they appear on the chromosome while PFGE  utilizes ∼20 bands sorted by size. 
The most important limitation of whole-genome sequencing at the present time is the 
cost time in spent preparing longer than the time required for PFGE analysis, sequencing, 
and analysing samples (Miller, 2013; Pendleton et al., 2013). 
The Centres for Disease Control and Prevention (CDC) and PulseNet possess 
standardized protocols to compare PFGE patterns for most foodborne pathogens, such as 
Salmonella, E. coli O157:H7, Shigella, Campylobacter jejuni, Listeria monocytogenes 
and Yersinia pestis (CDC, 2004; Cooper et al., 2006). 
There are several commercially available restriction enzymes, such as Sma I, Spe I, Xba I, 
Nhe I, Apa I and Avr II, with the ability to cleave DNA at specific sites on the genome 
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(Basim and Basim, 2001). The enzymes are regularly utilized to improve 
characterisation and discrimination between bacteria (Tenover et al., 1995). The 
restriction enzymes act to cut the genomic DNA into small fragments (8 – 25) which are 
separated by using agarose gel electrophoresis. Then the electronic images of PFGE (‘tiff’ 
format) can be analysed using commercially available software such as BioNumerics 
(CDC, 2004). 
To interpret the PFGE patterns in epidemiological investigations for the analysis of 
restriction patterns, the following criterion suggested, by Tenover et al. (1995), is often 
used: 
 Indistinguishable: strains are considered indistinguishable if their restriction 
patterns have the same band numbers and those bands are identical in size. 
 Closely related: strains have between one to three bands different from each 
other. 
 Possibly related: isolates are considered possibly related if they are differ by four 
to six band differences.  
 Unrelated strains: The isolates are considered unrelated if the strains differ by 7   
or more bands. 
Although phenotyping is a quick method for isolate identification, it is prone to the 
subjective reading of results, and dependence upon an external database. 16S rDNA 
sequence analysis is more reliable, although it requires a longer period of time before the 
results are obtained.  In addition, because of its universal distribution among bacteria 
16S rDNA sequences is a useful alternative when phenotypic characterisation methods 
fail. 16S rRNA gene sequences are used to study bacterial phylogeny and taxonomy for 
many reasons, specifically that all bacteria have a 16S rRNA gene, often existing as a 
multigene family or operons. Moreover, there is no change in the function of 16S rRNA 
as well as the large size of 16S rRNA gene (1500bp) which is really helpful in the 
bioinformatics analysis (Patel et al., 2001).  
This study used twenty bacterial strains isolated from mastic human breast milk by 
lactation consultants at different primary health-care centres in Spain (Delgado et al., 
2008). Initial studies were, therefore, necessary to confirm the identity of these strains 
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and to determine if any were clones, i.e., that same strain may have been isolated more 
than once. Hence, the strains were analysed using ID32E (phenotyping), pulsed-field gel 
electrophoresis and 16S rDNA sequence analysis. In addition, seventy five EFT isolates 
of K. pneumoniae (from Jordan) were also analysed, but only for PFGE profile due to 
time constraints.  
Initial PFGE subtyping for one hundred and thirty-three strains isolated from neonatal 
EFT from two local Nottingham hospitals (QMC and NCH) was undertaken by Alkeskas 
(former NTU PhD student) as part of his research (see Figure  3.1-4). His study was taken 
further by myself and the PFGE fingerprinting was re-analysed and the strains were re-
identified using 16S rRNA. While MBM strains and Jordan strains were analysed using 
PFGE technique by myself. DNA fingerprinting via PFGE for these strains was used to 
determine their genotypic similarities and the variation between isolates. Furthermore, 
this study investigated if the same strains were isolated from the same baby on more than 
one occasion, or from different neonates, and to identified if the same strains  
were isolated at different times from the NICUs. Previous research at NTU has also 
identified these strains by using ID20E, ID32E and 16S rDNA sequence analysis. The 
MBM strains were analysed by using ID32E, and 16S rDNA sequence analysis. 
3.2  Materials and Methods 
The preparation of culture media and conditions for this chapter were described 
previously in section 2.2 of chapter 2 ’Materials and Methods’. Briefly, the dendogram 
was created by BioNumerics software, version 3.5, dice coefficient and unweight pair 
group method with arithmetic mean (UPGMA) for cluster analysis. The analysis of the 
PFGE data was interpreted using criteria proposed by Tenover et al. (1995). 
3.3  Results 
3.3.1 Characterisation of Enterobacteriaceae strains using the PFGE technique 
The tolerance and optimisation for the bands were 1.50%, 1.75% and 1.60% for EFT 
strains, MBM strains and Jordan strains respectively. As according to a previous study 
by Hunter et al. (2005) Salmonella serotype Braenderup strain H9812 (NTU collection 
Salmonella strain 732) was chosen as the universal size standard; see [Appendix 1]. This 
Chapter 3 
  
73 
 
strain had coverage of a large range of DNA fragment sizes, even distribution of bands, 
and optimises stability of the PFGE pattern.  
The universal size standard was used to establish reference positions (visible restriction 
fragments in the pattern), which are used to normalise the electronic images (‘tiff’ 
format). The protocol that was used in this experiment has been standardised by the  
 CDC and PulseNet (2004). 
  Characterisation of enteral feeding tubes strains 3.3.1.1
One hundred thirty-three Enterobacteriaceae strains isolated from neonatal enteral 
feeding tubes from two local hospitals in Nottingham (NCH and QMC) were analysed. 
These were Ent. hormaechei, Ent. cancerogenus, Klebsiella spp., Ent. cloacae and 
 Ent. aerogenes. As shown in Figure 3.1, forty four Ent. hormaechei strains formed 
seven distinguishable pulsotypes and two unique strains. Fifty one strains of Ent. 
cancerogenus formed 6 distinguishable pulsotypes and there were two unique strains, 
see figure 3.2. In Figure 3.3, thirty three Klebsiella spp. strains formed 6 distinguishable 
pulsotypes and one unique strain. Finally, the remaining species are presented in one 
Figure (Figure 3.4) which were three strains of Ent. cloacae and two strains of Ent. 
aerogenes. They were clustered into two distinguishable pulsotypes, and there is one 
which was unique. 
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 Characterisation of Ent. hormaechei strains 
  
Figure ‎3.1: PFGE cluster analysis of Ent. hormaechei strains (as performed by Alkeskas). 
The dendrogram was generated by BioNumerics softwar e, version 3.5, dice coefficient 
and unweight pair group method with arithmetic mean (UPGMA) for cluster analysis. 
The tolerance and optimisation in the band was 1.50%. Ebh1- Ebh7 and U: indicates 
PFGE cluster groups; U: Unique. 
 
Dice (Opt:1.50%) (Tol 1.5%-1.5%) (H>0.0% S>0.0%) [0.0%-100.0%]
PFGE
1
0
0
9
5
9
0
8
5
8
0
7
5
7
0
PFGE
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
Ent. hormaechei
960
790
979
980
981
983
986
987
993
997
1074
1033
1034
1035
1052
1053
1075
1032
856
859
860
861
862
863
1066
1067
1069
1081
1084
1027
1068
1089
800
801
802
803
795
797
798
799
1038
1039
1040
1044
23/05/2007
24/01/2007
16/02/2007
16/02/2007
16/02/2007
16/02/2007
16/02/2007
16/02/2007
16/02/2007
16/02/2007
16/10/2007
16/10/2007
16/10/2007
16/10/2007
16/10/2007
16/10/2007
16/10/2007
16/10/2007
17/04/2007
17/04/2007
17/04/2007
17/04/2007
17/04/2007
17/04/2007
12/11/2007
12/11/2007
19/11/2007
12/11/2007
12/11/2007
16/10/2007
19/11/2007
19/11/2007
30/01/2007
30/01/2007
30/01/2007
30/01/2007
30/01/2007
30/01/2007
30/01/2007
30/01/2007
22/10/2007
22/10/2007
22/10/2007
16/10/2007
NCH
NCH
NCH
NCH
NCH
NCH
NCH
NCH
NCH
NCH
QMC
QMC
QMC
QMC
QMC
QMC
QMC
QMC
NCH
NCH
NCH
NCH
NCH
NCH
QMC
QMC
QMC
QMC
QMC
QMC
QMC
QMC
NCH
NCH
NCH
NCH
NCH
NCH
NCH
NCH
QMC
QMC
QMC
QMC
U
E
b
h
1
E
b
h
2
E
b
h
3
E
b
h
4
E
b
h
5
E
b
h
6
E
b
h
7
Date of 
isolation
strainspecies source
Chapter 3 
  
75 
 
Table ‎3.1: Summary of PFGE analysis of Ent. hormaechei strains. 
QMC: Queen’s Medical Centre. NCH: Nottingham City Hospital.Ebh1- Ebh7 indicates PFGE cluster groups, U: 
Unique. 
 
Table 3.1 and Figure 3.1 present the analysis of forty four EFT strains of  
Ent. hormaechei which previously have been isolated from two local hospitals; NCH (n 
= 24) and QMC (n = 20) [Appendix 3]. The strains were obtained from 19 patients. 
These strains were clustered into seven pulsotypes; Ehc1- Ehc7 and two unique strains. 
All strains in pulsotypes Ebh1-Ebh4 and Ebh6- Ebh7 showed a 100% similarity 
coefficient. 
From the same patient, 8 isolates of Ent. hormaechei were recovered which belonged to 
pulsotype Ebh1. These strains were isolated in one day (16
th
 February 2007). 
Pulsotype Ebh2 was composed of five strains of Ent. hormaechei. They were isolated 
from 2 patients, from same hospital (QMC) on the same day (16
th
 October 2007). Strains 
1033, 1034 and 1035 were isolated from the same patients and, strains 1052 and 1074 
were from another patient.  
Three strains of Ent. hormaechei belonged to pulsotype Ebh3, which were isolated on 
the same day (16
th
 October 2007). These strains were isolated from two different 
neonates in the same hospital. Two strains, 1053 and 1075, were isolated from the same 
patient while strain 1032 was isolated from a different patient. 
Six strains of Ent. hormaechei were grouped into pulsotype Ebh4. These strains were 
isolated from three different neonates in one day (17
th
 April 2007). They were in the 
Species Hospital Strain Number
PFGE 
cluster
Number of 
Strains
Period of 
isolation
Patients
790,960 U 2 Over four month 2
979, 980, 981, 983, 986,987,993,997 Ebh1 8 same day 1
856, 859, 860, 861, 862,863 Ebh4 6 same day 3
795, 797, 798, 799, 800,801,802,803 Ebh6 8 same day 6
1052, 1033, 1034, 1035, 1074 Ebh2 5 same day 2
1032, 1053, 1075 Ebh3 3 same day 2
1027, 1066, 1067, 1081, 1084, 1068, Ebh5 8 Over one month 3
1044, 1038, 1039, 1040 Ebh7 4 one week 2
NCH
QMC
Ent.hormaechei
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same hospital. Four strains, 860-863, were isolated from the same patient whereas strains 
856 and 859 were isolated from two different patients.  
A total of eight Ent. hormaechei strains belonging to pulsotype Ebh5 were isolated 
during a period of one month  (16
th
 October and 12
th
 and 19
th
 November 2007) from 3 
different patients in the same hospital (QMC). Pulsotype Ebh5 was composed of two 
sub-clusters. The similarity coefficient of each sub-cluster was 100% validating the 
clonality of the isolates in each sub-cluster. While the similarity coefficient of strains 
1068 and 1089 with the other 6 strains (1066, 1067, 1069, 1081, 1084 and 1027) was 91% 
which again validates that these isolates are higly identical. The difference between these 
strains was only one band.  
Eight Ent. hormaechei strains belonged to pulsotype Ebh6 which were isolated on the 
same day (30
th
 January 2007) from six different patients in the same hospital (NCH). 
Four strains out of eight strains were isolated from two different patients. Strains 795 and 
797 were isolated from the same patient while strains 798 and 799 were isolated from 
another patient. 
Four Ent. hormaechei strains were isolated during a one week period (16
th
 and 22
nd
 
October 2007) and belonged to pulsotype Ebh7. These were isolated from 2 different 
patients in the same hospital (QMC). Three strains of pulsotype Ebh7 were isolated from 
the same patient on the same day (22
nd
 October 2007) while one strain was isolated from 
another patient on different day (16
th
 October 2007). The similarity coefficient of the 
cluster was 100%.  
The remaining two Ent. hormaechei strains (790 and 960) were unique and were isolated 
from two different patients from the same hospital. 
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 Characterisation of Ent. cancerogenus strains 
 
Figure ‎3.2: PFGE cluster analysis of Ent. cancerogenus strains (as performed by Alkeskas). 
The dendrogram was generated by BioNumerics software, version 3.5, dice 
coefficient and unweight pair group method with arithmetic mean (UPGMA) for 
cluster analysis. The tolerance and optimisation in the band was 1.50%. Ebc1- Ebc6 
indicates PFGE cluster groups; U: Unique. 
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Table ‎3.2: Summary of PFGE analysis of Ent. cancerogenus strains. 
QMC: Queen’s Medical Centre. NCH: Nottingham City Hospital. Ebc1- Ebc6 indicates PFGE cluster groups, 
U:Unique. 
As displayed in Figure 3.2, the dendrogram of 51 isolates of Ent. cancerogenus from 
NCH (n = 44) and QMC (n=7), the strains have been obtained from 25 patients 
[Appendix 4]. These organisms were clustered into six distinguishable pulsotypes Ebc1- 
Ebc6 and two unique strains. The isolates of each pulsotype showed 100% similarity 
coefficient. All strains within each pulsotypes showed 100% similarity coefficient 
(Figure 3.2, Table 3.2). 
Five strains of Ent. cancerogenus belonged to pulsotype Ebc1, which were isolated 
during 2 days (2
nd
 and 4
th
 April 2007) from the same patient. 
A total of thirteen strains of Ent. cancerogenus were isolated over a period of two month 
(16
th
 and 17
th
 February and 24
th
 April 2007) from 3 different patients in the same 
hospital (NCH).These strains belonged to pulsotype Eb2. There was a large number of 
strains isolated from the same patients; see Table3.2.  
Twenty one strains of Ent. cancerogenus belonged to pulsotype Ebc3, which were 
isolated over a prolonged period of over two months (16
th
, 17
 th
 and 23
rd
 January, 
6
th
,11
th
,13
th
,16
th
, 17
th
 and 20
th
 February and 20
th
 March 2007) and the strains were 
isolated from 13 different neonates in the same hospital. Most strains in cluster Ebc3 
were isolated from the same patient on the same day. Two strains 807 and 808 were 
isolated from the same patient while four strains 814, 815, 816 and 817 were isolated 
Species Hospital Strain Number PFGE cluster
Number of 
Strains
Period of 
isolation
Patients
845,847,848,850,851 Ebc1 5 over one week 2
982,985,988,989,992,994,996,998,990, 991,907, 
908, 909
Ebc2 13
About three 
months
3
782, 783, 781, 784, 
807,808,810,814,815,816,817,818,824,825,826,827,
828,829,831,834,842
Ebc3 21 over two months 13
957, 966,969,972, Ebc5 4 same day 3
806 U 1 one day 1
1077 U 1 one day 1
1059, 1071, 1042, 1054 Ebc4 4 one week 4
1037, 1088 Ebc6 2 over one month 2
Ent. cancerogenus
NCH
QMC
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from one patient. In addition, two strains 825 and 826 were isolated from the same 
patient. Also strains 827, 828, 829 and 831 were isolated from the same patients.     
There were four strains of Ent. cancerogenus in pulsotype Ebc4, which were isolated in 
one week period (16
th
 and 22
nd
 October 2007) from 4 different patients in the same 
hospital (QMC).  
Four strains of Ent. cancerogenus belonged to pulsotype Ebc5, which were isolated on 
the same day (22
nd
 May 2007) and the strains were isolated from three different neonates 
in the same hospital. Two strains 969 and 972 were isolated from the same patient while 
strain 957 and 966 were isolated from different patients. 
Pulsotypes Ebc6 was composed of two strains of Ent. cancerogenus isolated over a 
prolonged period of one month (16
th
 October 2007 and 19
th
 November 2007) isolated 
from 2 different patients in the same hospital (QMC).  
Two strains (806 and 1077) were unique and were isolated from two different patients 
from different hospitals. 
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 Characterisation of  Klebsiella spp. strains 
Figure ‎3.3: PFGE cluster analysis of Klebsiella spp. (as performed by Alkeskas). 
 The dendrogram was generated by BioNumerics software, version 3.5, dice    coefficient 
and unweight pair group method with arithmetic mean (UPGMA) for cluster analysis. 
The tolerance and optimisation in the band was 1.50%. Kc1- Kc6 indicates PFGE cluster 
groups; U: Unique. 
 
 
Table ‎3.3: Summary of PFGE analysis of Klebsiella spp. strains. 
 
QMC: Queen’s Medical Centre. NCH: Nottingham City Hospital. Kc1- Kc6 indicates PFGE cluster groups, U: Unique. 
 
Dice (Opt:1.50%) (Tol 1.5%-1.5%) (H>0.0% S>0.0%) [0.0%-100.0%]
PFGE
1
0
0
9
5
9
0
8
5
8
0
7
5
7
0
6
5
6
0
5
5
5
0
4
5
PFGE
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. oxytoca
K. oxytoca
K. pneumoniae
K. pneumoniae
K. oxytoca
K. oxytoca
K. oxytoca
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
K. pneumoniae
1090
1091
1092
1046
1049
1048
1093
787
794
788
792
785
778
1078
1079
839
841
830
833
832
1006
1000
1001
1003
1004
1005
977
976
999
1002
1012
1013
1014
19/11/2007
19/11/2007
19/11/2007
22/10/2007
22/10/2007
22/10/2007
19/11/2007
23/01/2007
23/01/2007
23/01/2007
23/01/2007
23/01/2007
23/01/2007
31/10/2007
31/10/2007
28/02/2007
28/02/2007
20/02/2007
16/02/2007
16/02/2007
05/06/2007
05/06/2007
05/06/2007
05/06/2007
05/06/2007
05/06/2007
30/05/2007
30/05/2007
05/06/2007
05/06/2007
12/06/2007
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QMC
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NCH
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QMC
QMC
NCH
NCH
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NCH
NCH
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K
C
1
U
K
C
2
K
C
3
K
C
4
K
C
5
K
C
6
Date of 
isolation
strainspecies source
Species Hospital Strain Number PFGE cluster
Number of 
Strains
Period of 
isolation
Patients
K. oxytoca 832, 833, 830 Kc5 3
about one 
week
2
778, 785, 787, 788, 792,794 Kc2 6 same day 6
839,841 Kc4 2 same day 1
976, 977, 999, 1004, 
1006,1000,1002,1005,1001,1003,1012,1013,1014
Kc6 13 two weeks 5
1046, 1048, 1049, 1090, 1091,1092 Kc1 6 one month 2
1093 U 1 one day 1
K. oxytoca 1078, 1079 Kc3 2 one day 2
NCH
QMC
K. pneumoniae
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The strains of Klebsiella spp. were clustered into 6 pulsotypes isolated over a wide time 
period (Figure 3.3, Table 3.3). Thirty three strains of Klebsiella spp. had been isolated 
from NCH (n=24) and QMC (n=9) from 19 patients [Appendix 5]. These isolates were in 
6 clusters, Kc1-Kc6 and one unique strain. The strains in pulsotypes Kc1 and Kc3-Kc6 
displayed 100% similarity coefficient.  
Six strains of K. pneumoniae belonged to pulsotype Kc1. These were isolated over three 
weeks (22
nd
 October and 19
th
 November 2007) and from 2 different neonates in the same 
hospital (QMC). Three strains; 1046, 1048 and 1049, were isolated from the same 
patient on the same day (22
nd
 October 2007) while strains 1090, 1091 and 1092 were 
isolated from another patient on the same day (19
th
 November 2007).  
Pulsotype Kc2 was composed of six strains of Klebsiella spp. which were isolated on the 
same day (23
rd
 January 2007) from 6 different patients in the same hospital (NCH).Six 
strains of pulsotypes Kc2 was composed of three sub-clusters:  4, 1 and 1. The similarity 
coefficient of one sub-cluster was 100% with strains 787, 794, 788 and 792 which were 
isolated in one day from 4 different patients. However, these strains had a similarity 
coefficient (97%) with strain 785 which was caused by a difference of one band. On 
other hand, these two sub-clusters had a similarity coefficient with strain 778 (80%).    
From two different patients, 2 isolates of K.oxytoca were recovered which belonged to 
pulsotype Kc3. These strains were isolated on one day (31
st 
October 2007). 
Pulsotype Kc4 was composed of two strains of K. pneumoniae which were isolated in 
one day (28
th
 February 2007) and were isolated from the same patient.  
Three strains of K.oxytoca belonged to pulsotype Kc5, which were isolated 5 days apart 
(16
th
 and 20
th
 February 2007) and were from two different neonates in the same hospital. 
Two strains; 832 and 833, were isolated from the same patient on the same day while 
strain 830 was isolated from another patient. 
Thirteen strains of K. pneumoniae belonged to pulsotype Kc6. There were isolated 
during two weeks (30
th
 May and 5
th
 and 12
th
 June 2007) from five different neonates in 
the same hospital. Nine strains were isolated from 3 different patients; strains 999, 1004, 
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1006 from one patient, another three strains 1000, 1002 and 1005 were from the second 
and strains 1012, 1013 and 1014 from third patient. In addition, four strains were isolated 
from two different patients; 976, 977, 1001 and 1003. 
One strain, 1093, was unique and was isolated from one patient. 
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 Characterisation of Ent. cloacae and Ent. aerogenes strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎3.4: PFGE cluster analysis of Ent. cloacae and Ent.aerogenes (as performed by 
Alkeskas). 
The dendrogram was generated by BioNumerics software, version 3.5, dice coefficient 
and unweight pair group method with arithmetic mean (UPGMA) for cluster analysis. 
The tolerance and optimisation in the band was 1.50%. Eba1- Ebl1 indicates PFGE 
cluster groups; U: Unique 
Table ‎3.4: Summary of PFGE analysis of Ent. cloacae and Ent. aerogenes. 
 
QMC: Queen’s Medical Centre. NCH: Nottingham City Hospital. Ebl  and Eba  indicate PFGE cluster groups, U: 
Unique. 
 
Table 3.4 summarises the results of Figure 3.4. The five different isolates of 
Enterobacteriaceae (Ent. cloacae and Ent. aerogenes) have been obtained from two 
local hospital NCH (n = 2) and the remaining 3 were from QMC [Appendix 6]. The 
strains were clustered into two pulsotypes; Eba1 and Ebl1 and two unique strains. Thier 
analysis is described briefly below. 
Species Hospital Strain Number PFGE cluster
Number of 
Strains
Period of 
isolation
Patients
Ent. cloacae NCH 779, 789 Ebl1 2 one week 2
Ent. aerogenes 1056, 1058 Eba1 2 one week 2
Ent. cloacae 1028 U 1 one day 1
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From different patients 2 isolates of Ent. cloacae were recovered which belonged to 
pulsotype Ebl1. These strains were isolated in one week (16
th
 and 22
nd
October 2007). 
They displayed 100% of similarity coefficient. 
Two strains of Ent. aerogenes belonged to pulsotype Eba1, which were isolated during 
one week (16
th
 and 23
rd
 October 2007) and the strains were isolated from two different 
neonates in same the hospital. The similarity coefficient was 91%. The difference was 
one band. 
Two strains (1028 and 1094) were unique and were isolated from two different patients 
from the same hospitals. 
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 Characterisation of Enterobacteriaceae isolated from mastic breast milk 3.3.1.2
Figure ‎3.5: PFGE cluster analysis of MBM strains. 
PFGE profiles of twenty bacterial strains isolated from mastic human breast milk. The 
dendogram was created by BioNumerics software, version 3.5, dice coefficient and 
unweight pair group method with arithmetic mean (UPGMA) for cluster analysis. The 
tolerance and optimisation in the band was 1.75%.U: Unique and closely related indicate 
PFGE cluster groups. 
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Table ‎3.5: Summary of PFGE analysis of Enterobacteriaceae isolated from mastic 
human breast milk (MBM). 
 
Enc1-Enc3 indicate PFGE cluster groups, U: Unique. 
Table 3.5 is a summary of Figure 3.5 which presents the analysis of PFGE of twenty 
strains of Ent. ludwigii, Ent. cancerogenus and K. oxytoca from MBM in Spain.  The 
MBM isolates were clustered into 3 pulsotypes Enc1, Enc2 and Enc3 and 14 unique 
strains (Figure 3.5, Table 3.5). The PFGE of the MBM isolates revealed that two strains; 
1359 and 1360 (Enc1), showed 78% of similarity coefficient while two strains; 1355 and 
1358 (Enc2), were 89% similar according to Dice analysis and differed by only 3 bands 
(Figure 3.5). The similarity coefficient of two strains (1363 and 1364) with the others 
showed a similarity coefficient of 92%, which were clustered as Enc3. Therefore, they 
are probably six isolates of the same clone (Tenover et al., 1995). Since the original 
sampling by Delgado was confidential and little information exists with respect to the 
clustering and typing of strains we do not know if each of the two strains were from the 
same mother, but this was deemed highly likely. All other strains were < 80% similar 
and were therefore regarded as unique isolates, i.e. not clonal. 
 
 
 
 
Species Strain Number PFGE cluster
Genetic 
relatedness
1359, 1360 Enc1
1355, 1358 Enc2
1363, 1364 Enc3
1350,1357, 1361, 1362, 1365 
& 1367
Ent. ludwigii
1348,1349,1351, 1352 & 
1366
K.oxytoca 1353, 1354 & 1356
closely related
Unrelated
Ent. cancerogenus
U
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  Characterisation of K. pneumoniae strains isolated from EFT in Jordan 3.3.1.3
 
Figure ‎3.6: PFGE cluster analysis of K. pneumoniae strains isolated from EFT in Jordan. 
The dendogram was generated by BioNumerics software, version 3.5, dice coefficient 
and unweight pair group method with arithmetic mean (UPGMA) for cluster analysis. 
The tolerance and optimisation in the band was 1.60%. Kp1- Kp10 indicates PFGE 
cluster groups; U: Unique. 
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7days old
9 days old
9 days old
9 days old
21days old
21days old
21days old
36 days old
15 days old
36 days old
14 days old
19 days old
19 days old
19 days old
19 days old
16 days old
16 days old
16 days old
16 days old
9 days old
9 days old
9 days old
26 days old
26 days old
24days old
24days old
24days old
15 days old
15 days old
15 days old
15 days old
12 days old
12 days old
37days old
37days old
37days old
37days old
23 days old
23 days old
24days old
18 days old
18days old
12 days old
S26
S26
S26
S26
S26
S26
S26
S26
S26
S26
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
neosure
S26
S26
bebelac
S26
bebelac
S26
S26
S26
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
S26
S26
S26
bebelac
bebelac
bebelac
bebelac
bebelac
S26
S26
bebelac
bebelac
bebelac
bebelac
bebelac
neosure
neosure
neosure
neosure
neosure
S26
S26
S26
S26
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
bebelac
neosure
neosure
neosure
bebelac
Location Date of isolation Source of isolation Age of infant Milk information
K
p
1
0
U
U
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Table ‎3.6: Summary of PFGE analysis of K. pneumoniae strains isolated from Jordan 
hospital. 
 
KAH: King Abdulla Hospital. PRH: Princesses Rahma Hospital. Kp1-Kp10: indicates PFGE cluster groups; U: 
Unique. 
Table 3.6 show the summary of Figure 3.6 which presents the PFGE analysis of Jordan 
strains. There were seventy five EFT isolates of K. pneumoniae from two hospitals in 
Jordan which were PRH (n=60) and KAH (n=15); [Appendix 7]. The strains were 
clustered into 4 pulsotypes Kp1–Kp10 and there were two unique strains. The pulsotypes 
are described briefly below: 
A total of ten strains were isolated during a nine day period (12
th
, 15
th
, and 20
th
 
December 2011). These strains belonged to pulsotype Kp1, and were isolated from 6 
different patients receiving one type of infant formula (S26). Ten strains of pulsotype 
Kp1 were composed of two sub-clusters: containing 3 and 7 strains. The similarity 
coefficient within each sub-cluster was 100%. Similarity coefficient between the two 
strains sub-clusters 3 and 7 was 96%.  
All strains in pulsotypes Kp2-Kp10 showed 100% of similarity coefficient. Twenty three 
strains belonged to pulsotype Kp2. This pulsotype was isolated over a prolonged period 
of five months (4
th
, 6
th
, 7
th
 and 23
rd
 July and 10
th
, 15
th
 and 20
th
 December 2011), from 
two different hospitals in Jordan. Six strains were isolated from KAH hospital and 
Species Hospital Strain Number PFGE cluster
Number of 
Strains
Period of isolation Patients
 1744, 1745, 1746,1747,1748,1749,1751,1752, 1753,1754 Kp1 10 during 3 days 6
1681,1682,1689,1716,1717,1718,1719,1720,1721,1722, 1723, 
1724, 1725,1726, 1727, 1728,  
1736,1740,1741,1742,1743,1750,1756
KAH 1722,1723,1724,1727, 1728
 1683, 1684, 1685,1686,1687,1688 Kp3 6 over two weeks 2
 1737, 1738, 1739 Kp4 3 same day 2
1729, 1730, 1731, 1732, 1733 Kp5 5 one week 2
1709, 1710, 1711,1712, 1713, 1714,1715 Kp6 7 over two weeks 3
1691,1692,1693,1694, 1695,1696,1697,1698 Kp9 8 one week 3
1690 U 1 same day 1
 1699, 1700, 1701,1702 Kp7 4 over one month 2
1703,1705,1706,1707, 1708 Kp8 5 same day 2
 1734, 1735 Kp10 2 same day 1
1704 U 1 one day 1
KAH
K. pneumoniae
13
PRH
Kp2
PRH
23 over seven months
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seventeen strains were isolated from PRH hospital. These strains were isolated from 13 
different neonates where eight patients received bebelac, one received neosure and four 
received S26 infant formula. The Kp2 pulsotypes strains were isolated from a large 
number of neonates over a wide time period from two different hospitals. The result 
appears unlikely and needs further confirmation by using another restriction enzyme.   
Six strains of K. pneumoniae were grouped into pulsotype Kp3. These strains were 
isolated from two different neonates over two weeks (4
th
 and 23
rd
 July 2011). The 
hospitals used bebelac for infant feed.  
Three strains of K. pneumoniae belonged to pulsotype Kp4, which were isolated on the 
same day (10
th
 December 2011) and the strains were isolated from two different neonates, 
receiving S26 infant formula. 
Pulsotype Kp5 was composed of five strains of K. pneumoniae. There were isolated on 
one week (9
th
 and 15
th
 July 2011) from 2 patients, receiving bebelac infant formula. 
Seven strains of K. pneumoniae formed pulsotype Kp6, which were isolated over a two 
week period (6
th
 and 23
rd
 July 2011) from 3 different patients receiving S26 and bebelac 
infant formula.  
From 2 different patients, 4 isolates of K. pneumoniae were recovered which belonged to 
pulsotype Kp7. These strains were isolated over one months (31
st
 May and 4
th
 July 
2011).The babies were received neosure infant formula. 
Five strains of K. pneumoniae belonged to pulsotype Kp8, which were isolated on the 
same day (31
st
 May 2011) from two different patients, receiving different types of infant 
formula (S26 and bebelac).  
At one week period (4
th
 and 9
th
 July 2011) eight strains of K. pneumoniae were isolated 
which belonged to pulsotype Kp9. These were isolated from 3 different patients, 
receiving bebelac infant formula. 
Two strains of K. pneumoniae belonged to pulsotype Kp10, which were isolated on the 
same day (7
th
 December 2011) and from the same patient receiving neosure infant 
formula. 
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Two strains (1704 and 1690) were unique and were isolated from two different patients 
receiving neosure and bebelac infant formula respectively. 
3.3.2  Comparison of phenotypic and genotypic techniques for identification of 
Enterobacteriaceae 
All strains were identified using biochemical profiles based on API 20E and ID32E 
methods. Genotyping identification was also used to identify the isolates by using 16S 
rDNA sequence analysis. In addition, the phenotypic and genotypic results were 
compared with PFGE results.   
 Identiﬁcation‎of‎Enterobacteriaceae strains isolated from EFT 3.3.2.1
Table 3.7 part1 shows the comparison between phenotyping and genotyping 
identification technique. Most Ent. cloacae strains were re-identified by 16S rDNA 
sequence analysis and were subsequently re-assigned  as Ent. hormaechei. There were 
clustered into 7 clusters Ebh1-Ebh7 and four unique strains by using PFGE technique.  
An interesting result was that two strains which were initially identified as K. oxytoca by 
ID32E, but were re-identified by 16S rDNA sequence analysis as Ent. aerogenes. There 
were clustered in one cluster Eba1. Another two strains were identified by ID32E tests as 
Ent. cloacae and Ent. amnigenus however, were re-identified by 16S rDNA sequence 
analysis as Ent. hormaechei. They were clustered in one cluster Ebh7. 
In Table 3.7 part 2 shows that fifty one strains were previously identified as Klebsiella 
spp. and E. coli; six strains were identified as K. pneumoniae and 44 strains were 
identified as K. oxytoca, whereas one strain was E. coli by using API20E/ID32E tests. 
While in this study these strains were re-identified by 16S rDNA sequence analysis as 
Ent. cancerogenus, but their pulsotypes clustered into 6 clusters Ebc1-Ebc6 and two 
unique strains.  
All K. pneumoniae and 15 of K. oxytoca strains belonged to one cluster; pulsotype Ebc2. 
On the other hand, strains 1037 and 1088 were identified as K. oxytoca and E. coli 
respectively by ID32E, but they were identified as Ent. cancerogenus by 16S rDNA gene 
sequence analysis and both belonged to cluster Ebc6. 
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All strains in table 3.8 were identified as Klebsiella spp. by both API20E/ID32E tests 
and were in 6 pulsotypes Kc1-Kc6 and one unique strain. The exception was in clusters 
Kc1 and Kc6 which consisted of only one E. coli and 3 Ent. aerogenes strains 
respectively, as identified by ID32E test. However when re-identified by 16S rDNA, the 
strains in both Kc1 and Kc6 clusters were found to be K. pneumoniae.  
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Table ‎3.7: Identiﬁcation Enterobacteriaceae isolated from enteral feeding tubes by 
using phenotyping and genotyping techniques; part 1. 
 
QMC: Queen’s Medical Centre, NCH: Nottingham City Hospital. a and b indicate type of phenotyping test  API 20E 
and ID32E respectively. Ebh1- Ebh7, Ebl1 and Eba1 indicate   PFGE cluster groups,   U: Unique. 
 
 
 
 
 
Strain no. Source ID profile ID API 16S rDNA sequence PFGE cluster
979 3305573
a Ent. cloacae Ent.hormaechei
980 3305573
a „ „
981 3305573
a „ „
983 3305573
a „ „
986 3305573
a „ „
987 3305573
a „ „
993 3305573
a „ „
997 3305573
a „ „
856 7305573
a „ „
859 7305573
a „ „
860 7305573
a „ „
861 7305573
a „ „
862 7305573
a „ „
863 7305573
a „ „
795 7305573
a „ „
797 7305573
a „ „
798 7305573
a „ „
799 7305573
a „ „
800 7305573
a „ „
801 7305573
a „ „
802 7305573
a „ „
803 7305573
a „ „
960 3305573
a „ „
790 7305573
a „ „
779 7244773
a K. oxytoca Ent. cloacae
789 7244773
a K. pneumoniae „
1033 73015732
a Ent. cloacae Ent.hormaechei
1034 73015732
a „ „
1035 73015732
a „ „
1052 34064753331
b „ „
1074 74064753331
b „ „
1032 73015732
a „ „
1053 34064753331
b „ „
1075 34064753331
b „ „
1027 73015632
a „ „
1066 34064751131
b „ „
1067 34064751131
b „ „
1081 34064751131
b „ „
1084 34064751131
b „ „
1068 34064751131
b „ „
1069 34064751131
b „ „
1089 34064751131
b „ „
1044 34060743231
b „ „
1038 34074743231
b
Ent. amnigenus „
1039 34060743231
b Ent. cloacae „
1040 34060743231
b „ „
1058 47175757333
b K. oxytoca Ent. aerogenes
1056 44175757333
b „ „
1028 73055733
a Ent. cloacae Ent. cloacae U
QMC
Eba1
Ebh6
Ebh5
U
Ebh2
Ebh7
Ebl1
NCH
Ebh1
Ebh3
Ebh4
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Table 3.7: Identiﬁcation Enterobacteriaceae isolated from enteral feeding tubes by 
using phenotyping and genotyping techniques; part 2. 
 
QMC: Queen’s Medical Centre, NCH: Nottingham City Hospital. a and b indicate type of  API test ID20E and ID32E  
respectively. Ebc1- Ebc6 indicates PFGE cluster groups, U: Unique. 
 
 
 
 
 
 
 
Strain no. Source ID profile ID API 16S rDNA sequence PFGE cluster
982 7245773
a K. oxytoca Ent. cancerogenus
985 7245773
a „ „
988 7245773
a „ „
989 7245773
a „ „
992 7245773
a „ „
994 7245773
a „ „
996 7245773
a „ „
998 7245773
a „ „
990 7245773
a „ „
991 7245773
a „ „
845 7245573
a „ „
847 7245573
a „ „
848 7245573
a „ „
850 7245573
a „ „
851 7245573
a „ „
907 7245773
a „ „
908 7245773
a „ „
909 7045773
a „ „
782 7244773
a „ „
783 7244773
a „ „
781 7244773
a „ „
784 7204773
a K. pneumoniae „
807 7244773
a K. oxytoca „
808 7244773
a „ „
810 7245773
a „ „
814 7245773
a K. pneumoniae „
815 7245773
a „ „
816 7245773
a „ „
817 7245773
a „ „
818 7245773
a „ „
824 7245773
a K. oxytoca „
825 7245773
a „ „
826 7245773
a „ „
827 7245773
a „ „
828 7245773
a „ „
829 7245773
a „ „
831 7245773
a „ „
834 7245773
a „ „
842 7245773
a „ „
957 7245773
a „ „
966 7245773
a „ „
969 7245773
a „ „
972 7245773
a „ „
806 7244773
a „ „
1077 47575777333
b K. oxytoca Ent. cancerogenus
1042 47175757233
b „ „
1054 47075377333
b „ „
1059 44175757333
b „ „
1071 47175057333
b „ „
1037 45174757333
b „ „
1088 75565763420
b E. coli „
Ebc1
Ebc2
QMC
U
Ebc3
Ebc6
Ebc4
Ebc5
NCH
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Table 3.8: Identiﬁcation Enterobacteriaceae isolated from enteral feeding tubes by using 
phenotyping and genotyping techniques. 
 
   QMC: Queen’s Medical Centre, NCH: Nottingham City Hospital. a and b indicate type of phenotyping test API 20E 
and  ID32E respectively. Kc1- Kc6 indicates PFGE cluster groups, U: Unique. 
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  Identiﬁcation‎of‎Enterobacteriaceae  isolated from mastic human breast 3.3.2.2
milk 
The strains previously isolated from MBM were further analysed by phenotyping using 
ID32E following the procedure in section 2.2.1. The results are summarised in Table 3.9. 
As shown, all strains were identified as K. oxytoca. 16S rDNA gene sequence analysis 
was used to identify the recovered bacterial strains. As shown in Table 3.9, there was 
variation between ID32E results and 16S identification. The results obtained for the 
MBM isolates showed that out of the twenty strains identified as K. oxytoca by ID32E, 
twelve were Ent. cancerogenus and five were Ent. ludwigii with the more reliable 16S 
rDNA sequence analysis; see Table 3.9.  
The interesting finding was that six strains which were Ent. cancerogenus (1359, 1360, 
1355, 1358, 1363 and 1364) were identified as K. oxytoca by ID32E test and their ID 
profile was different; Table 3.9. However, these strains were identified by 16S rDNA 
sequence analysis as Ent. cancerogenus and their pulsotypes were Enc1, Enc2 and Enc3. 
Each of the two strains belonged to one cluster respectively; see Table 3.9. 
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Table ‎3.9: Identiﬁcation Enterobacteriaceae isolated from mastic human breast milk by 
using phenotyping and genotyping techniques. 
 
                     Enc1- Enc3 indicates PFGE cluster groups, U: Unique. 
 
 
 
 
 
 
 
 
 
 
Strain no. ID32E profile ID32E 16S rDNA sequence PFGE cluster
1350 4 7 1 7 5 7 5 7 3 3 1 K. oxytoca Ent. cancerogenus U
1355 4 7 1 7 5 7 5 7 3 3 1 „ „
1358 5 7 1 7 5 75 7 3 3 1 „ „
1357 4 7 1 7 5 7 5 7 3 3 1 „ „ U
1359 4 7 5 7 5 7 5 7 3 3 1 „ „
1360 4 7 1 7 5 7 5 7 3 3 0 „ „
1361 4 7 5 7 5 7 5 7 1 3 1 „ „
1362 4 7 5 7 5 7 5 7 3 3 1 „ „
1363 6 7 1 7 5 7 5 7 3 3 1 „ „
1364 7 7 1 7 5 7 5 7 3 3 1 „ „
1365 7 7 1 7 5 7 5 7 3 3 1 „ „
1367 4 7 1 7 5 7 5 7 3 3 1 „ „
1348 4 7 0 7 5 7 7 7 3 7 3 „ Ent. ludwigii
1349 4 7 5 7 5 7 5 7 3 3 1 „ „
1351 4 7 5 7 5 7 5 7 3 3 1 „ „
1352 4 7 1 7 5 7 5 7 3 3 0 „ „
1366 4 7 1 7 4 7 1 7 3 3 1 „ „
1353 4 7 5 7 5 7 5 7 3 3 1 „ K. oxytoca
1354 6 5 1 7 5 7 5 7 3 3 1 „ „
1356 4 4 1 7 5 7 5 7 3 3 1 „ „
Enc1
Enc2
Enc3
U
U
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3.4 DISCUSSION 
This project investigated the neonatal of infection with Enterobacteriaceae from MBM 
from Spain and EFT using strains from QMC and NCH (UK) and Jordan. The aim of 
this investigation was to assess neonatal exposure to bacteria. These studied strains do 
not have any associated clinical details; nevertheless, the aim of assessing and 
characterising strains from these three sources is important. EFT isolates of K. 
pneumoniae (from Jordan) were also analysed but only for PFGE profiling due to time 
constraints. Strains isolated from MBM and EFT included bacteria which are potentially 
pathogenic to neonates. The present study is a continuation the studies of Hurrell et al. 
(2009b) and Delgado et al. (2008) and has further investigated and characterised their 
strains. PFGE was applied to the EFT from QMC and NCH (UK), EFT isolates of K. 
pneumoniae (from Jordan) and MBM (Spain).  
In this study, one hundred and thirty-three Enterobacteriaceae strains have been 
obtained from two local hospitals in Nottingham, NCH and QMC. These strains were 
isolated from neonatal enteral feeding tubes; forty four of Ent. hormaechei, fifty one of  
Ent. cancerogenus, thirty three of Klebsiella spp., three strains of Ent. cloacae and two 
strains of Ent. aerogenes. These strains were isolated from 60 patients during 10 months 
and the period was from 17
th
 January to 19
th
 November 2007. This study applied PFGE 
as a DNA fingerprinting technique to identify the source of isolation, determine if the 
same strains were isolated at different times from the NICU and to confirm whether 
these strains caused the contamination of EFT which in turn increased the risk of 
exposure to neonates.   
The results of this investigation showed that the Ent. hormaechei strains were clustered 
into 7 pulsotypes (Ehc1-Ehc7) in addition to the two unique strains identified (Figure 3.1, 
Table 3.1). Ent. cancerogenus strains were clustered together into 6 pulsotypes (Ebc1– 
Ebc6) and two unique strains; (Figure 3.2, Table 3.2). Klebsiella spp. were grouped into 
6 pulsotypes and one unique strain (Figure 3.3, Table 3.3). The last group consisted of 
multiple isolates, Ent. cloacae and Ent. aerogenes which were clustered into two 
pulsotypes (Eba1 and Ebl1) and one unique strain. Each Eba1 and Ebl1 comprised of 2 
isolates; (Figure 3.4, Table 3.4). 
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The majority of the pulsotypes were isolated from the same patient in one day. For 
example, eight strains of Ent. hormaechei and six strains of K. pneumoniae (Figure 3.1, 
Table 3.1) were isolated from the same patient on 16
th
 February 2007 and 30
th
 January 
2007 respectively. These strains were clustered in Ebh1 and Kc2 (Figures 3.1 and 3.3). It 
is possible that the strain multiplied and contaminated the feeding tubes in a short time. 
The most explicable finding in this study is the identification of clusters Ebh6 and Kc2. 
The cluster Ebh6 comprised of eight strains which were isolated from six patients on the 
same day, while cluster Kc2 consisted of six strains isolated on the same day from six 
different patients. The results of this study indicate that one clone of each cluster 
potentially cross contaminated the neonatal enteral feeding tubes with diverse pulsotypes 
of Ent. hormaechei and K. pneumoniae during one week (23
rd
 and 30
th
 January 2007).  
One of the significant findings in this study is that three different clusters were isolated 
over a wide time period. There were eight strains of Ent. hormaechei in pulsotype Ebh5 
which were isolated from 3 patients in one month (16
th
 October and 12
th
 and 19
th
 
November 2007), twenty one strains of Ent. cancerogenus pulsotypes Ebc3 were isolated 
from 13 patients over two months (16
th
, 17
 th
 and 23
rd
 January, 6
th
,11
th
,13
th
,16
th
, 17
th
 and 
20
th
 February and 20
th
 March 2007)  and 6 strains of K. pneumoniae pulsotype Kc1 were 
isolated from two patients in one month (22
nd
 October and 19
th
 November 2007). Taken 
together, these results suggest the cross-transmission of indistinguishable clones of each 
pulsotype between different patients over a long period of time in the same NICUs. This 
finding may indicate the same origins, such as: environment, infant formula or carers.  
Furthermore, the collection of seventy five K. pneumoniae strains isolated from the EFT 
of neonates in NICUs from two hospitals in Jordan were analysed by using PFGE. The 
objective was to detect strains that were isolated at different times from the NICUs and 
to determine whether the strains have colonised the neonatal EFT which might have 
caused the colonisation in the NICUs leading to potentially increased exposure and risk 
to the neonates. 
The PFGE result of Jordan cultures indicated genetically indistinguishable  
K. pneumoniae strains, forming two small pulsotype clusters, Kp1 and Kp4, containing 
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ten and two strains respectively. It also showed that large groups Kp2 and Kp3 were 
comprised of forty and twenty three strains respectively. 
The Kp2 pulsotype was isolated over a prolonged period of seven months (22
nd
 May, 4
th
, 
7
th
, 23
rd
 July, 7
th
, 10
th
, 15
th
 and 20
th
 December 2011) from two different hospitals; KAH 
and RAH. A total of 23 strains belonged to Kp2 cluster isolated from 13 different 
patients; six of the strains were isolated from KAH hospital, while seventeen strains 
were from RAH hospital.  
Similarly, Kp3 pulsotype had formed one large pulsotype group which included 6 strains. 
This cluster was isolated over two weeks period (4
th 
and 23
rd
 July 2011) from 6 patients 
and the babies were fed the same type of infant formula, bebelac.  
In addition, Kp2 and Kp3 were isolated from thirteen and two patients respectively and 
bebelac infant formula was used to feed the babies. This finding indicates the existence 
of a clone for each group which showed 100% of similarity coefficient. Furthermore, the 
cross-transmission of an indistinguishable clone was determined from different neonates 
over a long period.  
Of particular interest was the Kp2 pulsotype; the result is quite unlikely since the strains 
were isolated from different of two hospitals. However, the most likely explanation 
seems to be the likelihood that both of these hospitals in Jordan used the same brand of 
infant formula “bebelac” which could have been contaminated with bacterial strains in 
Kp2 cluster. The KAH hospital fed the babies with bebelac in May and the PRH hospital 
started using this brand in July. So this clone possibly cross contaminated the neonatal 
enteral feeding tubes over a wide time period (from May to December) and infected a 
large number of neonates. However, this assumption needs verification of these results 
using a different restriction enzyme in the PFGE.  
 In this study, an interesting finding is the indistinguishable clone of K. pneumoniae Kp2 
and Kp3 clusters contaminating the feeding tubes in two different hospitals which could 
have originated from the same source. The possible sources could be the powdered 
infant formula, preparation of PIF for infants in NICU or the hands of care workers. This 
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can result in the contamination of fresh feed in the tube lumen leading to further bacterial 
multiplication.  
In this study, the findings of results for two sources of EFT from QMC and NCH (UK) 
and EFT from Jordan were consistent with FAO/WHO (2004, 2006) which found the 
PIF is not a sterile product and maybe an important source of bacterial pathogens that 
can cause serious illness in infants (i.e., children aged <1 year). In addition, previous 
studies by Muytjens et al. (1988) and Townsend et al. (2008a) reported that 
Enterobacteriaceae isolated from PIF include Ent. cloacae, K. pneumoniae, K. oxytoca, 
Ent. hormaechei, Cit. freundii, and E. coli. Furthermore, studies by Caubilla-Barron et 
al. (2007) and Iversen et al. (2008) found that C. sakazakii and Salmonella were 
associated with contaminated PIF which caused neonatal infections.  
The reconstitution temperature of PIF for infants in NICUs and the storage period could 
increase the growth of any bacteria and cross contamination in NICUs is then very likely. 
Forsythe (2009) reported that in a neonatal care unit, PIF (fortified breast milk and 
reconstituted powdered infant formula) was reconstituted at room temperature when 
required, not at higher temperatures. This procedure in NICUs across the UK may differ. 
A further research study in French hospitals by Rosset et al. (2007) reported that similar 
practices were used. They stated that samples were prepared with cold water (room 
temperature), kept at room temperature for <15 minutes and then stored in a cold cabinet 
at 4°C or below. In a water bath, multiple bottle heating was used to reheat samples for 
30 minutes. At the end of reheating, the temperatures were less than 47°C for 55% of the 
samples. The recommendation by FAO/WHO in 2006 is to limit the time from 
preparation to consumption and also prepared feeds should be stored at temperatures not 
more than 5°C. 
Another potential source of bacteria could be through a contaminated healthcare worker, 
which could lead to bacterial transmission between the patients. This may be consistent 
with previous studies that report the source of a nosocomial outbreak of colonisation and 
infection with a strain of Se. marcescens was from health care workers. This occurred in 
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an ICU in a Dutch University Medical Center from May 2002 through March 2003 (de 
Vries et al., 2006).  
The healthcare workers suffering from chronic otitis external have been linked 
epidemiologically with the outbreak of Methicillin-Resistant Staphylococcus aureus 
colonisation and infection in a NICU (Bertin et al., 2006). A study by Waters et al. 
(2004) detected Gram-negative bacilli previously associated with infections in neonates 
on the nurses’ hands, even after the hand hygiene was performed.   
Out of the twenty strains isolated from MBM, six strains of Ent. cancerogenus were 
divided into three clusters; Enc1- Enc3. The interesting finding is strains 1355 and 1358 
(Enc2), were found to have 89% similarity patterns (Figure 3.5), and two strains 1359 
and 1360 (Enc1) showed 78% of similarity coefficient, while cluster Enc3 (1363 and 
1364) showed a similarity coefficient of 92%.  These six strains were also found to be 
nearly identical by using 16S rDNA sequence analysis; additionally, the strains differ by 
only 3 bands by PFGE (Tenover et al., 1995). All other strains showed pattern < 80% 
similar patterns and, therefore, were regarded as unique isolates, i.e. not clonal. The 
results for the MBM isolates showed six strains were of particular interest which 
belonged to three pulsotypes. They were probably the same clone and most likely 
obtained from the same mother. 
Two strains, 779 and 789, were isolated from EFT (QMC and NCH) which were then 
identified using phenotypic and genotypic techniques. The phenotypic methods, 
including API20E and ID32E, identified the strains as Ent. cloacae and K. pneumoniae, 
while the genotypic method 16S identified both strains as Ent. cloacae. PFGE clustered 
both of these strains in Ebl1. This confirms that the 16S identification is more reliable 
than the phenotypic methods.  
Another important finding is that (Table 3.7 parts 1 and 2) there were two clusters, Kc1 
and Kc6, which included one E. coli and three strains of Ent. aerogenes respectively. 
These strains were initially identified by the ID32E test, but by 16S rDNA sequence 
analysis, they were re-assigned as K. pneumoniae in both clusters.   
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Also strains from MBM were characterised using standard phenotyping methods and 
compared with genotyping. These included Ent. cancerogenus, which previously had 
been misidentified as K. oxytoca by using the more common biochemical identification 
kits, compared with 16S sequence analysis (Table 3.9).  
It is of particular interest that six strains of Ent. cancerogenus were clustered into three 
pulsotypes ( Ecn1- Ecn3) and were misidentified as K. oxytoca by ID32E. This finding 
indicted that the phenotypic method incorrectly identified most of the strains compared 
with the genotypic technique. This finding was confirmed with PFGE results which 
showed similarity classification. The identities of these strains are presented in Table 3.7 
parts 1, 2 and 3.8 and Table 3.9. 
The most probable explanation is that genotypic identification is more accurate than 
phenotyping and characterisation of bacteria by PFGE is a suitable technique for strain 
relatedness.  
The findings of the current study were consistent with Iversen et al. (2004b and 2004c), 
who reported that the API 20E and ID32E tests are imperfect techniques to utilise for 
identification of bacteria because they could give false-negative and false-positive results. 
Moreover, 16S rDNA sequence analysis results in the current study have agreed with the 
findings of Iversen et al. (2004b and 2006b), who demonstrated that some strains 
identified as C. sakazakii by a biochemical test belonged to diverse species, including 
two species Ent. amnigenus and Ent. cloacae. 
Furthermore, Townsend et al. (2008a) acquired ‘Cronobacter’ (C. sakazakii) strains 
from a hospital for further analysis which were identified by using the phenotypic 
technique. Townsend et al. (2008a), using PFGE, revealed that they were clonal and 
were isolated from a NICU outbreak which the hospital was not aware of.  Subsequent 
16S rDNA sequencing re-identified the strains as Ent. hormaechei. Hence, the hospital 
had not only not recognised they had an outbreak but had also misidentified the 
organisms by using incorrect techniques.   
Additionally, Muytjens et al. (1988) highlighted the incidence of Cronobacter spp. (C. 
sakazakii) in powdered infant formula. Initially these strains were identified in 1988 
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using biochemical profiling, whereas Townsend et al. (2008a) have used 16S rDNA 
sequence analysis to re-identify the strains, some of which were Ent. hormaechei. This 
indicated that Muytjens et al. (1988) had misidentified the organisms which were present 
in powdered formula that could be a source of exposure to neonates because of using 
unsuitable identification methods. 
In summary, neonatal enteral feeding tubes and mastic human breast milk were 
contaminated by a total of twenty-four pulsotypes of Enterobacteriaceae; 21 EFT and 3 
MBM. The same pulsotypes spread among the EFT of infants in the same NICUs, 
indicating the same origins, such as: environment, infant formula or carers. Genotypic 
identification is a more reliable technique to identify strains than phenotyping and 
characterisation of bacteria by PFGE is a suitable technique for strains relatedness.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 104 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4: PHYSIOLOGICAL TRAITS 
OF BACTERIAL ISOLATES 
 
 
 
 
 
Chapter 4 
 
105 
 
4.1 Introduction 
 
Enteral feeding tubes are widely used to feed low birth weight infants in NICUs and  
may be in situ for several days.  A previous study demonstrated that the enteral feeding 
tube may be a very important source of bacteria entering neonates, and could also be  
a place for opportunistic intestinal pathogens to multiply (Hurrell et al., 2009b). 
Enterobacteriaceae are able to form biofilms on enteral feeding tubes as they can attach 
to inert surfaces and grow (Murga et al., 2001; Thompson et al., 2006; Zogaj et al., 
2003).  
Lately, considerable attention has been focused on the microbiological safety of PIF.  
The FAO/WHO (2004) carried out a risk assessment of the organisms associated with 
neonatal infections and PIF. They categorised the organisms into groups: Category 1 as 
‘clear evidence of causality’, which were Cronobacter spp. (formely Enterobacter 
sakazakii) and Salmonella serovars, while other Enterobacteriaceae were considered 
Category 2 ‘causality plausible’.  
In 2006 FAO/WHO added Acinetobacter spp. to the latter group. These organisms are 
opportunistic pathogens, although at present there is no evidence of any outbreaks in 
NICUs of these organisms. NTU, in collaboration with local NICUs, discovered that the 
organism was present in EFT from neonates on non-formula feeding regimes (Hurrell et 
al., 2009b). This indicates that neonate exposure to Cronobacter may not exclusively be 
due to reconstituted formula, and the increased exposure to bacterial pathogens may be 
linked to more general feeding practices.   
From two local NICUs in Nottingham, the bacteria from 129 neonatal enteral feeding 
tubes were studied by Hurrell et al. (2009a and b). According to their study, 
Enterobacteriaceae due to their ability to adhere and multiply on feeding tubes, posed a 
far greater risk to neonatal health than Cronobacter alone. This was evident from the 
isolation of a wide range of Enterobacteriaceae from 76% of the feeding tubes which 
included E. coli, Ent. cancerogenus, Ent. hormaechei, K. pneumoniae, K. oxytoca, 
Raoutella spp., Se. liquefaciens and Se. marcescens, in addition to Cronobacter and 
Yersinia spp.  
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The infants fed reconstituted PIF showed the highest amount of Enterobacteriaceae 
biofilm formation averaging 4.2 log10 cfu/tube. Longer duration (48 hours) of milk in the 
feeding tube and the absence of antibacterial agents, unlike breast milk, may allow these 
bacteria to multiply and grow. Compared to the tubes of infants fed fortified breast milk 
(3.6 log10 cfu/tube), the lowest number of bacteria was obtained from the EFT of infants 
fed unfortified breast milk (1.4 log10 cfu/tube).  
Biofilms of Enterobacteraceae were recovered from 81% of neonates fed sterile ready to 
feed formula. It was proposed that the gastroesophageal reflux from the throat could be 
the source of bacteria. The study by Hurrell et al. (2009a) also indicated the ability of 
bacteria to grow in the nasogastric tubes of 10
7
cfu/tube within 8 hours which increased 
to 10
9 
cfu/tube within 24 hours, in situ. It is plausible that the bacterial biofilm in vivo 
may contaminate the routine feeds and on ageing may detach and survive the passage 
through the neonate’s stomach ultimately reaching the intestial as a bolus with the feed. 
Therefore, the biofilm formation on the EFT pose a great risk to the neonate’s health and 
should be considered as an important risk factor.  
It was concluded from this study that it was important to focus on the microbiological 
safety of neonatal feed, not only with respect to Cronobacter spp. and infant formula but 
that attention should also be given to the general practices of the feed preparation (Holý 
and Forsythe, 2014). Subsequently, this may reduce the neonate’s exposure to a wide 
variety of Enterobacteraceae, some of which could be resistant to antibiotics. Similarly, 
the placement of feeding tube in neonates for prolonged durations should also be 
considered to reduce the exposure to bacterial pathogens. Thus, the biofilm formation on 
the EFT represents a significant risk factor for neonatal infections.  
Acidity of stomach acts as an important line of defence in protecting against infections 
through ingestion (Martinsen et al., 2005; Smith, 2003). According to Hurrell et al. 
(2009b) reported that the gastric stomach's pH value of neonates fed breast milk, ready-
to-feed and powdered infant formulas ranges from 2.5, 3.5 and 4.3, respectively. The 
several of bacteria are killed at a pH less than 2.0 (Zhu et al., 2006). The bacterial killing 
in the stomach is also simplified by the proteolytic activity of the gastric enzymes as they 
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cause the release of peptides from, for instance, lactoferrin play important role as 
antimicrobials (Nibbering et al., 2001; Ryley, 2001). 
The aims of this chapter was to determine the pertinent physiological traits of Ent. 
ludwigii, Ent. hormaechei, Ent. cancerogenus, Ent. cloacae Ent. aerogenes and K. 
oxytoca. Biofilm formation (Stepanovic et al., 2004) on plastic surfaces was determined 
using casein, whey and soy- based infant formulas at 20°C and 37°C.  Previous studies 
on Cronobacter (NTU, unpublished) have shown that biofilm formation is affected by 
formula type and temperature, such that more attachment occurs at body temperature 
and, therefore, when the organism comes in contact with the enteral feeding tube in situ.   
Biofilm formation analysed using the cell wall structures could be adherence to surfaces; 
such as capsule.  Heat tolerance to 55°C was used as a representative temperature used 
for the reconstitution of powdered infant formulas. The survival curve of strains at pH 
3.5 (HCl acidified formula) was determined as this is a representative of the neonatal 
stomach conditions on ingestion (Hurrell et al., 2009b). The collation of this information 
is useful in identifying the potential exposure of neonates to strains due to heat tolerance, 
biofilm formation and acidic pH survival as potential risks to neonates in NICUs. 
4.2 Materials and methods 
 
The detailed preparation of culture media and experimental conditions have been 
described previously in section 2.4. 
Selected strains of Ent. ludwigii, Ent. hormaechei, Ent. cancerogenus, Ent. cloacae,  
Ent. aerogenes and K. oxytoca were used in this chapter. Their sources and designated 
culture collection numbers are preceded in Tables 2.7 (chapter 2). Three types of formula, 
whey (Cow and Gate), casein (SMA1), and soy-based (Cow and Gate infasoy) infant 
formula were used to grow bacteria cultures for 18-20 hours (stationary phase) at 
different temperatures depending on the experimental protocol. The procedure for this 
chapter has been described earlier: 
- Heat tolerance in section 2.4.1 
- Biofilm formation in section 2.4.2 
- Capsule formation in section 2.4.3 
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- Acid tolerance in section 2.4.4 
Pathogenic bacteria in PIF should not be considered safe at any level because illnesses 
resulting from the management of contaminated PIF do not need a high number of 
pathogens, as even small numbers can colonize the neonate and cause disease. However, in 
this study, the heat tolerance of the isolate was carried out by D-value determination which 
was calculated as the time required for a 1 log reduction in the viable count at 55ºC. The 
results were then classified as following: 
1- The D- value of less than 4 minutes indicates that the strains are heat sensitive.  
2- The D-value between 4 minutes to 15 minutes indicates that the strains are moderatley 
tolerant to heat.  
3- The D- value of more than 15 minutes indicate that the strains are heat resistant. 
In the UK, to prepare PIF it sould use water that has been boiled in a kettle and left to cool 
for 30 minutes, These products are not reconstituted with water and cannot be exposed to 
heat treatment to kill intrinsic bacteria. Thus, the time required to kill the bacteria less than 
15 minutes is still milk hot to fed neonates.  
4.3 Results 
4.3.1 Heat tolerance 
Ent. ludwigii 
 
As shown in Table 4.1, Ent.ludwigii strain 1352 was more heat resistant than the 
remaining strains. It had a D-value of > 50 minutes at 55°C in whey and casein-based 
infant formula as presented in Figures 4.1 A and B. Whereas, Ent.ludwigii strain 1348 
showed a very different death rate D55 =11.5 minutes in casein-based infant formula 
compared with D55 =5 minutes in whey-based infant formula. Ent. ludwigii strains 1349 
and 1351 showed moderate heat resistance and the viability decline was linear in casein-
based infant formula (D values were D55 = 6 and 9.5 minutes respectively). Strain 1349 
showed clear difference in survival in whey-based infant formula with D55 ≤ 4 minutes, 
and was deemed sensitive to heat. Furthermore, Ent. ludwigii strains 1366 and 1439 
showed sensitivity to heat and subsequently had lower D-values in whey and casein-
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based infant formula (Table 4.1, Figures 4.1 B and B).  In general, Ent. ludwigii heat 
treated in whey-based infant formula product had similar D- values to those determined 
in the casein-based infant formula product. However, in casein-based infant formulas the 
Ent.ludwigii strains were more heat tolerant and had shorter log-periods. 
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(A) 
 
(B) 
Figure ‎4.1: Survival of Ent. ludwigii in (A) whey-based infant formul and (B) in casein-
based infant formula at 55°C. 
Ent. Ludwigii isolates survived for different length time in whey-based infant 
formula compered to casein-based infant formula. Ent. Ludwigii isolates 1348,  
1349, 1351, 1352, 1366 and 1439 were incubated in either whey-based (Panel A)  
or casein-based (Panel B) formula for 30 minutes at 55°C. Aliquots were 
removed at the indicated times for cfu 1 log (D value) is indicated in Table 
4.1. Experiments were performed in duplicate and data are presented as the average of 
two independent experiments. Error bars represent standard deviation. 
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 Ent. cancerogenus 
 
There was variation in thermotolerance between Ent. cancerogenus strains.  
Ent. cancerogenus strains were differentiated into three groups based on their capability 
of heat resistance. 
Heat resistant: Ent. cancerogenus strains 909 and 1350 showed high thermoresistance in 
whey-based infant formula and moderate heat resistance in casein-based infant formula 
with D55 >50 minutes, (Figures 4.2 A and B). In contrast, strain 1367 showed heat 
resistance at 55ºC in casein and had moderate heat resistance in whey. 
Heat moderately tolerant: The Ent. cancerogenus strains 1037, 1355, 1358, 1360-1362 
and 1365 were moderately resistant to heat at 55°C in whey and casein-based infant 
formula, as seen in Table 4.1. 
Heat sensitive: Ent. cancerogenus strains 806, 824, 845,  848,  957, 1042,  1077, 1357, 
1359, 1363 and 1364 were more sensitive to heat in both whey and casein-based infant 
formula except strain 1042 and 1357 which were moderate to heat in whey-based infant 
formula with D55= 6.5 and 6 minutes, respectively. (See Figure 4.2 A and B, Table 4.1). 
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(A) 
 
(B) 
Figure  4.2: Survival of Ent. cancerogenus in (A) whey-based infant formul and (B) in 
casein based-infant formula at 55°C. 
Ent. cancerogenus isolates survived for different length time in whey-based infant 
formula compered to casein-based infant formula. Ent. cancerogenus isolates 806,  
824, 845, 848, 909, 957, 1037, 1042, 1077, 1350, 1355, 1357, 1358, 1359, 1360, 1361, 
1362, 1363, 1364, 1365, and 1367 were incubated in either whey-based (Panel A)  
or casein-based (Panel B) formula for 30 minutes at 55°C. Aliquots were 
removed at the indicated times for cfu 1log (D value) is indicated in Table 
4.1. Experiments were performed in duplicate and data are presented as the average of 
two independent experiments. Error bars represent standard deviation 
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 Ent. hormaechei 
Ent. hormaechei strains 1075, 1053 and 1038 showed more heat tolerance (resistant)  
at 55°C in whey and casein-based infant formula. The D-value of Ent. hormaechei 
strains 1075 and 1038 were D55= 11, 20 and >50 minutes  in whey, and 11, 8.5 and  >50 
minutes  in casein respectively. However, Ent. hormaechei strain 1053 showed high 
resistance in whey only, while demonstrating moderately tolerant resistance to heat in 
casein-based infant formula.  
Ent. hormaechei strain 790 was moderately tolerant to heat in whey and casein based-
infant formula, and the D-value was 6.5 and 5 minutes respectively.  
The sensitivity of Ent. hormaechei strains 795, 798, 860 and 1034  to heat results 
showed a high rate of death to 55°C in whey and casein-based infant formula. The D-
values for these organisms at 55°C were less then 4 minutes. 
Ent. cloacae 
Two strains of Ent. cloacae, 779 and 789, showed variation between contradictory 
moderate heat tolerance and resistance at  55ºC in whey and casein-based infant formula; 
the exception was strain 779 which was  moderately tolerant to heat in casein-based 
infant formula with D55 > 10 minutes; (see Figure 4.3 A and B, Table 4.2).  
 Ent. aerogenes 
Ent. aerogenes strain 1056 was more sensitive to heat in both whey and casein-based 
infant formula. The D-values for this organism at 55°C were 2 minutes in both types of 
milk; (see Figure 4.3 A and B, Table 4.2). 
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(A) 
 
(B) 
Figure  4.3: Survival of Ent. hormaechei, Ent. cloacae strains (779 and 789) and  Ent. 
aerogenes strain 1056  in (A) whey-based infant formul and (B) in casein-based infant 
formula at 55°C. 
Ent. hormaechei, Ent. cloacae and Ent. aerogenes isolates survived for different length 
time in whey-based infant formula compered to casein-based infant formula.  
Ent. hormaechei isolates 790, 795, 798, 860, 1034, 1038, 1053 and 1075, Ent. cloacae 
isolates 779 and 789 and  Ent. aerogenes isolate 1056 were incubated in either whey-
based (Panel A) or casein-based (Panel B) formula for 30 minutes at 55°C. 
Aliquots t were removed at the indicated times for cfu 1 log (D value) is 
indicated in Table 4.2. Experiments were performed in duplicate and data are 
presented as the average of two independent experiments. Error bars represent standard 
deviation. 
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K. oxytoca 
Differences in the survival of K. oxytoca at 55ºC were noted in the two types of formula 
(whey and casein-based infant formula). The K. oxytoca strain 1356 was thermoresistant 
at 55ºC in whey and casein-based infant formula with a D-value more than 50 minutes 
and was nonlinear. Whereas moderate resistance to heat in whey based infant formula 
was demonstrated by K. oxytoca strain 1353 with D55 =5.5, and sensitive to heat in 
casein-based infant formula with a D-value undetected D55=3 minutes; (presented in 
Figure 4.4 A and B, Table 4.2).  
K. oxytoca strain 1354 showed moderate resistance to heat in whey and casein-based 
infant formula. 
In Table 4.2, Figures 4.4 A and 4.4 B the K. oxytoca strains 832, 1078 and 1079 showed 
sensitive behavior to heat at 55ºC in whey and casein-based infant formula and the D-
values were not detected before 4 minutes. 
Summary  
In this study across all the bacterial species,1/6 strain of  Ent. ludwigii, 2/21 strains of 
Ent. cancerogenus and 1/8 strains of Ent. hormaechei and 1/6 strains of K. oxytoca 
showed the highest thermal resistance on both based infant formula at 55°`C. These 
strains were not affected by both formula types at 55°`C.  
Clonally related strains (same pulsotype) showed the same death rate at 55ºC. For 
instance, Ent. cancerogenus strains 845, 848, 1363, 1364, 795 and 798 and K. oxytoca 
strains 1078 and 1079 were sensitive to heat tolerance at 55ºC on whey and casein-based 
infant formula. These belong to four clusters; Enc1, Enc3, Ebh6 and Kc3 with each 
pulsotype comprising two strains respectively (Tables 4.1 and 4.2). 
Also, two strains (1355, 1358) of Ent. cancerogenus showed the same response to heat at 
55ºC in whey and casein-based infant formula, which was moderately resistant, and they 
belonged to the same pulsotype (Enc2); see Table 4.1. 
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(A)
(B) 
Figure ‎4.4: Survival of K. oxytoca in (A) whey-based infant formul and (B) in casein-
based infant formula at 55°C.  
K. oxytoca isolates survived for different length time in whey-based infant formula 
compered to casein-based infant formula. K. oxytoca isolates 832, 1078, 1079, 1353, 
1354 and 1356 were incubated in either whey-based (Panel A) or casein-based 
(Panel B) formula for 30 minutes at 55°C. Aliquots were removed at the 
indicated times for cfu 1 log (D value) is indicated in Table 4.2. Experiments 
were performed in duplicate and data are presented as the average of two independent 
experiments. Error bars represent standard deviation. 
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Table ‎4.1: D-value for Ent. ludwigii and Ent. cancerogenus strains in two different 
types of formula milk. 
 
EFT: Indicates enteral feeding tube, MBM: Indicates human mastic breast milk and CSF: indicates cerebrospinal fluid. 
Ebc1-6 and Enc1-3indicates PFGE cluster groups, U: Unique. D- value indicate the time required for a reduction in the 
viable count at by 1 log. R, M and S indicate resistant, moderate and sensitive strains to heat tolerance at 55ºC 
respectively. 
 
 
 
Ent.ludwigii 1348 MBM Unknown casein 11.5 M
whey 5 M
" 1349 „ Unknown casein 6 M
whey 4 M
" 1351 „ Unknown casein 9.5 M
whey 5 M
" 1352 „ Unknown casein > 50 R
whey > 50 R
" 1366 „ Unknown casein 2.5 S
whey 1 S
" 1439 CSF Unknown casein 2 S
whey 1 S
Ent.cancerogenus 806 EFT 24 casein 2 S
whey 2 S
" 824 „ 36 casein 1 S
whey 2 S
" 845 „ 45 casein 1 S
whey 2 S
" 848 „ 48 casein 2.5 S
whey 2.5 S
" 909 „ 58 casein > 50 R
whey > 50 R
" 957 „ 81 casein 1 S
whey 1 S
" 1037 „ 112 casein 8 M
whey 9 M
" 1042 „ 128 casein 3.5 S
whey 6.5 M
" 1077 „ 118 casein 1.5 S
whey 2.5 S
" 1350 MBM Unknown casein > 50 R
whey > 50 R
" 1357 „ Unknown casein 3.5 S
whey 6 M
" 1358 „ Unknown casein 7.5 M
whey 6.5 M
" 1355 „ Unknown casein 7.5 M
whey 8 M
" 1359 „ Unknown casein 0.5 S
whey 3.5 S
" 1360 „ Unknown casein 8.5 M
whey 6 M
" 1361 „ Unknown casein 7 M
whey 9 M
" 1362 „ Unknown casein 10.5 M
whey 4 M
" 1363 „ Unknown casein 3.5 S
whey 4 M
" 1364 „ Unknown casein 2 S
whey 1 S
" 1365 „ Unknown casein 9 M
whey 6 M
" 1367 „ Unknown casein 19 R
whey 5 M
D55 (min) Category
Ebc1
Ebc3
Source of 
isolates
Neonatal No.
PFGE 
cluster 
Formula
U
U
Enc2
Enc1
Enc3
Ebc2
Ebc5
Ebc6
Ebc4
 StrainSpecies
U
U
U
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Table ‎4.2: D-value for Ent. hormaechei and K. oxytoca in two different types of formula 
milk. 
 
EFT: Indicates enteral feeding tube, MBM: Indicates human mastic breast milk and CSF: indicates cerebrospinal fluid. 
Ebh2-4, 6 and 7; Ebl1; Eba1 and Kc3 and 5 indicates PFGE cluster groups, U: Unique. D- value indicate the time 
required for a reduction in the viable count at by 1 log. R, M and S indicate resistant, moderate and sensitive strains to 
heat tolerance at 55ºC respectively. 
Ent. hormaechei 790 EFT 4 casein 5 M
whey 6.5 M
" 795 „ 17 casein 2 S
whey 2 S
" 798 „ 18 casein 2 S
whey 1 S
" 860 „ 52 casein 1 S
whey 1.5 S
" 1034 „ 110 casein 2.5 S
whey 1.5 S
" 1038 „ 113 casein > 50 R
whey > 50 R
" 1053 „ 117 casein 8.5 M
whey 20 R
" 1075 „ 117 casein 11 M
whey 11 M
Ent. cloacae 779 EFT 2 casein 4 M
whey > 50 R
" 789 „ 12 casein 13 M
whey 10.5 M
Ent. aerogenes 1056 EFT 118 casein 2 S
whey 2 S
K.oxytoca 832 EFT 36 casein 3 S
whey 2 S
" 1078 „ 120 casein 2.5 S
whey 2.5 S
" 1079 „ 121 casein 2 S
whey 1 S
" 1353 MBM Unknown casein 3 S
whey 5.5 M
" 1354 „ Unknown casein 6.5 M
whey 4.5 M
" 1356 „ Unknown casein > 50 R
whey > 50 R
Formula D55 (min) Category StrainSpecies Source of isolates Neonatal No.
PFGE 
cluster 
U
Ebh7
Ebh3
Ebl1
U
Ebh6
Ebh4
Ebh2
Eba1
Kc5
Kc3
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4.3.2  Biofilm formation by Enterobacteriaceae on three types of formula milk at 
different temperatures 
The biofilm formation values had to be corrected for the non-specific binding of crystal 
violet to the microtitre tray and un-inoculated formula. The relative biofilm formation 
value was determined by dividing the strain value by the corresponding control value. The 
results were then categorised as: 
1- No biofilm formation: OD strain = OD control 
2- Low biofilm formation: OD strain ≤  2x OD control 
3- Moderate biofilm formation: OD strain ≤ 4x OD control 
4- High biofilm formation: OD strain > 4x OD control. 
Twenty strains isolated from MBM and twenty three strains isolated from EFT (Tables 2.2 
and 2.4 respectively) in section 2.1.1 were tested for biofilm formation in three types of 
formula milk (whey, casein and soya-based infant formula) at 20°C and 37°C.  
The results are summarised below and summarised in Table 4.3. 
 
  Whey-based formula 4.3.2.1
 At 20°C: 
Twenty four out of fourty four strains were able to form biofilm at 20°C including 
4/6 strains of Ent. ludwigii, 4/8 strains of Ent. hormaechei, 2 strains of Ent. cloacae, 17/21 
strains of Ent. cancerogenus and 3/6 strains K. oxytoca formed relatively low levels of 
biofilm. The rest of strains were not able to form biofilm at 20°C; (Figure 4.9).   
 At 37°C: 
All strains formed biofilms on whey-based infant formula at 37°C. The high biofilm level 
was produced by Ent. ludwigii strain 1439 and K. oxytoca strain 1353. Moderate levels of 
biofilm were produced by 3/6 strains of Ent. ludwigii, 6/8 strains of Ent. hormaechei, 2 
strains of Ent. cloacae, 1 strain of Ent. aerogenes, 17/21 strains of Ent. cancerogenus and 
4/6 strains of K. oxytoca. The remaining strains only formed low levels of biofilm; (see 
Figure 4.9).  
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Interestingly, the same level of biofilm was observed by Ent. hormaechei strains 1053 
and 1075 in whey at 37ºC which were isolated from the same patient and belonged to 
pulsotype Ebh3; (Table 4.3). In addition, Ent. cancerogenus strains (1355 and 1358) 
and Ent. cancerogenus strains (1359 and 1360) showed moderate biofilm level in 
whey-based infant formula at 37°C and  belonged to pulsotypes Enc2 and Enc1 
respectively. Ent. cancerogenus 1363 and 1364 also showed moderate biofilm 
formation and  belonged to pulsotype Enc3 (Table 4.3).   
The biofilm formation at 37°C was significantly higher than the formation at 20°C 
(p<0.05). 
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Figure  4.5: : Biofilm formation in whey-based infant formula at 20°C and 37°C. 
Experiments were performed in triplicate and data are presented as the average of two independent experiments. Error bars 
represent standard deviation of two independently repeated experiment. 
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  Casein-based formula 4.3.2.2
 At 20°C: 
There was no high biofilm on casein-based infant formula at 20°C. Moderate biofilms 
were produced by 1/6 strains of Ent. ludwigii, 2/8 strains of Ent. hormaechei and 3/21 
strains of  Ent. cancerogenus. Low level of biofilm was formed by 5/6 strains of  
Ent. ludwigii, 1/8 strains of  Ent. hormaechei, two strains of Ent. cloacae, 3/21 strains of 
Ent. cancerogenus and 1/6 strains of K. oxytoca. The rest of strains showed low biofilm 
at this temperature; see Figure 4.10.  
 At 37°C: 
High biofilm formation was seen by 2/6 strains of Ent. ludwigii, 1/8 strains of   
Ent. hormaechei, 8/21 strains of  Ent. cancerogenus and 1/6 strains of K. oxytoca. 
Moderate biofilm levels were formed by 1/6 strains of Ent. ludwigii,, 3/8 strains of  
Ent. hormaechei, 2 strains of  Ent. cloacae, 1 strain of Ent. aerogenes, 8/21 strains of   
Ent. cancerogenus and 3/6 strains of K. oxytoca (Figure 4.10, Table 4.3).  
Low biofilm levels were produced by 3/6 strains of Ent. ludwigii, 4/8 strains of  
Ent. hormaechei, 5/21 strains of Ent. cancerogenus and 2 /6 strains of K. oxytoca; (Figure 
4.10). The difference in the quantity of biofilm formation between the two temperatures 
(20°C and 37°C) was statistically significant in most strains. Results are summarised in 
Figure 4.10 and Table 4.3.  
It was also noted that most strains which belonged to the same pulsotype showed the same 
biofilm result; for example, Ent. cancerogenus strains 1359 and 1360 belonged to cluster 
Enc1 and  formed high biofilm on infant formula at 37°C and  produced low biofilm at 
20°C. Also, Ent. cancerogenus strains 1363 and 1364 belonged to group Enc3 which 
formed  low biofilm at 20°C and 37°C (Table 4.3). 
  Soya-Powder Infant formula 4.3.2.3
 At 20°C: 
None of the tested strains produced high levels of biofilm formation in soya milk at both 
temperatures 20°C and 37°C. There was low biofilm formation by all Ent. ludwigii,  
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Ent. hormaechei, Ent. cloacae, Ent. aerogenes, Ent. cancerogenus and K. oxytoca strains 
at 20°C (Figure 4.11, Table 4.3). 
 At 37°C: 
Three Ent. cancerogenus strains (1355, 1357 and 1358) and 1 K. oxytoca strain (1356) 
formed moderate biofilm levels at 37°C, and low biofilm was formed by all strains of  
Ent. ludwigii, Ent. hormaechei, Ent. cloacae, Ent. aerogenes, Ent. cancerogenus and  
K. oxytoca strains at 37°C (see Figure 4.11, Table 4.3). 
Biofilm formation in soya milk was statistically significantly different at 20°C and 37°C 
(p<0.05).  
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Figure  4.6: Biofilm formation in casein-based infant formula at 20°C and 37°C. 
Experiments were performed in triplicate and data are presented as the average of two independent experiments. Error bars 
represent standard deviation of two independently repeated experiment. 
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Figure ‎4.7: Biofilm formation in soya powder infant formula at 20°C and 37°C. 
Experiments were performed in triplicate and data are presented as the average of two independent experiments. Error bars 
represents standard deviation of two independently repeated experiment.
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4.3.2.4 Comparison of different levels of biofilm formation at 37°C 
In Ent. ludwgii, biofilm formation was significantly higher in casein and whey-
based infant formula than soya-based infant formula (p < 0.001), while there was 
no significant difference between casein and soya-based formula. 
In Ent. cancergenus, biofilm formation was significantly higher in casein based-
infant formula than both whey and soya-based infant formula (p < 0.001); 
however, the biofilm level was significantly higher in whey compared with soya-
based formula. 
In Ent. hormaechei and K. oxytoca, biofilm formation was significantly higher in 
casein and whey-based infant formula than soya-based infant formula (p<0.001).  
In Ent. cloacae and Ent. aerogenes, biofilm formation was not significantly 
different between the three types of formula (whey, casein and soya) . 
In summary, it was found that the relative biofilm formation was higher at 37ºC 
compared with 20ºC by most tested strains in all types of formula (Table 4.3). 
The quantity of biofilm was detected on three types of formula which was higher 
on casein-based infant formula compared with whey and soya-based infant 
formula in all strains. 
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Table ‎4.3: Biofilm formation level on based-infant formula (whey, casein and soya) 
by EFT strains and MBM strains. 
 
Summarised the biofilm formation level on three types of based infant formula (whey, casein and soya) by enteral 
feeding tube strains (EFT) and mastic human breast milk strains (MBM). CSF: indicates cerebrospinal fluid. 
Ebh2-4, 6 and 7; Ebl1 and Kc3 and 5 indicates PFGE cluster groups, U: Unique. Strains were categorised as 
follows: (N) No biofilm formation: OD strain = OD control, (L) low biofilm formation: OD strain ≤ 2x OD 
control, (M) Moderate biofilm formation: OD strain ≤ 4x OD control and (H) high biofilm formation: OD 
strain >4x OD control. EFT: Indicates Enteral feeding tube, MBM: Indicates human mastic breast milk and CSF: 
indicates Cerebrospinal fluid. 
 
 
20⁰C 37⁰C 20⁰C 37⁰C 20⁰C 37⁰C
Ent. ludwigii 1348 MBM Unknown L L L L L L
„    1349 „ Unknown L M L L L L
„    1351 „ Unknown N L L L L L
„    1352 „ Unknown N M L H L L
„    1366 „ Unknown L M M H L L
„    1439 CSF Unknown L H L M L L
Ent. hormaechei 790 EFT 4 U L L M H L L
„    795 „ 17 N M L L L L
„    798 „ 18 L M L M L L
„    860 „ 52 Ebh4 N L L L L L
„    1034 „ 110 Ebh2 N M L L L L
„    1038 „ 113 Ebh7 N M L L L L
„    1053 „ 117 L M M M L L
„    1075 „ 117 L M L M L L
Ent. cloacae 779 EFT 2 L M M M L L
„ 789 „ 12 L M M M L L
Ent . aerogenes 1056 EFT 118 Eba1 N M L M L L
Ent. cancerogenus 806 ETF 24 U N M L M L L
„ 824 „ 36 Ebc3 N M L H L L
„ 845 „ 45 N M L M L L
„ 848 „ 48 N M L M L L
„ 909 „ 58 Ebc2 N M L L L L
„ 957 „ 81 Ebc5 N L L M L L
„ 1037 „ 112 Ebc6 N M L M L L
„ 1042 „ 128 Ebc4 N M L M L L
„ 1077 „ 118 N M L L L L
„ 1350 MBM Unknown L M M H L L
„ 1357 „ Unknown U L M L M L M
„ 1355 „ Unknown L M M H L M
„ 1358 „ Unknown L M M H L M
„ 1359 „ Unknown L M L H L L
„ 1360 „ Unknown L M L H L L
„ 1361 „ Unknown N M L N L L
„ 1362 „ Unknown N L L M L L
„ 1363 „ Unknown N L L L L L
„ 1364 „ Unknown N L L L L L
„ 1365 „ Unknown L M L H L L
„ 1367 „ Unknown N M L H L L
K. oxytoca 832 EFT 36 Kc5 N M L L L L
„    1078 „ 120 N L L L L L
„    1079 „ 121 N M L M L L
„    1353 MBM Unknown L H M H L L
„    1354 „ Unknown L M L L L L
„    1356 „ Unknown L M L M L M
 Biofilm formation
whey casein soya
U
Species Strain Source of isolates Neonatal No. PFGE cluster 
Ebh6
Ebh3
Ebl1
Ebc1
Enc3
Kc3
U
U
U
Enc2
Enc1
U
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4.3.3 Capsule formation on milk agar 
Bacterial capsule production was determined by colony appearance on milk agar 
(whey, casein and soya-based) at 20°C (after 24 hours and 48 hours) and 37°C (after 
24 hours). The results were classified into three categories according to the relative 
scale of high, medium and low capsule production which are represented by ≥ +++, 
++ and + respectively, Figure 4.8.   
The amount of capsular material varied according to the incubation temperature, 
time, and milk agar composition; (Table 4.4). No highly mucoid colonies were 
apparent after 24 hours incubation at 20°C, but these did appear after 48 hours 
incubation. Capsular strains were found in Ent. ludwigii, Ent. hormaechei, Ent. 
cancerogenus, and K. oxytoca.  However, the number of capsular strains varied 
between species.   
 On whey milk agar the capsule production was recorded for all Ent. ludwigii 
at 20ºC and 37ºC, except strain 1366 which produced medium capsular 
material at 37ºC only. The high level of capsular material was by  
5/6 Ent. ludwigii at 37ºC and by 1 strain at 20ºC, whereas 4/6 Ent. ludwigii 
showed medium level of capsular material at 20ºC; see Table 4.4. 
With respect to Ent. hormaechei, 4/8 strains produced high capsular material 
on whey at 20ºC and 1 strain of Ent. hormaechei strain (1075)  produced high 
capsule production at 37ºC. Three strains of Ent. hormaechei produced 
medium capsular material at 20ºC and 1 strain produced low capsular 
material at 37ºC (Table 4.4, Figure 4.8). 
Two strains of Ent. cloacae (779 and 789) formed low capsular material 
 at 20ºC, while at 37ºC  they produced medium/high capsular material 
respectively.  
 Ent. aerogenes strain 1056  produced high capsular material at 20°C, but it 
was not able to form capsular material at 37°C; Table 4.4, Figure 4.8. 
Ent. cancerogenus strains 1364, 806, 957 and 1361  produced high capsular 
material at 20ºC, while at 37ºC the high capsular material was by strains 
1364, 1361, 1357, 1363 and 1037. The majority of Ent. cancerogenus, 5/21 
and 9/21 strains,  produced medium capsular material at 20°C and 37°C 
respectively (Table 4.4, Figure 4.8). Of particular note was that most Ent. 
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cancerogenus produced capsular material at 37ºC.   
Some K. oxytoca (2/6) strains  produced high capsular material in whey- 
based infant formula at 37ºC and another 2/6 strains produced medium 
capsular material at 37ºC , and low capsular material was by K. oxytoca 3/6 
and 1/6 strains at 20°C and 37°C respectively (Table 4.4, Figure 4.8). No 
capsule production was formed by 1/6 Ent. ludwigii, 11/21 Ent. 
cancerogenus and 1/6 K. oxytoca in whey-based infant formula at 20°C, 
while 6/8 Ent. hormaechei, 3/21 strains of Ent. cancerogenus, 1/6 K. oxytoca 
and 1 strain of Ent. aerogenes were not able to produce capsules in whey 
milk agar at 37°C. In contrast, Ent. hormaechei strain 798, Ent. 
cancerogenus strains 1358 and 909 and K. oxytoca strain 832 were not able 
to produce capsules in whey milk agar at both temperatures. 
 On casein milk agar most species were able to produce capsular material at 
20ºC and 37ºC. 3/6 and 5/6 Ent. ludwigii strains produced high capsular 
material at 20ºC and 37ºC respectively, while 3/6 and 1/6 Ent. ludwigii 
produced medium capsular material at 20ºC and 37ºC respectively.  
Ent. hormaechei strains 1034, 790, 860,1053 and 798  produced high 
capsular material at 20ºC, while strain 1075 formed high capsular material at 
37ºC. Medium capsular material was formed by Ent. hormaechei strains 
1075 and 860 at 20ºC and 37ºC respectively. Ent. hormaechei strain 1038 
produced low capsular material at 37ºC. Of particular note was strain 1034 
which produced considerable capsular material at 20ºC after 48 hours (Table 
4.4, Figure 4.8).    
Ent. cloacae strains 779 and 789  formed low capsular material at 20ºC, 
whereas at 37ºC medium/high capsular material was produced respectively.  
The high capsular material was produced by Ent. aerogenes strain 1056 at 
20°C; however, it was not able to  produce capsular  material at 37°C; (Table 
4.4, Figure 4.8). 
The high capsular material was formed by 5/21 and 10/21 strains  
of Ent. cancerogenus at 20°C and 37ºC respectively. While the medium 
capsular material was produced by 8/21 and 10/21 strains of  
Ent. cancerogenus at 20°C and 37ºC respectively (Table 4.4, Figure 4.8). 
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K. oxytoca strains 1078, 1354 and 1356  produced high capsular material at 
20°C and 37ºC. The exception was strain 1356 which formed low capsule at 
20°C. The rest of strains produced medium capsular material at 37°C (Table 
4.4, Figure 4.8). 
 On soya powder infant formula agar the capsule production was produced by 
most species, the exception was by Ent. cancerogenus strain 909 which was 
not able to produce capsular material at both temperatures. 3/6 and 5/6 of 
Ent. ludwigii produced high capsular material at 20ºC and 37ºC respectively. 
All Ent. hormaechei produced high capsular material at 20ºC, while 5/8 of 
Ent. hormaechei formed high capsular material at 37ºC (Table 4.4, Figure 
4.8).  
Ent. cloacae strains 779 and 789  produced medium capsular material  
at 20ºC, whereas at 37ºC these strains formed high/medium capsular  
material respectively. The high/medium capsular material was produced by  
Ent. aerogenes strain 1056 at 20°C and 37°C  respectively (Table 4.4, Figure 
4.8). 
The high capsule production was by 4/21 and 6/21 of Ent. cancerogenus at 
20ºC and 37ºC respectively. Furthermore, 2/6 and 2/6 of K. oxytoca formed 
high capsular material at 20ºC and 37ºC respectively (Table 4.4, Figure 4.8). 
The ability of strains to produce capsular material at 20ºC and 37ºC was 
observed in casein-based infant formula and soya powder more than in whey-
based infant formula and the capsular material production appeared on milk 
agar (whey, casein and soya based) at 20°C after 48 hours by most strains. 
Ent. ludwigii, Ent. cancerogenus Ent. cloacae, Ent. aerogenes, and  
K. oxytoca strains showed  the ability to produce more capsular material on 
milk agar (whey, casein and soya based) at 20ºC and 37ºC, compared with 
Ent. hormaechei strain (see Table 4.4, Figure 4.8). 
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Figure  4.8: Capsule formation on milk agar by Enterobacteriaceae strains. 
Capsular material classified into three categories according to the relative scale of 
high, medium and low capsule production. (A) indicates no capsule production; (B) 
indicates low  capsule production; (C) indicates medium capsule and (D) indicates 
high capsule production. Capsular material was confirmed by India ink which 
appeared as a clear halo around the bacterium. 
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Table ‎4.4: Capsule production on based infant formula (whey, casein and soya) by 
EFT strains and MBM strains. 
 
Summarised the results of capsular material divided into three categories according to the relative scale of high, 
medium and low capsule production which are represented by ≥ +++, ++ and + respectively.(-) indicates no 
capsule production. EFT: indicates enteral feeding tube, MBM: indicates human mastic breast milk and CSF: 
indicates Cerebrospinal fluid. 
 
20°C 20°C 37°C 20°C 20°C 37°C 20°C 20°C 37°C
24h 48h 24h 24h 48h 24h 24h 48h 24h
Ent.ludwigii 1351 MBM + +++ ++++ + +++ ++++ - +++ +++
„ 1439 CSF - ++ +++ - ++++ +++ - +++ +++
„ 1352 MBM - ++ +++ - ++ +++ - +++ +++
„ 1348 „ + ++ +++ + ++ +++ - ++ +++
„ 1349 „ - ++ +++ - ++ +++ - ++ +++
„ 1366 „ - - ++ - +++ ++ - ++ ++
Ent. hormaechei 1034 EFT ++ +++ - +++ +++++ - - +++ +++
„ 790 „ - ++++ - - ++++ - - +++ ++
„ 860 „ ++ +++ - ++ ++++ ++ - +++ +++
„ 1075 „ - ++ ++++ - ++ +++ - +++ ++
„ 1053 „ ++ +++ - ++ +++ - - +++ +++
„ 798 „ - - - ++ +++ - - +++ ++
„ 795 „ + ++ - - - - + +++ +++
„ 1038 „ ++ ++ + - - + - +++ +++
Ent. cloacae 779 EFT + + ++ + + +++ - ++ +++
„ 789 „ + + +++ + + ++ - ++ ++
Ent . aerogenes 1056 EFT ++ +++ - + +++ - - +++ ++
Ent. cancerogenus 1364 MBM + +++ ++++ - +++ ++++ - + ++
„ 806 EFT ++ ++++ ++ - ++ ++++ + ++ +++
„ 1361 MBM - ++++ ++++ - ++++ +++ + +++ ++
„ 1357 „ + ++ +++ ++ ++ +++ - ++ +++
„ 1363 „ - - ++++ - ++ ++++ + ++ ++
„ 957 EFT ++ +++ ++ + +++ ++ - +++ ++
„ 1360 MBM + ++ ++ +++ ++++ ++ - ++ ++
„ 1350 „ - - ++ - ++ +++ + +++ +++
„ 1365 „ - - ++ + ++ ++ - + ++
„ 1359 „ - ++ ++ - ++ +++ - + +++
„ 1077 EFT - ++ + - +++ +++ - + -
„ 1037 „ - - +++ - - +++ + +++ +++
„ 824 „ - - ++ - - ++ - ++ ++
„ 845 „ - - + - - ++ - ++ ++
„ 848 „ - - ++ - - ++ - ++ +
„ 1362 MBM - + ++ - + ++ - ++ ++
„ 1042 EFT + ++ - + ++ ++ - ++ +++
„ 1355 MBM - - + - ++ ++ - + ++
„ 1367 „ - - + - + ++ - + ++
„ 1358 „ - - - - + +++ - + ++
„ 909 „ - - - - - - - - -
K. oxytoca 1078 EFT - +++ + - +++ ++++ - + ++
„ 1354 MBM - + ++++ + +++ +++ - +++ +++
„ 1356 „ + + ++ + + ++++ - +++ ++
„ 1079 EFT - - +++ - - ++ - + ++
„ 1353 MBM - + ++ - + ++ - ++ ++
„ 832 EFT - - - - - ++ - ++ +++
Species Strain
Source of 
isolates
Capsule formation
whey casein soya
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4.3.3 Acid tolerance of organisms to pH 3.5 (HCl acidified formula) 
The ability of Ent. ludwigii, Ent. hormaechei, cloacae, Ent. aerogenes,  
Ent. cancerogenus and K. oxytoca to tolerate acidic conditions at pH 3.5 was 
determined. These strains were exposed to two types of formula (whey and casein) 
which were adjusted to pH 3.5 for two hours at body temperature. 
All strains were clearly resistant to two hours exposure to pH 3.5 in whey and casein 
infant formula: the viable counts were observed over the course of the 2 hours 
exposure to pH 3.5 for all strains. The variation across the strains in each type of 
formula was very broad. There was no correlation between the source of the strains 
(that is, enteral feeding tube isolated compared with mastic human breast milk 
strains) and their acid resistance. The results are presented in Figures 4.12-4.19. 
These results will serve as a base for bacterial attachment and invasion of host cells 
studies in chapter 5. The ability of organisms to survive at pH 3.5 (similar to the 
acidic environment of the stomach) means that these organisms are most likely to be 
pathogenic and able to invade the intestine, thus causing human infections.  
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Figure ‎4.9: Survival of Ent. ludwigii in whey-based infant formula at pH 3.5 for 2h. 
Experiments were performed in duplicate and data are presented as the average of 
two independent experiments. The viable count of cells was measured during 2h at 0, 
5, 10, 15, 20, 30, 45, 60, 90 and 120 minutes.  
 
 
 
 
Figure  4.10: Survival Ent. ludwigii in casein-based infant formula at pH 3.5 for 2h. 
Experiments were performed in duplicate and data are presented as the average of 
two independent experiments. The viable count of cells was measured during 2h at 0, 
5, 10, 15, 20, 30, 45, 60, 90 and 120 minutes. 
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Figure ‎4.11: Survival of Ent. hormaechei, Ent. cloacae and Ent.aerogenes strains in 
whey-based infant formula at pH 3.5 for 2h. 
Experiments were performed in duplicate and data are presented as the average of 
two independent experiments. The viable count of cells was measured during 2h at 0, 
5, 10, 15, 20, 30, 45, 60, 90 and 120 minutes. 
 
 
Figure  4.12: Survival of Ent. hormaechei, Ent. cloacae and Ent. aerogenes strains in 
casein-based infant formula at pH 3.5 for 2h. 
Experiments were performed in duplicate and data are presented as the average of 
two independent experiments. The viable count of cells was measured during 2h at 0, 
5, 10, 15, 20, 30, 45, 60, 90 and 120 minutes. 
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Figure  4.13: Survival of Ent. cancerogenus in whey-based infant formula at pH 3.5 
for 2h. 
Experiments were performed in duplicate and data are presented as the average of 
two independent experiments. The viable count of cells was measured during 2h at 0, 
5, 10, 15, 20, 30, 45, 60, 90 and 120 minutes. 
 
 
Figure ‎4.14: Survival of Ent. cancerogenus in casein-based infant formula at pH 3.5 
for 2h. 
Experiments were performed in duplicate and data are presented as the average of 
two independent experiments. The viable count of cells was measured during 2h at 0, 
5, 10, 15, 20, 30, 45, 60, 90 and 120 minutes. 
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Figure ‎4.15: Survival of K. oxytoca in whey-based infant formula at pH 3.5 for 2h. 
Experiments were performed in duplicate and data are presented as the average of 
two independent experiments. The viable count of cells was measured during 2h at 0, 
5, 10, 15, 20, 30, 45, 60, 90 and 120 minutes. 
 
 
 
 
 
Figure  4.16: Survival of K. oxytoca in casein-based infant formula at pH 3.5 for 2h. 
Experiments were performed in duplicate and data are presented as the average of 
two independent experiments. The viable count of cells was measured during 2h at 0, 
5, 10, 15, 20, 30, 45, 60, 90 and 120 minutes. 
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4.4 DISCUSSION 
The present study was  designed to determine the physiological attributes for 
representative strains defined by using PFGE, with respect to stress survival which was 
affected by formula type and temperature at 55°C, biofilm formation, capsule 
production and acid tolerance of organisms to pH 3.5 (HCl acidified formula).  
Most strains survived at 55°C (Tables 4.1 and 4.2). In this study, the considerable 
finding was that same death rate at 55ºC was demonstrated by strains which belonged 
to the same cluster by PFGE analysis. For example, the pulsotypes of Enc1, Enc2, 
Enc3, Ebh6 and Kc3 Ent. cancerogenus strains 845, 848, 1355, 1358, 1363 and 1364, 
 Ent. hormaechei strains 795 and 798, and K. oxytoca strains 1078 and 1079, 
respectively were sensitive to heat tolerance at 55ºC on whey and casein-based infant 
formula.  
This finding may suggest that these strains was possibly originated from the same 
source and the same clone contaminated different feeding tubes. For the MBM strains  
Ent. cancerogenus strains (1355, 1358, 1363 and 1364), it was probably that these 
organisms were isolated from the same mother. Therefore, the neonates could be 
exposed to the ingestion of these organisms either from contaminated milk or from 
infant formula. The findings of this study were consistent with Forsythe (2009), who 
found that in a neonatal care unit, fortified breast milk and reconstituted powdered 
infant formula were reconstituted at room temperature when required, and not at 
higher temperatures. Similar procedures were reported by Rosset et al. (2007) in a 
study of French hospitals in that samples were reconstituted with room temperature 
water.  
On the other hand, the ability of tested strains to survive at 55ºC may become a 
sourse of infection of neonates in NICUs which was previously described by Iversen 
et al. (2004a). They found that C. sakazakii is capable of growing in PIF during 
storage at refrigeration temperatures and adhere to infant-feeding equipment, which 
probably becomes a sourse of infection. In addition, C. sakazakii strains were able to 
grow in PIF between 6° and 45°C,  with the optimum being 37° to 43°C (Iversen et 
al., 2004a). The meeting by FAO and WHO in 2006 acknowledged that the 
reconstitution of PIF with water between 40° and 50°C (unless used immediately), 
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holding bottles at room temperature and extended feeding periods were linked with a 
rise in relative risk. 
 Biofilm formation was investigated as this may be a means of organism persistence 
in the NICUs and attachment to enteral feeding tubes.  This study found that the 
relative biofilm formation was higher at 37ºC compared with 20ºC by most tested 
strains in all types of formula (Figures 4.9, 4.10 and 4.11). The notable result was 
that the Ent. hormaechei strains 1053 and 1075 and Ent. cancerogenus strains 1355, 
1358, 1359, 1360, 1363 and 1364 were clustered into 4 pulsotypes, Ebh3, Enc2, Enc1  
and Enc3 (each pulsotype consists of two strains) respectively, and formed the same 
quantity of biofilm in whey and casein-based infant formula at 37ºC and 20ºC. 
However, Ent. hormaechei strains 1053 and 1075 only exhibited the same level of 
biofilm in whey-based infant formula at 37ºC (Table 4.3). This finding probably 
indicates that the same clone was cross contaminated between different feeding tubes 
and the prevalence of same clone was recovered from the same mother (MBM 
strains).  
The quantity of biofilm that was detected on the three types of formula was higher in 
casein-based infant formula compared with whey and soya-based infant formula in 
all strains. These observations indicate the importance of the nutrient type present in 
milk in biofilm formation. Furthermore, these findings are in agreement with other 
studies (Kim et al., 2006; Meadows, 1971). Research has shown that nutrients and 
other media components influence the attachment of bacteria to surfaces of various 
materials (i.e biofilm formation) (Hood and Zottola, 1997). Meadows  (1971) found 
that casein enhanced the attachment of E. coli, P. fluorescens and Aeromonas 
liquefaciens to glass surfaces. Whey protein has shown the same effect in stainless 
steel surfaces (Speers et al., 1985).  
In general, across all the bacterial species that were tested, this study confirmed the 
previous research (Hurrell et al., 2009) which demonstrated that the organisms may 
originate from the attached bacterial biofilm, and break off in clumps. The bacterial 
multiplication occurs at room temperature during the feeding period compared with 
the tube at 37°C (which can be in place for >48 hours). This can result in the 
contamination of fresh feed in the tube lumen leading to further bacterial 
multiplication. Bacteria enter the neonate’s stomach as clumps of cells which may 
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survive passage through the neonate's stomach. The ability to invade intestinal cells 
may be a strong indication of potential virulence and poor outcomes in the neonatal 
host.  
The ability of strains to produce capsular material was determined by colony 
appearance on milk agar (whey, casein and soya) at 20°C (after 24 hours and 48 
hours) and 37°C (after 24 hours). The major of Ent. ludwigii, Ent. cloacae, Ent. 
aerogenes, Ent. hormaechei, Ent. cancerogenus and K. oxytoca strains  demonstrated 
ability to produce capsular material on the three types of milk agar (whey, casein and 
soya) at 37ºC compared with 20ºC. A possible explanation for this might be that body 
temperature possibly plays an important role in the indication of capsule material. 
In this study, an interesting finding is that all species are able to produce capsule 
material in soya-based infant formula compared with whey and casein-based infant 
formula at 37ºC (Tables 4.3 and 4.4). This finding may be a strong indication that the 
differentiation of composition between the three types of formula possibly affects the 
strains produce capsular material. For example, whey and casein-based infant 
formula is comprised of lactose as the carbohydrate source while soya-based infant 
formula consist of glucose which may be required for the bacteria to produce 
capsular material. 
A further discovery was the correlation between biofilm formation and capsular 
material production on casein milk agar at 20ºC and 37ºC by all species except  
Ent. hormaechei. This could be due to the casein-based infant formula nutrients 
required to get attached to the surface, such as a feeding tube, to survive and grow. 
These observations are consistent with Van Acker et al. (2001) who suggested that 
infant formula milk may contain nutrients which were important for bacteria (C. 
sakazakii) for pre-attachment to stainless steel or feeding tubes to survive and grow. 
 In addition, Scheepe-Leberkühne and Wagner (1986) also suggested bacterial 
attachment and adherence to a surface can be enhanced by producing 
exopolysaccharide capsular material. Another previous study also stated that profuse 
capsular material may contribute to forming biofilm by clinical isolates of 
Cronobacter (Caubilla-Barron et al., 2007).  
Tolerance of acidic conditions was determined by expository tested strains to two 
types of formula (whey and casein) after adjusting the pH 3.5 for two hours at body 
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temperature (Figures 4.12-4.19). All of the tested strains were able to tolerate the 2 
hours exposure time at pH 3.5. The viable counts were no difference between the two 
types of infant formula. 
The results of this research support the idea that gastric juice is playing an important 
role in controlling the outcome of food-borne infections. The capability of organisms 
to survive in the acidic environment of the stomach is an indictor that these 
organisms may be pathogenic bacteria which could be able to invade the intestine, 
thus causing human illness. Previous studies found that the reduction in gastric 
acidity promotes survival rates of some common food-borne pathogens (Peterson, 
1989) and with a reduction of the infective dose (Cash et al., 1974; Schlech et al., 
1993). 
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5.1  INTRODUCTION 
The ability of bacterial strains to cause infection depends upon a number of factors 
including (but not limited to) adhesion, colonisation, activation of disease process, 
serum resistance and the production of toxins. However, the essential factor is the 
capability of the micro-organism to attach to the host surfaces, such as mucous 
membranes, gastric and intestinal epithelial or endothelial tissue (Boyle et al., 2003; 
Finlay and Falkow, 1997; Klemm and Schembri, 2000).  There is significant 
evidence which indicates that markedly diverse microbial pathogens utilize common 
strategies to cause infection and disease. For example, numerous different bacterial 
pathogens share common mechanisms in expression of their abilities to attach, invade 
and cause damage to host cells and tissues, in addition to surviving host defences, 
thereby causing infection (Wilson et al., 2002 ). 
In order to study the host, pathogens and intestinal micro-flora interactions tumour 
derived models such as Caco-2, T84 and HT-29 are widely used (Cencič and 
Langerholc, 2010). Caco-2 cell lines are used as the model cell lines for the small 
intestine while HT-29 for the large intestine in vitro to determine the ability of 
bacterial adhesion and invasion to human cells and tissues (Grajek and Olejnik, 
2004). Enterotoxigenic E. coli is one example causing diarrhoea by secretion of 
enterotoxin after attaching to the intestinal mucosa (Gaastra, 1996). 
The host immune response utilizes phagocytic cells as a critical line of defence 
against infection. The capability of a pathogen to persist and replicate within 
macrophages is a potent way of evading the defence mechanisms of the host. Sal. 
Typhimurium is one of the examples which enters and replicates within the 
macrophages and causes damage to them (Lindgren et al., 1996). C. koseri causing 
neonatal infection is another bacterium that displays the ability to survive and 
replicate within macrophages which in turn may contribute to the establishment of 
chronic central nervous system infections including brain abscesses (Townsend et al., 
2003). A further study by Townsend et al. (2008a) found that Cronobacter spp. 
strains showed the ability to persist and even replicate within human U937 
macrophages.   
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Despite the availability of effective antimicrobial therapy, neonatal bacterial 
meningitis remains a disease with unacceptable rates of morbidity and mortality. 
Community-acquired bacterial meningitis in Europe and the United States has a 
strong association with Se. pneumoniae and Neisseria meningitidis, both of which are 
considered as the most common etiologic agents; Se. pneumoniae  alone is associated 
with two-thirds of cases (Arda et al., 2008; Brouwer et al., 2010; van de Beek et al., 
2004). Additionally, fatal infections of neonates, such as necrotizing enterocolitis, 
septicaemia and meningitis, have also been associated with Cronobacter (Bowen and 
Braden, 2006 and 2008).   
The blood-brain barrier model of HBMEC is used to study the interaction between 
pathogenic bacterial and HBMEC in vitro. The blood-brain barrier is responsible for 
preserving biochemical homeostasis within the central nervous system (CNS). It 
occurs as a single layer of specialised brain microvascular endothelial cells (BMEC) 
which display continuous tight junctions and a conspicuous absence of pinocytosis 
(Betz and Goldstein, 1986; Patrick et al., 1992).  
A study by Badger et al. (1999) demonstrated that Citrobacter has shown the ability 
to invade and replicate within HBMEC. Histological studies of infant rat brains 
infected with C. koseri had shown that this model closely mimics the course of 
infection observed in humans (Kline et al., 1988). Previous studies have shown that 
E. coli K1 and group B streptococci (GBS) invaded brain microvascular endothelial 
cells (BMEC) in vitro and were able to penetrate the blood brain barrier in the 
experimental newborn rat model of haematogenous meningitis (Badger et al., 1998; 
Kim et al., 1992; Nizet et al., 1997).  
Similarly, C. sakazakii strains isolated from a NICU outbreak were able to invade 
rBCEC4 (Townsend et al., 2008a).Virulence traits were investigated also for Ent. 
hormaechei strains by Townsend et al. (2008b), who demonstrated that Ent. 
hormaechei strains were shown to invade both gut epithelial (Caco-2) and blood–
brain barrier endothelial cells (rBCEC4), and to persist in macrophages (U937). 
The most common feature of the invasive bacterium is its ability to avoid the 
bactericidal effects of host serum (Hoe et al., 1999; Hol et al., 1995; Porto et al., 
1989). Briefly, a bacterium that has the ability to survive on human blood possesses 
the potential to spread to different organs, avoiding the killing mechanism of 
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complement and antibody-mediated opsonization. In addition, serum resistance in 
species comprising of pathogens and commensals is often attributed to the pathogens 
as an acquired trait that allow them to cause disease in their host (Williams et al., 
2001).  
Specifically, serum resistance is a common trait of meningococci isolated from blood 
or cerebrospinal fluid (Figueroa and Densen, 1991). Clinical isolates of V. vulnificus 
were able to survive in human serum (Bogard and Oliver, 2007). Furthermore, a 
previous study by Townsend et al. (2008b) reported that Ent. hormaechei strains 
isolated from different neonates during a nosocomial outbreak in a California hospital 
were serum-resistant. 
The production of haemolysis is also associated with virulence in different bacterial 
species. Haemolysins produce a group of lytic toxins which then play an essential 
role in the disease production. For example, E. coli produces α- or β haemolysins. 
These two types of haemolysin are required for the exponential growth, but the 
calcium ions are required for lytic activity by α- haemolysins (Chart et al.,    8).  β 
haemolytic group A streptococi and S. aureus break down the barriers of a tissue to 
spread in the host while the microbes remain outside the host cells: this strategy is 
called extracellular invasion. These species are able to secrete some enzymes that 
degrade host cell molecules such as hyaluronidase (cleaves proteoglycans in 
connective tissue), streptokinase and staphylokinase (breaks down fibrin clots), lipase 
(degrades accumulated host oils), and nuclease (digests released RNA and DNA) 
(Wilson et al., 2002). 
Iron is an essential element of bacterial pathogenesis for growth, replication and 
progression of infection (Braun and Winkelman, 1987). The ability of pathogenic 
bacteria to obtain iron from the host is one of the determinants for bacterial virulence. 
Bacteria require iron for a variety of metabolic processes, such as amino acid 
synthesis, oxygen transport, respiration, nitrogen fixation, methanogenesis, the citric 
acid cycle, photosynthesis and DNA biosynthesis, and the amount of free iron 
available in the human host is not enough for bacterial growth because of the 
presence of iron-binding glycoproteins such as transferrin and lactoferrin (Sandy and 
Butler, 2009). 
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The microorganisms act to synthesize and secrete siderophores,  
low-molecular-weight, affinities for ferric iron, which act to sequester and solubilise 
the iron from host sources and facilitate its uptake by the bacterium (Pal and Karuna, 
2010; Schwyn and Neilands, 1987; Crosa, 1987).  Yersiniabactin is a part of an iron-
uptake system which has been first described in Yersinia spp., and the genes are 
located on a High-Pathogenicity Island (HPI) (Carniel, 2002). Lately, the existence of 
yersiniabactin-mediated iron uptake system has been discovered in several species of 
the family Enterobacteriaceae (Bach et al., 2000; Schubert et al., 2000). Previously 
the studies have suggested that Yersinia spp., E. coli and probably K. Pneumonia 
isolated including the HPI are more virulent than strains lacking this island (Bearden 
et al., 1997; Carniel et al., 1992; Lin et al., 2008). 
The HPI of Y. pestis is known as the pgm locus, which contains about 102 kb  
of chromosomal DNA and comprises of the irp1 and irp2 and fyuA or psn genes 
involved in iron storage and uptake the hemein storage (hms) locus  
(Perry et al., 1990). The irp1 and irp2 genes coding for the two iron-repressible  
high-molecular-weight proteins HMWP1 and HMWP2, which seemingly are 
involved in the production of yersiniabactin (Lucier et al., 1996); and the fyuA or psn 
gene  plays an important role for ferric yersiniabactin uptake or pesticin sensitivity 
where it serves as coding for the yersiniabactin receptor. FyuA also acts as a receptor 
for pesticin (Carniel et al., 1992; Carniel et al., 1989; Heesemann et al.,1993;  Rakin 
et al.,1994). 
In Gram-negative pathogens, the most important contributing factor to β-lactam 
resistance is β-lactamase production (Livermore, 2003). β-lactams are various 
antibiotic molecules that are categorised based on their chemical structures (Pitout 
and Laupland, 2008). The β-Lactam family of molecules is constituted of four 
groups: penicillins, cephalosporins, monobactam, and carbapenems. Carbapenems 
(imipenem, ertapenem, meropenem, and doripenem) are the most recently developed 
molecules having a broad spectrum of antibacterial activity (Nordmann et al., 2012), 
While β lactamases are enzymes produced by bacteria that inactivate β-lactam 
antibiotics by hydrolysis. 
These enzymes are divided into four groups depending on their activity profile. 
Description of these enzymes is given below:  
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(i) Penicillinases inactivate penicillins, but do not affect cephalosporins, aztreonam, 
or carbapenems;  
(ii) Cephalosporinases preferentially inactivate cephalosporins and aminopenicillins, 
but do not degrade other penicillins (carboxy- and ureido-penicillins), aztreonam, and 
carbapenems; 
(iii) Extended-spectrum β-lactamases (ESBLs) act to inactivate all β-lactams except 
carbapenems and are inhibited by clavulanic acid; and 
(iiii) Carbapenemases deactivate carbapenems and may also deactivate other types of 
β-lactam molecules, depending on the enzyme (Nordmann et al., 2012). 
The ESBLs are one group of β lactamases which have the capability to hydrolyse and 
cause resistance to different types of the newer β-lactam antibiotics, comprising the 
expanded-spectrum (or third-generation) cephalosporins (eg, cefotaxime, ceftriaxone, 
ceftazidime) and monobactams (eg, aztreonam), but not the cephamycins (eg, 
cefoxitin and cefotetan) and carbapenems (eg, imipenem, meropenem, and 
ertapenem) (Bradford, 2001).  
The ability of organisms to produce ESBLs remains an important reason for therapy 
failure with cephalosporins and possess major consequences for infection control 
(Paterson and Bonomo, 2005). Furthermore, most of ESBLs can be divided into three 
groups: TEM, SHV, and CTX-M types (Paterson and Bonomo, 2005). The major 
ESBLs-producing organisms isolated worldwide are K. pneumoniae and E. coli, but 
these enzymes have also been identified in some other members of 
Enterobacteriaceae and in particular non-fermenters (Jacoby and Munoz-Price, 
2005). In a Further discovery by Hurrell et al. (2009b), the antibiograms for the 
Enterobacteriaceae were isolated where all the Se. marcescens strains were resistant 
to amoxillin and co-amoxiclav. In addition, a quarter of Ent. hormaechei isolates 
were resistant to the 3
rd 
generation cephalosporins, ceftazidime and cefotaxime.  
During the period of study, K. pneumoniae and Se. marcescens caused infections in 
the two NICUs. 
The ESBLs were detected in three of these strains (Hurrell et al., 2009b).  The 
antibiotic resistance patterns of the remaining strains could be due to repressed 
chromosomal AMPC β-lactamase production (Bonnet, 2004). It was proposed that 
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the empirical use of antibiotics may be selecting for ESBL organisms such as Se. 
marcescens and K. pneumoniae.  Although no link was established (due to 
restrictions in sampling) with feeding tube isolates, it was notable that these two 
species were also responsible for neonatal infections in both NICUs during the study 
period. 
Bacteria are known to attach and grow in feeding tubes, but further details regarding 
their potential virulence is still awaited. Hence, this part of the project was  
focused on the virulence potential of Ent. ludwigii,  Ent. hormaechei, Ent. cloacae,  
Ent. aerogenes and K .oxytoca. 
5.2 Materials and methods 
Thirty four Enterobacteriaceae composed of Ent. ludwigii, Ent. hormaechei,  
Ent. aerogenes, Ent. cloacae, Ent. cancerogenus and K. oxytoca were isolated from 
both the previous Nottingham NICU study (Hurrell et el., 2009b) and from Delgado 
et al. (2008).  They were used to determine the ability of the strains to attach to the 
human epithelial cells, as given in Tables 2.4 and 2.6. The attachment and invasion of 
Caco-2 human epithelial cells was determined after a 3 hours exposure period. E. coli 
1230 and Salm. Enteritidis strain 358 were used as negative and positive controls 
respectively.  Salm. Enteritidis is a documented enteric pathogen capable of attaching 
and invading Caco-2 cells, the procedure described in section 2.5.1.3 and 2.5.1.4. 
Selected strains listed in Table 2.7 section 2.1.1 in chapter 2, were used in this study. 
As Ent. hormaechei is associated with cases of bacterial meningitis and also we have 
Ent. ludwigii strain (NTU1439) from Nottingham QMC hospital that was isolated 
from a case of neonatal meningitis during the period of study, thus we carried out an 
in vitro study to investigate the ability of these strains to invade capillary endothelial 
cells which comprise the HBMEC the procedure described in section 2.5.1.3 and 
2.5.1.4. Ent. aerogenes and Ent. cloacae were not included in this study because, at 
the time this study was initiated, these strains were considered as K. oxytoca.  
However, later we identified these strains as Ent. aerogenes and Ent. cloacae using 
16S rDNA sequence analysis. The attachment and invasion of HBMEC was 
determined after a 3 hours exposure period the procedure described in section 2.5.1.3 
and 2.5.1.4. E. coli 1230 and C. koseri strain 48 were used as negative and positive 
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controls respectively. The in vitro study we carried out to determine the ability of 
Ent. ludwigii, and Ent. hormaechei to invade rBCEC4 was compared with the 
HBMEC cell line. The positive and negative controls were C. koseri 48 and E. coli 
1230 respectively.  
The U937 macrophage cell lines were used to investigate the ability of tested strains 
to persist in macrophages for up to 48 hours.  Ent. ludwigii, Ent. hormaechei,  
Ent. cloacae, Ent. aerogenes and K. oxytoca strains were used to infect the U937 
macrophage cell line. These strains were used with previous cell lines. Strains of 
C. koseri 48 and E. coli 1230 were used as positive and negative controls respectively; 
section 2.5.1.5. Giemsa staining was used to stain Caco-2 human epithelial cells  
after 3 hours incubation of  ~10
8
 bacteria. As part of a study, the virulence factor, 
haemolysin production, was examined and the method was described in section 2.5.2. 
The ability of bacteria to resist serum was detected because serum resistance is 
attributed to disease in their host. The method is described in section 2.5.3. 
Siderophore production was carried out to determine the ability of strains to obtain 
iron from the host. The method is described in section 2.5.4. The antimicrobial 
susceptibility of each strain to several classes of antibiotics was tested by using the 
disc diffusion method. As recommended by Health Protection Agency (2006), E. coli 
NCTC 10418 was used as the control strain. A PCR detection analysis was used to 
determine the high pathogenicity island genes. The preparations of culture media and 
conditions for this chapter were described previously in section 2.5 in chapter 2 of 
materials and methods. 
5.3  Results 
Bacterial attachment and invasion of host cells 
The tested bacteria strains showed interacted of bacteria with different mammalian 
cells and the results are given in the following section:  
5.3.1  Bacterial attachment to Caco-2 human epithelial cells 
The Caco-2 cell line was used to determine the ability of the strains to attach to the 
human epithelial cells. To facilitate the classification of strains, attachment levels 
were divided into three groups (high, medium and low) the cut of point. The cut off  
points were  experimental decision because of the variation between results of strains. 
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A cut off value of more than 10% of recovered cfu/ml was considered as the high 
attachment of strains to Caco-2 human epithelial cells, medium attachment refers to 
the attachment of strains between 5% and 10% cfu/ml, while less than 5% cfu/ml was 
considered as low attachment. 
As seen in Figure 5.1, all strains showed the ability to attach to the Caco-2 human 
epithelial cells. Two of the K. oxytoca strains, 1356 and 1079, showed a high level of 
attachment. A medium level of attachment was shown by 4/6 strains of Ent. ludwigii, 
3/8 strains of Ent. hormaechei and 1/6 strains of K. oxytoca, whereas low attachment 
was reported by 2/10 strains of Ent. ludwigii, 5/8 strains of Ent. hormaechei, 3/6 
strains of K. oxytoca and all Ent. aerogenes and Ent. cloacae strains, 
As shown in Figure 5.2, all Ent. cancerogenus strains attached to Caco-2 human 
epithelial cells and the high level of attachment was shown by strains 1350, 1077, 
1037, 806 and 1360, whereas the medium level of attachment was observed by 
strains 845, 957, 1359, 1355 and 1364. The rest of Ent. cancerogenus strains showed 
low attachment to Caco-2 human epithelial cells. Using one-way ANOVA, Ent. 
Ludwigii; strains 1348, 1349, 1351 and 1366, Ent. hormaechei strains; 798, 860 and 
1034,  
Ent. cancerogenus strains; 806, 845, 957, 1037, 1077, 1350, 1355, 1359, 1360 and 
1364 and k. oxytoca strains; 1353, 1356 and 1079 showed significantly more 
attachment than E. coli 1230 (p < 0.05).  
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Figure ‎5.1: Attachment of Ent. ludwigii, Ent. hormaechei, Ent. aerogenes, Ent. cloacae and K. oxytoca to the mammalian Caco-2 cell line.  
Salm. Enteritidis 358 and E. coli 1230 were used as positive and negative controls respectively. Data represents the mean of results of two 
independent experiments in triplicate. Error bars represent the standard deviation of two independent experiments.  MOI= 100.
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Figure ‎5.2: Attachment of Ent. cancerogenus to the mammalian Caco-2 cell line.  
Salm. Enteritidis 358 and E. coli 1230 were used as positive and negative controls respectively. Data represents the mean of results of two 
independent experiments in triplicate. Error bars represent the standard deviation of two independent experiments. MOI= 100.
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5.3.2  Bacterial invasion Caco-2 human epithelial cells 
To determine the ability of strains to invade Caco-2 human epithelial cells, 
gentamicin protection assay was used. In Figures 5.3 and 5.4 most strains invaded 
Caco-2 human epithelial cells at very low levels, however Ent. hormaechei strain 
1053 showed four fold less invasion to Caco-2 human epithelial cells than  Salm.  
Enteritidis.  
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Figure ‎5.3: Invasion of Ent. ludwigii, Ent. hormaechei, Ent. aerogenes, Ent. cloacae and K. oxytoca to the mammalian Caco-2 cell line.  
Salm. Enteritidis 358 and E. coli 1230 were used as positive and negative controls respectively. Data represents the mean of results of two 
independent experiments in triplicate. Error bars represent the standard deviation of two independent experiments. MOI= 100. 
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Figure ‎5.4: Invasion of Ent. cancerogenus the mammalian Caco-2 cell line.  
Salm. Enteritidis 358 and E. coli 1230 were used as positive and negative controls respectively. Data represents the mean of results of two 
independent experiments in triplicate. Error bars represent the standard deviation of two independent experiments. MOI= 100. 
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5.3.3  Bacterial attachment HBMEC 
The HBMEC cell line was used to determine the ability of the strains to attach to the 
HBMEC.  The attachment levels were divided into three groups (ie high, medium and 
low). Since it was a variation between results of strains, therefor the cut off  points 
were  experimental decision. The cut off values to define the groups are given below: 
1. High attachment level=  >6% cfu/ml 
2. Medium attachment level= 2-6% cfu/ml 
3. Low attachment level= < 2% cfu/ml. 
Figure 5.5 illustrates that all strains showed the ability to attach the HBMEC and the 
rate of attachment was less than 6% of recovered cfu/ml. Three of Ent. ludwigii 
strains 1366, 1351 and 1348 and 6/8 of Ent. hormaechei showed medium levels of 
attachment, whereas low attachment was reported by the rest of the strains. The 
positive control showed a high level of attachment that was 12% of recovered cfu/ml. 
Statistically, one of Ent. ludwigii strain 1366, five out of eight Ent. hormaechei 
strains 795, 798, 1034 1038 and 1053 were showed significantly more attachment 
than E. coli 1230 (p < 0.05). 
5.3.4 Bacterial invasion of HBMEC 
To detect the value of invasion of HBMEC cells by tested strains, the level of 
invasion was divided into two categories:  
1. < 0.1% cfu/ml low value of invasion 
2. > 0.1% cfu/ml high value of invasion 
As shown in Figure 5.6, there was no invasion by most of Ent. ludwigii except strain 
1439 which invaded at a very low rate of recovered cfu/ml, while 4/8 of  
Ent. hormaechei invaded HBMEC and the high invasion was by strain 1075.Thus, on 
average, Ent. hormaechei was the most invasive as compared to  Ent. ludwigii. 
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Figure ‎5.5: Attachment of Ent. ludwigii and Ent. hormaechei to the mammalian HBMEC cell line.  
E. coli 1230 and C. koseri 48 were used as negative and positive controls. Data represents the mean of results of two independent experiments in 
triplicate. Error bars represent the standard deviation of two independent experiments.  
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Figure ‎5.6: Invasion of Ent. ludwigii and Ent. hormaechei to the mammalian HBMEC cell line.  
E. coli 1230 and C. koseri 48 were used as negative and positive controls. Data represents the mean of results of two independent experiments in 
triplicate. Error bars represent the standard deviation of two independent experiments.  
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5.3.5 Bacterial attachment rBCEC4 
Figure 5.7 shows a range of attachment of Ent. ludwigii, and Ent. hormaechei to 
rBCEC4.  The cut-off to define the degree of attachment is given below: 
1. High attachement level =  > 6% cfu/ml 
2. Medium attachment level =  2-6% cfu/ml 
3. Low attachment level =  < 2% cfu/ml 
Ent. ludwigii strains 1348, 1366 and 1351 and Ent. hormaechei strains 860, 1075, 
795, 1038 and 1053 showed high levels of attachment where the number of recovered 
cells was in the range between 9.50% to 14.50% cfu/ml. The medium level of 
attachment was by 2/6 of Ent. ludwigii and 1/8 of Ent. hormaechei, while low 
attachment was shown by the rest of the strains. 
5.3.6 Bacterial invasion of rBCEC4 
The ability of tested strains to invade the rBCEC4 was determined. The level of 
invasion was divided into two groups high and low.  The degree of invasion is 
defined as is given in section 5.3.4 (see Figure 5.8). 
All Ent. ludwigii and Ent. hormaechei invaded rBCEC4 at different values. One 
strain of Ent. ludwigii, which was NTU1439 from Nottingham QMC hospital  from a 
case of neonatal meningitis, and 3/8 strains of Ent. hormaechei (798, 1053 and 1075)  
showed high levels of invasion. The value recovered cells were between 0.15% to 
0.50 % cfu/ml. The rest of strains  invaded the rBCEC4 at a low level, which were 
less than 0.1% cfu/ml. C. koseri strain 48 (positive control) invaded rBCEC4 at 
0.35% cfu/ml. 
Statistically, All Ent.ludwagii strains except strain 1349 and Ent. hormaechei strains 
860, 7 5,  038,  053 and  075 attached rBCEC4 cells at a significantly (p ≤ 0.05) 
greater value than E. coli 1230.  
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Figure ‎5.7: Attachment of Ent. ludwigii and Ent. hormaechei to the mammalian rBCEC4 cell line.  
 E. coli 1230 and C.koseri 48 were used as negative and positive controls. Data represents the mean of results of two independent experiments in 
triplicate. Error bars represent the standard deviation of two independent experiments.   
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Figure ‎5.8: Invasion of Ent. ludwigii and Ent. hormaechei to the mammalian rBCEC4 cell line.  
 E. coli 1230 and C. koseri 48 were used as negative and positive controls. Data represents the mean of results of two independent experiments in 
triplicate. Error bars represent the standard deviation of two independent experiments. 
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5.3.7 U937 macrophage uptake and persistence studies 
After invasion, a number of bacterial pathogens have the ability to survive and 
replicate within host cells. The host immune response utilizes phagocytic cell as a 
critical line of defence against infection. The capability of a pathogen to persist and 
replicate within macrophages is a potent way of evading the defence mechanisms of 
the host.  
Three strains of Ent. hormaechei out of eight strains and 1/2 strain of Ent. cloacae 
persisted in macrophages for 48 hours. In contrast, Ent. cloacae strain 779 did not 
persist after a 24 hours period. Ent. hormaechei 798 strain demonstrated a high level 
of persistence at 24 hours, while Ent. cloacae 789 strain showed high replication at 
48 hours.  
Ent. hormaechei 798 strain displayed a high level of replication. All Ent. ludwigii and 
K. oxytoca strains showed no uptake by U937 macrophage cells, or were rapidly 
killed following uptake (Figure 5.9). 
The only significant replicate was observed at 48 minutes for strain 798 (P < 0.05).   
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Figure ‎5.9: Ent. ludwigii, Ent. hormaechei, Ent. aerogenes, Ent. cloacae and K. oxytoca persistence in U937 macrophage cells after 45 
minutes, 24h and 48 h. E. coli 1230 and C. koseri 48 were used as negative and positive controls. Data are means ± standard errors of two 
independent experiments performed in triplicate of two independent experiments.  
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5.3.8 Summary of potential risk for Enterobacteriaceae 
Evaluation of the ability of opportunistic pathogenic bacteria to attach and invade 
Caco-2, HBMEC and rBECE4 cells and survive within macrophages are an 
important consideration. The data for these results was summarised in Table 5.1. The 
potential risk for 23 strains of Enterobacteriaceae was determined and categorised as 
high, moderate and low with regard to their virulence potential. Six strains showed 
high potential risk; 3 of the strains persisted within macrophages which included Ent. 
hormaechei strains 798, 1038 and 790, while an other 3 strains, Ent. hormaechei 
1053 and 1075 and Ent. ludwigii 1439, were able to invade rBMCE4 at high levels. 
Ent. hormaechei 798 and 1075 strains also showed high invasion to rBMCE4 and 
HBMEC respectively. Two strains of Ent. cloacae (779 and 789) showed moderate 
risk. The rest of the strains showed low potential risk.  
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Table ‎5.1: Summary of virulence factors for Ent. hormaechei, Ent. ludwigii, Ent. cloacae, Ent. aerogenes and K. oxytoca. 
EFT: Indicates enteral feeding tube, MBM: Indicates human mastic breast milk and CSF: indicates cerebrospinal fluid. NK: unknown.  
attachment   invasion attachment   invasion attachment   invasion
Ent. hormaechei 798 EFT 18 same day Ebh6 6 Moderate Low Persist Low High Moderate Low High
" 1053 " 117 1 day 2 Low High Killed High High Moderate Low High
" 1075 " 117 1 day 2 Low Low Killed High High Low High High
" 1038 " 113 1week Ebh7 2 Low Low Persist High Low Moderate Very low High
" 790 " 4 one month U 1 Low Low Persist Low Low Low Very low High
Ent. ludwigii 1439 CSF A1 " N/A 1 Low Very low Killed Moderate High Low Very low High
Ent. cloacae 779 EFT 1 1 week 2 Low Low Persist -Killed N/A N/A N/A N/A Moderate
" 789 " 12 " 2 Low Very low
Replicates- 
Persist
N/A N/A N/A N/A Moderate
Ent. hormaechei 795 " 17 same day Ebh6 6 Low Low Killed High Very low Moderate No Low
" 860 " 52 " Ebh4 3 Moderate Very low Killed High Very low Moderate Very low Low
" 1034 " 110 " Ebh2 2 Moderate Very low Killed Moderate Very low Moderate Very low Low
Ent. aerogenes 1056 " 118 1 week Eba1 2 Low Low Killed N/A N/A N/A N/A Low
Ent. ludwigii 1348 MBM NK NK U NK Moderate Very low Killed High Very low Moderate No Low
" 1349 " NK " " " Moderate No Killed Low Very low Low No Low
" 1351 " NK " " " Moderate Very low Killed High Very low Moderate No Low
" 1352 " NK " " " Low No Killed Moderate No Low No Low
" 1366 " NK " " " Moderate No Killed High No Moderate No Low
K. oxytoca 832 EFT 36 ~1 week Kc5 2 Low Very low Killed N/A N/A N/A N/A Low
" 1078 " 120 NK NK Low Low Killed N/A N/A N/A N/A Low
" 1079 " 121 " " High Very low Killed N/A N/A N/A N/A Low
" 1353 MBM NK " U " Moderate Very low Killed N/A N/A N/A N/A Low
" 1354 " " " " " Low Very low Killed N/A N/A N/A N/A Low
" 1356 " " " " " High Very low Killed N/A N/A N/A N/A Low
Neonates of 
patients isolates 
represented
Species Strain
Source 
of 
isolates
Neonate 
Number
Period of 
isolation
Kc3
Caco-2
Ebh3
Ebl1
Potential 
risk
rBMCE4 HBMEC
Macrophage 
response
PFGE 
cluster
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5.3.9 Patterns of adherence of Enterobacteriaceae to Caco-2 cells 
Giemsa staining was used to determine the adhesion patterns of Ent. ludwigii,  
Ent. hormaechei, Ent. cloacae, Ent. aerogenes and K. oxytoca to Caco-2 human 
epithelial cells. Three different adhesion patterns could be distinguished on Caco-2 
human epithelial cells:  
(i)  Aggregative adhesions: Large clusters of adhering bacteria which cover the cell 
surface, observed for 6/8 strains of Ent. hormaechei and 1/6 strains of K. oxytoca (see 
Table 5.2, Figure 5.10 (A)). 
(ii) Diffuse adhesions: Bacteria distributed over the cell surface; observed in only one 
strain ie, Ent. aerogenes (see Table 5.2, Figure 5.10 (B)). 
(iii) Localized adhesions: Distribution in small groups; observed in all Ent. ludwigii 
and Ent. cloacae strains, 5/6 strains of  K. oxytoca, 2/8 strains of  Ent. hormaechei; 
(see Table 5.2, Figure 5.10 (C)). 
The strains showed the same adhesion patterns belonging to the same pulsotype (see 
Table 5.2). Examples of the different patterns of adhesion as observed on Caco-2 
human epithelial cells can be seen in Figure 5.10 A, B and C. 
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Table ‎5.2: Description patterns of adherence of Enterobacteriaceae to Caco-2 cells.
 
EFT: Indicates enteral feeding tube, MBM: Indicates human mastic breast milk and CSF: indicates cerebrospinal      
fluid. Ebh2-4, 6 and 7; Ebl1 and Kc3 and 5 indicates PFGE cluster groups, U: Unique. 
 
 
 
 
 
 
 
Ent. ludwigii 1348 MHM Localized 
" 1349 " "
" 1351 " "
" 1352 " "
" 1366 " "
" 1439 CSF "
Ent. hormaechei 790 EFT U Aggregative
" 795 " "
" 798 " "
" 860 " Ebh4 "
" 1034 " Ebh2 "
" 1038 " Ebh7 Localized 
" 1053 " „
" 1075 " Aggregative
Ent. cloacae 779 EFT Localized 
" 789 " "
Ent. aerogenes 1056 EFT Eba1 Diffuse 
K. oxytoca 832 " Kc5 Localized 
" 1078 " "
" 1079 " "
" 1353 MBM "
" 1354 " "
" 1356 " Aggregative
U
Ebh6
Ebh3
Ebl1
Kc3
U
Species Strain
Source of 
isolates
Adherence patternPFGE cluster 
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Figure ‎5.10: Light microscopy of Giemsa stained Caco-2 human epithelial cells, 
showing the three types of bacteria adherence patterns, after 3 hours incubation of 
10
8
 bacteria.  (A) Aggregative adhesion, (B) Diffuse adhesion, and (C) Localized 
adhesion. Magnification is x200.  
 
A 
B 
C 
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5.3.10 Haemolysin production 
Seventeen out of the twenty-three strains showed β- haemolysis on horse blood agar 
and 21/23 strains showed α- haemolysis on sheep blood agar. Six isolates showed no 
haemolysis on horse blood agar whereas 1 strain presented the gamma type of 
haemolysis (non- haemolysis) on sheep blood agar, (Table 5.3).  
5.3.11 Serum sensitivity 
All Ent. cloacae, Ent. aerogenes, K. oxytoca and 4/6 strains of Ent. ludwigii and 6/8 
strains of Ent. hormaechei were resistant to human serum (log differentiation was ≥ 
- 0.09) and the high resistance to serum was observed by Ent. ludwigii strain 1349, 
Ent. cloacae strain 789 and K. oxytoca strains 1354 and 1356 (log differentiation was 
≥1). However, 4 strains were intermediate to human serum which were Ent. ludwigii 
strains 1351 and 1439 and Ent. hormaechei strains 1053 and 1075.  
Salm. Enteritidis strain 358 and E. coli strain 1230 were completely resistant and 
sensitive to serum, respectively. The results were presented as a viable count 
(log10cfu/ml) by using log differentiation between the viable count of bacteria at time 
zero and after 4 hours. The results are shown in Table 5.3. 
5.3.12  Siderophore production 
Bacteria need iron for a variety of metabolic processes, where the bacteria synthesise 
and secrete small organic molecules called siderophores which then actively chelate 
iron. All strains Ent. ludwigii,  Ent. hormaechei, Ent. cloacae, Ent. aerogenes and  
K. oxytoca were positive for siderophores production, which was represented by 
orange halos around the colony growth. Y. enterocolitica 8081 (positive control) 
showed a positive result as well.  The results are presented in Table 5.3. 
5.3.13 Determination of high pathogenicity island 
The uptake iron genes irp1 and irp2 were absent from all tested strains while gene 
fyuA was detected in all Ent. cloacae strains, Ent. aerogenes strains, 4/6 strains of  
Ent. ludwigii, 1/8 strains of Ent. hormaechei, and 4/6 strains of  K. oxytoca (Figures 
5.11 and 5.12, Table 5.3). 
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Figure ‎5.11:  lane 1: ladder 100bp; lanes 2 negative control; lane 3: PCR product 
of fyuA gene size 547bp using Ent. hormaechei, Ent. cloacae, 
Ent. aerogenes and Ent. ludwigii DNA. Under the UV light, using the In  
Genius® gel documentation system (Syngene; UK) DNA samples were 
visualized. Y. enterocolitica strain 8081 was used as positive control. 
 
 
 
 
 
Figure ‎5.12: lane 1: ladder 100bp; lanes 2 negative control; lane 3: PCR product 
of fyuA gene size 547bp using K. oxytoca DNA. Under the UV light, using the 
InGenius® gel documentation system (Syngene; UK) DNA samples were 
visualized. Y. enterocolitica strain 8081 was used as positive control.  
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Table  5.3: Description of haemolysin production (horse/sheep blood), serum sensitivity determination and siderophore production.  
 
(α) indicated positive/partial haemolysis and greenish color around the colonies. (ß) indicated to clearing around colonies on blood agar. (─) indicated a lack of clearing or another 
change around colonies on blood agar (non-haemolysis) or indicated absent gene. (+) indicated positive haemolysis. (R) indicated serum-resistant strains; (I) indicated serum-
intermediate strains. The serum sensitivity data represents the mean of two independent experiments in duplicate. 
horse blood sheep blood
Log differentiation 
cfu/ml
Result irp1 irp2 fyuA 
Ent. ludwigii 1348 ─ α 0.76 R + ─ ─ +
" 1349 ─ α 1.05 R + ─ ─ +
" 1351 β α ─ 0.06 I + ─ ─ +
" 1352 β α 0.67 R + ─ ─ +
" 1366 β α 0.37 R + ─ ─ ─
" 1439 β α ─ 0.05 I + ─ ─ ─
Ent. hormaechei 790 β α 0.90 R + ─ ─ ─
" 795 ─ α 0.82 R + ─ ─ +
" 798 β α 0.15 R + ─ ─ ─
" 860 β α 0.10 R + ─ ─ ─
" 1034 β α 0.66 R + ─ ─ ─
" 1038 β α 0.04 R + ─ ─ ─
" 1053 β α ─ 0.59 I + ─ ─ ─
" 1075 β α ─ 0.30 I + ─ ─ ─
Ent. cloacae 779 ─ α 0.09 R + ─ ─ +
" 789 ─ α 1.16 R + ─ ─ +
Ent . aerogenes 1056 β α 0.84 R + ─ ─ +
K. oxytoca 832 β ─ 0.90 R + ─ ─ +
" 1078 β α 0.88 R + ─ ─ ─
" 1079 β α 0.86 R + ─ ─ ─
" 1353 β α 0.98 R + ─ ─ +
" 1354 ─ α 1.26 R + ─ ─ +
" 1356 β α 1.00 R + ─ ─ +
Strep. pyogenes NCTC 9994 β β N/A N/A N/A N/A N/A N/A
E . coil 1230 N/A N/A ─2.40 S N/A N/A N/A N/A
Salm . Enteritidis 358 N/A N/A 1.23 R + N/A N/A N/A
Y. enterocolitica  8081 N/A N/A N/A N/A + + + +
Species Strain
Uptake iron genesSerum sensitivityHaemolysin production
Siderophore 
production
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5.3.14 Determination of antibiotic susceptibility testing by the disc diffusion 
method 
All Ent. ludwigii strains were resistant to ampicillin, doxycycline, cephalothin, 
cefoperazone and cefotaxime. The exception was strain 1439 which was intermediate 
to cefuroxime and sensitive to cefoperazone. Most of Ent. ludwigii strains showed 
sensitivity to streptomycin, co-amoxiclav, imipenem, meropenem, ciprofloxacin, 
chloramphenicol and cefpodoxime. The exceptions were strains 1348 and 1439, 
which were resistant to streptomycin and intermediate to co-amoxiclav, respectively; 
and strains 1349 and 1439, which were both resistant to chloramphenicol. Ent. 
ludwigii strains showed intermediate resistance to the rest of the antibiotics tested. A 
summary of results is given in Table 5.4. All Ent. ludwigii strains were not able to 
produce ESBLs.  
All Ent. hormaechei strains were sensitive to amikacin and ciprofloxacin. In contrast,  
all Ent. hormaechei strains were resistant to ampicillin, co-amoxiclav, doxycycline, 
cephalothin, cefuroxime and cefotaxime, excluding 2 strains 790 and 1075 which 
were resistant to co-amoxiclav (Table 5.4). The combination disc method was used to 
detect ESBLs production. Three strains of Ent. hormaechei (795, 798 and 860) 
produced ESBLs and they were resistant to 3
rd
 generation cephalosporin. The rest of 
the strains did not produce ESBLs (see Table 5.4).    
All Ent. cloacae strains were resistant to gentamicin, streptomycin, doxycycline and 
cephalothin and intermediate to ampicillin and ceftriaxone. Only 1 strain (ie. 789) 
was resistant to cefuroxime, cefoperazone and cefotaxime. Ent. cloacae strains were 
sensitive to the rest of the antibiotics tested. The exception was by strains 779 and 
789 which were intermediate to ceftazidime and amikacin respectively. Ent. cloacae 
strains did not produce ESBLs (see Table 5.4).    
In this study, Ent. aerogenes 1056 showed resistance to gentamicin, streptomycin, 
ampicillin, doxycycline, cephalothin, cefuroxime and cefoperazone, while it was 
intermediate to ceftriaxone, ceftazidime and trimethoprim. This strain (1056) was 
sensitive to the rest of the antibiotics tested and was not able to produce ESBLs (see 
Table 5.4).    
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All K. oxytoca strains were resistant to streptomycin, ampicillin, doxycycline and 
cephalothin. However, 4/6 strains of K. oxytoca were resistant to gentamicin; 5/6 
strains which were resistant to cefoperazone; 1/6 strains were resistant to cefotaxime; 
5/6 strains were resistant to cefuroxime; and 2/6 strains were resistant to co-
amoxiclav, cefuroxime and chloramphenicol. K. oxytoca strains were intermediate to 
amikacin, ceftriaxone, ceftazidime and imipenem, trimethoprim by 1/6, 2/6, 2/6, 4/6 
and 4/6 strains of K. oxytoca respectively. Most of the K. oxytoca showed sensitivity 
to most of the antibiotics tested (see Table 5.3). All K. oxytoca strains were not able 
to produce ESBLs (Table 5.4). 
Across all strains used in this study it was noted that Ent. ludwigii, Ent. hormaechei, 
Ent. cloacae, Ent. aerogenes and K. oxytoca  showed resistance to doxycycline, 
cephalothin and cefuroxime and were sensitive to ciprofloxacin and meropenem.  
Three strains of Ent. hormaechei produced ESBLs and  E. coli NCTC 10418 was 
sensitive to all antibiotics tested. 
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       Table ‎5.4: Description of antibiotic resistance profiles of Enterobacteriaceae isolates. 
 
         R, resistant; I, intermediate; s, sensitive. (Yes) indicated strain is produce ESBLs and (no) indicated strain is not produce ESBLs. 
Ent . aerogenes 
1348 1349 1351 1352 1366 1439 790 795 798 860 1034 1038 1053 1075 779 789 1056 832 1078 1079 1353 1354 1356
Gentamicin    10µg R I I R R I I I I R I R R I R R R S R S R R R
Amikacin  30µg R S I I I S S S S S S S S S S I S I S S S S S
Streptomycin 10µg R S S S S S S R R S S S S S R R R R R R R R R
Ampicillin   10µg R R R R R R R R R R R R R R I I R R R R R R R
Co-amoxiclav 20+10 S S S S S I S R R R S R R S S S S S S R R S S
Tetracyclines Doxycycline  30µg R R R R R R R R R R R R R R R R R R R R R R R
Quinolones Ciprofloxacin 1µg S S S S S S S S S S S S S S S S S S S S S S S
Cephalosporins 1 Cephalothin   30µg R R R R R R R R R R R R R R R R R R R R R R R
Cephalosporins 2 Cefuroxime     30µg R R R R R I R R R R R R R R I R R R I R R R R
Ceftriaxone 30µg I I I I I I S R R R S I I R I I I I S I R I I
Cefoperazone   30µg R R R R R S S R R R S R S R S R R R S R R R R
Cefotaxime 30µg  R  R  R  R  R  R R R R R R R R R S R S R S S S S S
Ceftazidime  30µg  I  I  I  I  I  I  I  R R  I  I  I  I I  I  S  I  S  S  I  I  I  I
Cefpodoxime 10µg S S S S S S S R R R S S S S S S S S S S S S S
Imipenem 10µg S S S S S S S S S S S S S S S S S S S S S I I
meropenem 10µg S S S S S S S S S S S S S S S S S S S S S S S
Trimethoprim 2.5µg I I I I S I S R R I I I I I S S I I S I S S S
Chloramphenicol 30µg S R S S S R R R R R S R R R S S S S S R R S S
ESBL production no no no no no no no yes yes yes no no no no no no no no no no no no no
Antibiotic Con.
Interpretation of zone diameters (mm)
Ent. ludwigii Ent. hormeachei Ent. cloacae K. oxytoca
Aminoglycoside
penicillin
Group
_
Carbapenems
Cephalosporins 3
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5.4 DISCUSSION 
Pathogenic bacteria use a number of strategies to cause disease in human hosts, some 
of which include adhesion, colonisation, activation of disease process, serum 
resistance and toxins production. The most important factor is the ability of bacteria 
to attach to the host surfaces, such as mucous membranes, gastric and intestinal 
epithelial or endothelial tissue (Boyle et al., 2003; Finlay and Falkow, 1997; Klemm 
and Schembri, 2000). Enterobacteriaceae are the most common opportunistic 
pathogens, particularly E. coli, Enterobacter spp., Klebsiella spp., Serratia spp., and 
Salmonella, which are considerably implicated with a wide range of morbidity and 
mortality (Friedland et al., 2003; Adamson et al., 2012).  
In the present study, an attempt was made to determine the relationship between 
haemolysin production and other virulence associated factors in selected strains of 
Enterobacteraceae. There was a relationship between haemolysin production and 
other factors, such as serum resistance and siderophore production, which may be 
associated with neonates’ infection. 
This study was focused on investigating the potential virulence of 
Enterobacteriaceae from EFT and MBM by determining whether or not they pose  
a risk of infection to neonates. Forty three Enterobacteriaceae composed of  
Ent. ludwigii, Ent. hormaechei, Ent. aerogenes, Ent. cloacae, Ent. cancerogenus and 
K. oxytoca strains were chosen to be part of the study as they were the most 
representative of the species isolated. The potential of virulence for the 43 strains to 
mammalian cells was determined using attachment and invasion studies of Caco-2 
tissue culture cells, while the attachment and invasion rBECE4 and HBMEC tissue 
culture cells were only studied for 14 strains (Ent. ludwigii, Ent. hormaechei). 
Macrophage survival was studied for 23 strains (Ent. ludwigii, Ent. hormaechei, Ent. 
aerogenes, Ent. cloacae and K. oxytoca using the U937 cell line of human monocyte 
cells. 
This study demonstrated that all strains showed the ability to attach to epithelial and 
endothelial cell lines. The viable counts obtained exhibit the ability of strains to 
attach to Caco-2, HBMEC and rBECE4 cells. There were differences in the ability of 
Ent. ludwigii, Ent. hormaechei, Ent. cancerogenus Ent. aerogenes, Ent. cloacae and 
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K. oxytoca to attach to intestinal epithelial cells (Caco-2) (see Figures 5.1-5.4).  The 
viable counts showed that Ent. cancerogenus and K. oxytoca strains were able to 
attach to Caco-2 cells at relatively high levels compared with the rest of strains 
(Figure 5.2). Whereas Ent. ludwigii and Ent. hormaechei strains attached to rBECE4 
cells at higher numbers compared to their ability to attach to HBMEC cells (Figures 
5.5, and  5.7). However, all strains were able to attach to the different types of 
epithelial and endothelial cell lines. 
The ability of bacteria to adhere to host surfaces, such as skin, mucous membranes 
(oral cavity, nasopharynx, urogenital tract), and deeper tissues (lymphoid tissue, 
gastric and intestinal epithelia, alveolar lining, endothelial tissue), is a key step in the 
host-pathogen interaction. Hosts produce numerous mechanical forces, such as saliva 
secretion, coughing, sneezing, mucous flow, peristalsis, and blood flow, which act to 
wash microbes away from susceptible surfaces. However, microbial pathogens 
express factors that bind to molecules on various host tissue cells and render the 
microbe resistant to these mechanical washing forces (Podschun and Ullmann, 1998). 
As a result, microbial biochemical processes cause diseases, including proliferation, 
toxin secretion, host cell invasion, and activation of host cell signalling cascades 
(Wilson et al., 2002).  
Once adhered to a host surface, some pathogenic bacteria can gain access deep into 
the host and continue the infection cycle. In this study, there were variations between 
species in their invasion of Caco-2 cells; for example, all Ent. hormaechei were able 
to invade Caco-2 cells compared to the remaining species. Additionally, there was no 
direct association between attachment and invasion rates of Caco-2 cells; for example, 
Ent. cancerogenus strains 1350, 1077, 1037, 806 and 1360 and K. oxytoca strains 
1356 and 1079 had the highest attachment rates, yet 1053 had the highest invasion 
rates (Figures. 5.1 and 5.3). 
Previous studies reported that K. oxytoca had been associated with septicaemia, soft 
tissue, intravenous, meningitis, liver abscess, and gastrointestinal disease. This is 
commonly observed in immunocompromised hosts or those with underlying 
conditions (Green et al., 2009). Townsend et al. (2008a) demonstrated that virulence 
traits were associated with Ent. hormaechei, and they are capable of invading deep 
tissues (causing systemic infection and the symptoms that it causes to spread 
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throughout the systems of the body). Furthermore, Ent. hormaechei associated with 
sepsis were able to invade gut epithelial cells. This demonstrates the virulence 
potential of Ent. hormaechei for this host site and suggests that its ability to invade 
intestinal cells may be a strong indication of potential virulence and pathogenicity in 
the neonatal host.  
According to Table 5.1, six isolates were classed as high risk, indicating they could 
increase the exposure of infants to the bacteria from infant formula administered 
through EFT. These strains were Ent. hormaechei strains 790, 798, 1038, 1053 and 
1075 and Ent. ludwigii strain 1439. In this study, the level of risk was determined 
according to the ability of strains to invade mammalian cells (Caco-2, HBMEC and 
rBECE4 cells) and to persist in human macrophages. Ent. hormaechei strains 790, 
798, 1038, 1053 and 1075 and Ent. ludwigii strain 1439 showed low levels of 
invasion to Caco-2 cells, whereas Ent. hormaechei strain 1053 showed a high level of 
invasion to Caco-2 cells.  
On the other hand, the virulence potential of Ent. hormaechei and Ent. ludwigii 
strains to invade brain capillary endothelial cells was determined using HBMEC and 
rBECE4 cells. Interestingly, three strains of Ent. hormaechei (789, 1053 and 1075) 
showed similar invasion to both cell lines (HBMEC and rBECE4); however, Ent. 
ludwigii strain 1439 was able to invade rBECE4 cell line at much higher levels than 
HBMEC cell line. Ent. ludwigii strain 1439 was isolated from a case of neonatal 
meningitis (CSF) that was obtained from Nottingham QMC hospital. This study is an 
in vitro appraisal evaluating the virulence of the isolate in relationship to clinical 
symptoms. There is a strong likelihood that the baby could have acquired the strain 
from the environment, through the skull, as its skull was opened for the brain surgery.  
It was possible to directly associate clinical symptoms and results with in vitro 
studies. For Ent. hormaechei strains isolated from EFT, there was no clinical data for 
the patients; however,  the ability of Ent. hormaechei strains to invade HBMEC and 
rBECE4 cell lines may be a strong indication of potential virulence and pathogenicity 
in the neonatal host to cause meningitis. Hervas et al. (2001) reported that  
Ent. hormaechei may be associated with meningitis because sepsis and meningitis 
were associated with Enterobacter spp. In addition, this result is consistent with a 
previous study by Townsend et al. (2008b), who studied virulence assays of clinical 
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isolates with associated patient details and clinical symptoms. They found that C. 
sakazakii strains were able to invade HBMEC and rBCEC4 cells. 
Also demonstrated was the ability of selected strains of Ent. ludwigii,  
Ent. hormaechei, Ent. aerogenes, Ent. cloacae and K. oxytoca to persist in human 
macrophages. Three strains of Ent. hormaechei (790, 1038 and 798) and 2 strains of 
Ent. cloacae (779 and 789) were able to persist and replicate in macrophages for 48 
hours. However, Ent. cloacae strain 779 showed decreased levels of persistence after 
24 hours while Ent. hormaechei strain 798 persisted at high levels within the 
macrophages up to 48 hours and then was killed (Figure 5.9). Ent. ludwigii,  
Ent. aerogenes and K. oxytoca strains were killed by macrophages.  
These results compared the ability of selected strains to invade mammalian cells. The  
important finding was that three Ent. hormaechei strains (790, 798 and 1038) were 
able to invade three types of cell lines (Caco-2, HBMEC and rBECE4 cells) (Table 
5.1, Figures. 5.3, 5.6, 5.8 and 5.9). These results indicate there could be a relationship 
between the invasion of epithelial and brain endothelial cells, and also persistence 
and replication in human macrophage cells. The ability of strains to invade capillary 
endothelial cells may give access to the brain by crossing the blood-brain barrier 
which may led to infected neonates. Moreover, the persistance and replication of the 
strains in human macrophage cells could be important to facilitate host immune 
evasion and dissemination.  
These results were consistent with the study conducted by Townsend et al. (2008b), 
who studied a NICU outbreak of C. sakazakii infections in France. They found that 
all C. sakazakii strains were able to attach and invade Caco-2 human epithelial cells, 
and invade rat brain capillary endothelial cells, and also most of the strains persisted 
in macrophage cells for 48 hours. They suggested that these features act to facilitate 
host immune evasion and spreading.  
Patterns of adherence of Enterobacteriaceae to Caco-2 cells were studied. Selected 
strains of Ent. ludwigii, Ent. hormaechei, Ent. aerogenes, Ent. cloacae and K. 
oxytoca did adhere to Caco-2 cells, and there were different patterns of adherence. 
Whether the pattern of adherence relates to the pathogenicity of the strains is 
unknown. In this study, there was no relationship between types of adherence 
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patterns and ability to invade the Caco-2 human epithelial cells (as shown in Table 
5.2, Figure 5.10 A, B and C). 
A number of virulence factors, that including haemolysins production, serum 
sensitivity determination, siderophore production and antimicrobial susceptibility, 
were investigated. 
Haemolysin production is one of the toxins that are secreted by pathogenic bacteria 
and may play an essential role in disease. Haemolysins are classified to three 
different types of haemolysins: α-haemolysin, β-haemolysin and γ-haemolysin. These 
are found in most clinical isolates, such as E. coli and Serratia species (König et al., 
1987; Welch, 1987; Schmidt et al., 1995). The present study shows that all Ent. 
ludwigii, Ent. hormaechei, Ent. aerogenes, Ent. cloacae and K. oxytoca strains were 
α-haemolytic on sheep blood agar, except K. oxytoca strain 832, while β-haemolysin 
was observed on horse blood by 17/23 strains. Previous studies have shown that the 
most important virulence factor commonly expressed by extra-intestinal pathogenic 
bacteria, such as E. coli, is α-haemolysin (Balsalobre et al., 2006).  
Another study by Ring et al. (2002) demonstrated that β-hemolysin plays an 
important role for the result of group B streptococcal sepsis by contributing to liver 
failure and high mortality. Thus, these results suggest that the strains have the ability 
to cause haemolysis and thereby damage the cell membrane of RBCs through 
production of β-haemolysis which is a potential risk factor to neonatal health. 
The sensitivity to normal human serum of isolated Enterobacteriaceae was 
determined. All Ent. ludwigii, Ent. hormaechei, Ent. aerogenes, Ent. cloacae, and K. 
oxytoca strains were serum resistant, except four strains, Ent. ludwigii strains 1351 
and 1439 and Ent. hormaechei strains 1053 and 1075, which survived in blood serum 
at an intermediate rate. A common feature of many different species causing 
bacteremia is the capability to avoid the bactericidal effects of human serum (Porto et 
al., 1989; Hol et al., 1995;  Hoe et al., 1999). 
Several previous studies found that a common feature of meningococci isolated from 
blood or cerebrospinal fluid is serum resistance (Figueroa and Densen, 1991). 
Similarly, the clinical isolated of V. vulnificus exhibited the ability to survive in 
human serum (Bogard and Oliver, 2007). Furthermore, Ent. hormaechei nosocomial 
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outbreak strains isolated from different neonates in a California hospital  showed 
serum-resistance (Townsend et al., 2008b). The finding in the current study could be 
explained by the ability of strains to survive in blood serum which possibly indicates 
an increased risk to neonates. 
Iron is an important element for pathogenic bacteria to grow, replicate and progress 
an infection (Braun and Winkelman, 1987). Bacterial ability to obtain iron from the 
host is one of the determinants for the virulence of a pathogen. All 
Enterobacteriaceae isolates showed active siderophores production. The 
identification and characterization of the molecular virulence factors of genes that 
allow pathogens to cause infection in the hospital pathogenic bacteria have been used 
(Wilson et al., 2002). Since all of the investigated Enterobacteriaceae produce 
siderophores, the irp1, irp2, fyuA genes in HPI were detected as uptake iron genes. 
The siderophore yersiniabactin production is connected with virulence in Yersinia 
species (Schubert et al., 2000).  
The uptake iron gene fyuA was detected in all Ent. cloacae strains, and  
Ent. aerogenes strains, 4/6 strains of Ent. ludwigii, 1/8 strains of Ent. hormaechei, 
and 4/6 strains of K. oxytoca, while genes  irp1 and irp2 were absent from all tested 
strains (Figures 5.11 and 5.12, Table 5.2). The interesting finding is that the strains of 
Ent. ludwigii, Ent. hormaechei, and K. oxytoca  produced siderophores 
phenotypically, while genetically lost genes irp1, irp2 and fyuA. This finding may 
suggest that these strains possibly use different iron uptake systems. 
All Ent. ludwigii, Ent. hormaechei, Ent. aerogenes, Ent. cloacae, and K. oxytoca 
strains  showed multiple resistances to a broad spectrum of antibiotics. The 
interesting finding was three strains of Ent. hormaechei (795, 798 and 860) exhibited 
resistant to aminoglycoside, pencillin, tetracycline, chloramphenicol, quinolones and 
cephalosporins 1, 2 and 3, but  were sensitive to carbapenems. In addition, the high 
levels of cephalosporins resistance in Enterobacteriaceae may be because of hyper 
production of chromosomal AMPC. This finding is consistent with Hurrell et al. 
(2009b) who reported that many of Ent. hormaechei strains isolated from ENT from 
QMC and NCH hospitals were resistant to the 3
rd
 generation cephalosporins, 
ceftazidime and cefotaxime, and ESBLs were detected. This demonstrates that 
neonates are directly exposed to antibiotic resistant strains in NICUs during feeding. 
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Recently, the incidence of neonatal infections caused by Enterobacteriaceae has been 
increasing and they are now considered as major causative agents in NICU outbreaks 
(Gastmeier et al., 2007; McGuire et al., 2004; Kaufman et al., 2004). E. coli, 
Enterobacter spp., Klebsiella spp., Serratia spp. and Salmonella are considered as the 
most common opportunistic pathogens which are implicated with morbidity and 
mortality (Friedland et al., 2003; Adamson et al., 2012). These organisms are able to 
cause many different types of infections such as sepsis, brain meningitis, pneumonia 
and urinary tract infections, particularly in intensive care units (ICU) (Kollef et al., 
1999; Ibrahim et al., 2000). Enterobacteriaceae such as E. coli, Klebsiella, Proteus, 
Serratia and Citrobacter spp. have the ability to cause nosocomial infections. Several 
of these species are the members of human normal flora such as E. coli and Ent. 
cloacae and possibly can cause infections via selection following an empiric 
antimicrobial regime (Iversen and Forsythe, 2004a; Stoll et al., 2005). 
This project concerns the risk assessment to neonates from ingested 
Enterobacteriaceae from MBM and EFT. This study was set up with the aim of 
assessing and characterising strains from these two sources and also, to study 
physiological traits associated with exposure and to determine virulence traits. The 
strains from the EFT of neonates in intensive care units from the UK have been 
published by NTU (Hurrell et al., 2009b), whereas the strains from MBM were from 
an external source from Spain (Delgado et al., 2008). Strains isolated from MBM and 
EFT included bacteria which are potentially pathogenic to neonates. The present 
study is a continuation of these studies and has further investigated and characterised 
these strains. Later on, an additional member of Enterobacteriaceae, K. pneumoniae 
isolated from EFT (obtained from Jordan) was also included in this study. These  
K. pneumoniae strains were analysed, but only for PFGE profiling due to time 
constraints. Enterobacteriaceae from EFT and MBM in this study were initially 
identified using phenotyping methods and compared with genotyping. 
The PFGE technique was used to determine if isolates are indistinguishable or 
closely related. This technique is based on multilocus enzyme restriction; as 
described by Tenover et al. (1995). There are many laboratories which use PFGE to 
determine strain relatedness and to identify the source of a strain or outbreak (Agasan 
et al., 2002; Bender et al., 2001). 
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A total of thirty-four pulsotypes of Enterobacteriaceae from EFT (21 from the UK 
and 10 from Jordan) and 3 MBM pulsotypes were identified from neonatal enteral 
feeding tubes and mastic human breast milk using PFGE. The same pulsotypes were 
disseminated across enteral feeding tubes of different infants in the same NICUs. 
Furthermore, the same pulsotypes were spread between enteral feeding tubes of 
infants in the same NICUs, indicating the same origins, such as: environment, infant 
formula or carers. The exception was one cluster of Jordanian strains which was the 
Kp2 pulsotype. This pulsotype showed an unexpected result because the strains were 
isolated from two different hospitals (the KAH and PRH Jordan). According in 
Figure 1.1 in section 1.6 the explanation for this observation could be that the same 
brand of infant formula “bebelac” was used in the two hospitals in Jordan which 
could have been contaminated with bacterial strains in the Kp2 cluster. The KAH and 
PRH hospitals fed the babies with bebelac in May and July respectively and  this 
clone may have cross contaminated the neonatal enteral feeding tubes for a long time 
period (from May to December) and infected an enormous number of neonates. In 
addition, health care worker (e,g. Doctors, Nurses) may be working in tow hospital 
and may transmission of strains between two hospital. Another source could be 
medical equipment supplier that used medical equipment, healthcare equipment, 
hospital equipment, and more. These two hospitals may be provided with equipment 
from same company. However, this assumption needs verification by using a 
different restriction enzyme in the PFGE.  
These findings are consistent with previous studies which stated that PIF is not a 
sterile product and can possibly be contaminated with pathogens that can lead to 
serious disease in infants who are less than one year old. The potential for 
contamination of PIF during production has been studied by FAO/WHO (2004 and 
2006) and several surveys of the PIF drew attention towards the pathogens that may 
contaminate this infant foodstuff (Iversen and Forsythe, 2004; Muytjens et al., 1988). 
In 2004, the report by the Food and Agriculture Organization of the United Nations 
and the World Health Organization concluded that Sal. Enterica and C. sakazakii are 
the microorganisms of greatest concern in PIF (FAO/WHO, 2004 and 2006). 
Another previous study by Morgan et al. (2012) is agreement with this study they 
reported that the contamination of healthcare workers' protective clothing during 
routine care of patients with multidrug-resistant organisms is most frequent with A. 
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baumannii. The major determinant of transmission to healthcare workers' gloves or 
gowns was environmental contamination.  
The EFT strains (UK) were isolated over the period from January to November 2007. 
This study demonstrated that twenty-one pulsotypes of Enterobacteriaceae were 
isolated from contaminated neonatal enteral feeding tubes for which no clear  
sources were known. These pulsotypes included; seven Ent. hormaechei, six  
Ent. cancerogenus, six K. oxytoca, one Ent. cloacae and one Ent. aerogenes 
pulsotype.  Previous studies stated that some of these most commonly faced species;  
Ent. aerogenes, Ent. cloacae, Ent. agglomerans and C. sakazakii have been 
associated with infections in humans (Andresen et al., 1994; Burchard et al., 1986; 
Chow et al., 1991; Gallagher, 1990; Gaston 1988; Haddy et al., 1991; Hawkins et al., 
1991; Stenhouse et al., 1992). 
This study has shown that three different clusters of K. oxytoca,  Ent. cancerogenus 
and Ent. hormaechei strains were isolated over a wide time period and comprised of a 
large number of strains. This indicates that a large number of strains were colonising 
the enteral feeding tubes; for instance, pulsotypes group Kc1 and Kc6 of K. oxytoca 
comprised 6 and 13 strains, isolated over a one month period and a two weeks period 
and isolated from two and five patients, respectively [Appendix 5]. Similarly, for two 
large pulsotype groups Ebc2 and Ebc3 of Ent. cancerogenus, each group included 13 
and 21 strains and was isolated over a prolonged period of three months and two 
months, respectively [Appendix 4]. In addition, pulsotype group Ebh5 of Ent. 
hormaechei comprised 8 strains, isolated during a one month period from 16 October 
to 19 November from three patients.  
These findings may indicate the cross-transmission of indistinguishable clones of 
each pulsotype among different patients for long periods in the same NICUs. 
However, the rest of the pulsotypes for the Ent. hormaechei, Ent. cancerogenus and 
Klebsiella spp. showed a large variety of PFGE profiles (Figures 3.1-3 and Figure 
3.6). This indicates the enteral feeding tubes were colonised by a broad range of 
Enterobacteriaceae. The diversity in PFGE profiles indicates that the EFT could be 
contaminated from different sources. The significant explanation for this finding is 
that the same NICU was contaminated by the same pulsotypes which spread between 
the enteral feeding tubes of infants and colonised different patients. Thus, the 
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contamination of feeding tubes could be from the same sources, such as: 
environment, infant formula or carers, (Figure 1.1 in section 1.6). 
These findings are in agreement with Muytjens et al. (1988) who isolated 
Enterobacteriaceae from PIF including Ent. hormaechei, Ent. cloacae, E. coli, 
K. pneumoniae and K. oxytoca. Likewise, studies by Caubilla-Barron et al. (2007) 
and Iversen et al. (2008) recovered C. sakazakii and Salmonella from contaminated 
PIF and linked them with neonatal infections. 
The increase in bacterial growth and cross contamination in NICUs is likely to be 
affected by the reconstitution temperature of PIF for infants. Forsythe, (2009) 
reported that in NICUs, PIF (fortified breast milk and reconstituted powdered infant 
formula) was prepared at room temperature, not at the higher temperatures required 
when the formula was needed. The procedure used within NICUs may be different 
across the UK. 
Another potential source of bacterial cross transmission between the patients is the 
contaminated health care worker. The most common organisms which can be 
transmitted from patient to patient on the hands of the health care team are the 
Enterobacteriaceae (Brady, 2005). Health care workers were considered as the 
source of a nosocomial outbreak of colonisation and infection with a strain of  
Se. marcescens (de Vries et al., 2006). Paper can be source for cross-contamination 
of bacterial pathogens in medical settings if current recommendations on hand 
hygiene aren't meticulously followed (H"ubner et al., 2011). 
Outbreaks of MRSA colonisations and infections in NICUs have previously been 
epidemiologically linked with health care workers infected with chronic otitis 
external (Bertin et al., 2006). Another study indicated that Gram-negative bacilli 
which were previously linked with infection in neonates could be observed on the 
nurses’s hands even after normal hand hygienic practices were followed (Waters et 
al., 2004).  Likewise, the immediate environment of the patient, such as patient 
gowns, bed linen, bedside furniture, and other objects, become contaminated with 
patient flora (Bonten et al., 1996; Samore et al,. 1996).  
In this study, a collection of twenty Enterobacteriaceae strains isolated from MBM 
were also characterised by the PFGE technique. Six strains of Ent. cancerogenus 
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were divided into three pulsotypes; Enc1- Enc3, and the rest of the strains were 
unique.  The interesting finding is each pulsotype (Enc1- Enc3) consisted of two 
strains and were found to have 78%, 89% and 92% similarity patterns, respectively 
(Figure 3.5). The PFGE result showed the strains differ by only 3 bands and they are 
probably two isolates of the same clone for each pulsotype. Additionally, these six 
strains were also found to be nearly identical by using 16S rDNA sequence analysis. 
The results of the MBM isolates indicated clonality of six strains belonging to three 
pulsotypes which are likely to be isolated from the same mother. On the another 
hand, the explanation for this observation could be that the same clone may have 
cross contaminated human milk from nurse or breast pump, see Figure 1.1 in section 
1.6. 
Strains used in this study were identified using both phenotypic (API20E and ID32E) 
and genotypic (16S rDNA sequence analysis) techniques. Using phenotypic  
techniques API 20E and ID32E, the strains isolated from EFT, were clustered as  
Ebl1 and Ebh7 respectively (Table 3.7, part 1 and 2). Each cluster had two strains;  
Ent. cloacae and K. pneumoniae  belonging to pulsotype Ebl1 and Ent. amnigenus 
and Ent. cloacae were clustered under Ebh7. Interestingly, using 16S rDNA sequence 
analysis, the strains were re-identified as Ent. cloacae and Ent. hormachei, 
respectively.   
Similarly, four strains misidentified using the phenotypic method ID32E, one of the 
strains was identified as E. coli and three other strains as Ent. aerogenes (Table 3.8). 
However, using PFGE it was shown that all the four strains belonged to Kc1 and Kc6 
pulsotype, respectively. Furthur analysis using 16S rDNA sequence analysis, all of 
these four were re-identified as K. pneumoniae. 
The MBM strains were also characterised using standard phenotyping methods and 
compared with genotyping techniques (Table 3.8). The interesting finding was that 
six strains of Ent. cancerogenus were clustered into three pulsotypes (Ecn1- Ecn3) 
and had previously been misidentified as K. oxytoca using a more common 
biochemical identification kit, ID32E.  
Overall, these findings confirm that 16S rDNA sequence analysis is a more reliable 
identification method in comparison to phenotypic techniques. This is in agreement 
with previous studies which reported that API 20E and ID32E tests are imperfect 
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techniques for the identification of bacteria because they could give false-negative 
and false-positive results (Iversen et al., 2004a and b). As in this study, strain 
misidentification was reported by Iversen et al. (2004a and 2004b) who demonstrated 
that some strains identified as Ent. sakazakii using biochemical test actually belonged 
to diverse species, including two species Ent. amnigenus and Ent. cloacae.  
A selection of species from PFGE analysis were chosen to determine the  
physiological attributes with respect to stress survival. These species included  
Ent. ludwigii, Ent. hormaechei, Ent. cancerogenus, Ent. cloacae, Ent. aerogenes and 
K. oxytoca. The effect of formula type and temperature at 55°C on stress survival of 
bacteria was determined.  
Biofilm formation on plastic surfaces was determined using casein, whey and soy-
based infant formulas at 20°C and 37°C, capsule production at 20°C and 37°C and 
acid tolerance of organisms to pH 3.5 (HCl acidified formula). 
The ability of strains to survive at 55°C were determined and most strains survived at 
55°C (Table 4.1 and 4.2). An interesting finding was that strains showing the same 
death rate at 55°C also belonged to the same pulsotype. For example, pulsotypes of 
Ebc1, Ebc2, Enc3, Ebh6 and Kc3 for Ent. cancerogenus strains 845, 848, 1355, 1358, 
1363 and 1364, Ent. hormaechei strains 795 and 798, and K. oxytoca strains 1078 
and 1079, each pulsotype comprising two strains respectively, were sensitive to heat 
tolerance at 55ºC on whey and casein-based infant formula. 
Based upon this finding, it may be concluded that these strains have the same source 
of origin and various feeding tubes were possibly contaminated by the same clone. 
As the MBM Ent. cancerogenus strains (1355, 1358, 1363 and 1364) were isolated 
from the same mother too, or breast pump, there is also a possibility of ingestion of 
these strains by neonates where they could have been exposed to the contaminated 
milk or the infant formula.  
This finding is consistent with previous studies that have demonstrated fortified 
breast milk and reconstituted PIF were prepared in a neonatal care unit at room 
temperature when required, and not at higher temperatures (Forsythe, 2009). Another 
study by Rosset et al. (2007) reported that, in a study of French hospitals, similar 
procedures were used by reconstituting the samples with room temperature water. 
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Besides, the survival of strains at 55ºC possibly is one of the significant traits 
resulting in infections of neonates in NICUs which was previously defined by Iversen 
and Forsythe, (2004a) who demonstrated that C. sakazakii strains can grow in PIF 
between 6° and 45°C and the optimisation temperature of growth being 37°C to 
43°C. According to a FAO and WHO meeting (2006), when lukewarm water is used 
for the reconstitution of PIF (if not used immediately) or when the bottles were stored 
at room temperature and prolonged feeding periods, the relative risk was found to be 
enhanced. 
The most important goals of this study were to determine the ability of bacteria to 
form a biofilm on the surface of feeding tubes at different temperatures (20°C and 
37°C), as well as to investigate whether the biofilm formation is affected by different 
types of formula, more details in section 1.10, Figure 1.2. The temperature and type 
of formula may be a mean for the persistent survival of the organism in the neonatal 
intensive care unit and the factor for possible attachment of the organism to the 
surface of the enteral feeding tubes. In the current study, most strains in all types of 
formula formed a high level of biofilm at 37ºC compared with 20ºC, (Figures 4.9, 
4.10 and 4.11). 
All the three kinds of formula were subjected to biofilm quantification, where all the 
strains resulted in high biofilm formation in casein-based infant formula when 
compared with whey or soya-based infant formula. This shows the biofilm formation 
was affected by the type of nutrition present in the milk and these findings 
corroborate the previous studies (Kim et al., 2006; Meadows, 1971) 
A previous study has reported that the nutrient sources and other media components 
affect the attachment of the biofilm forming bacteria on the surface of various 
materials (Hood and Zottola, 1997). Meadows (1971) has shown that casein 
enhanced the attachment of various organisms (E. coli, Pseudomonas fluorescens and 
Aeromonas liquefaciens) to glass surfaces and the same result was also observed for 
stainless steel surfaces when whey was present (Speers et al., 1985). 
On the other hand, the strains in the same pulsotype formed the same quantity of 
biofilm in whey and casein-based infant formula at 37ºC and 20ºC. For example, 
 Ent. hormaechei strains 1053 and 1075 and Ent. cancerogenus strains 1355, 1358, 
1359, 1360, 1363 and 1364 belonged to corresponding to pulsotypes respectively viz. 
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Ebh3, Enc2, Enc1 and Enc3 (a pulsotype has two strains). The strains formed 
equivalent biofilm formation at 37ºC and 20ºC in both the whey and casein-based 
infant formula.  Ent. hormaechei strains 1053 and 1075 only exhibited the same level 
of biofilm in whey-based infant formula at 37ºC; Table 4.3. Based upon these 
findings, it can be concluded that the same strain contaminated different feeding 
tubes and the same clone has been recovered from the same mother (MBM strains). 
The findings of this investigation are in agreement with the study previously 
conducted by Hurrell et al. (2009b) where bacteria were shown to have the potential 
to break away from the biofilm in clumps and plausibly be a souce of contamination. 
Therefore when fresh feed is added into the tube lumen, bacterial multiplication and 
contamination could further be enhanced. When injested by the neonate, the bacteria 
may be able to survive in the stomach and endure passage to the intestines. The 
ability of the bacteria to pass through the intestinal cells may be an implication of 
either the bacteria’s virulence or poor immunity in the neonatal host. 
Several characteristics of bacteria may add to their capacity to form biofilms and 
make them resistant to environmental pressures. the ability of bacterial to form 
biofilm and attachment to mammalian cells based on  EPS which is component of 
colonic acid and cellulose. Similarity, the genes pgaC, yhjN and wcaD have 
associated with the ability of E. coli O157:H7 to form biofilms on plastic surfaces as 
well as alfalfa sprouts and Caco-2 cell lines, as their deletion resulted in significant 
reduction in biofilm formation (Matthysse et al. 2008). Moreover, EPS expression in 
the wells (neonates EFT) could be linked with the capability of bacteria to form 
biofilm.  
Production of capsular material was determined for Ent. ludwigii, Ent. cloacae,  
Ent. aerogenes, Ent. hormaechei, Ent. cancerogenus and K. oxytoca strains by colony 
appearance on milk agar (whey, casein and soya) at 20°C (after 24 hours and 48 
hours) and 37°C (after 24 hours). Most strains produce capsular material on the three 
types of milk agar (whey, casein and soya) at 37ºC compared with 20ºC. These 
results indicate that production of capsules around the bacteria depends on the body 
temperature. 
Interestingly, all the species under investigation were able to synthesize capsular 
material in soya-based infant formula at 37ºC (Table 4.3 and 4.4, Figuer 4.8) rather 
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than in whey-based or casein-based infant formula. This finding also demonstrates 
that the composition of the infant formula also influences the synthesis  
of  the capsular material by the bacteria under investigation. For instance, whey-
based or casein-based formula were comprised of lactose and soya-based formula 
contained glucose (section 1.7, Table 1.2). Lactose is a disaccharide derived from the 
condensation of galactose and glucose, the latter might be needed for the synthesis of 
the capsular material. Glucose could only be obtained from whey-based or casein-
based formula upon breaking down of the oxygen bond, a process which may have 
slowed down capsular formation in comparison to soya based formula.   
This study also revealed the correlation between the formation of the biofilm and  
the synthesis of the capsular material by all the species of bacteria except  
Ent. hormaechei on casein milk agar at both the temperatures (20ºC and 37ºC). 
This may be due to the nutrient required for the synthesis of the material which 
results in the attachment survival and growth of the bacteria on the surface of the 
feeding tubes. This is in agreement with the previous studies by Van Acker et al. 
(2001) where they reported that infant formula milk may contain a factor which aids 
the bacteria in attaching to the surface of the stainless steel or feeding tubes for their 
growth and survival.  
Moreover, it is also in agreement with the report by Scheepe-Leberkühne and 
Wagner (1986), who suggested that the attachment and adherence by bacteria may be 
due to the synthesis of exopolysaccharides. One other earlier study has also suggested 
that the copious synthesis of the capsular material contributes to the formation of 
biofilm in the clinical isolates of Cronobacter (Caubilla-Barron et al., 2007). Hence 
the biofilm produced by the bacteria may protect it from desiccation and also aid in 
masking the bacteria from the host’s immune response, resulting in the development 
of the disease. 
There was a correlation between capsular material production by strains on milk agar 
and uptake and persistence of strains within macrophages. For example, Ent. cloacae 
779 and 789 produced capsules on three types of infant formula and those strains 
persisted in microphages. Previous study by Guerry and Szymanski, (2008) 
demonstrated that capsular material productions may play a role in resistance to 
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desiccation, serum activity and contribute to the survival of pathogenic bacteria after 
ingestion by phagocyte cells. 
As previously mentioned, the bifilm formation on EFT may ultimately lead to 
colonisation of neonate’s stomach as they the bacteria may get detached as cluster 
thereby contaminating the feed.  
As previously discussed, the organisms originating from the bacterial biofilm on EFT 
surface detach and break off in clumps. These biofilms and clumps will contaminate 
any fresh feed in the tube lumen leading to further bacterial multiplication. Bacteria 
enter the neonate stomach, and clumps of cells may survive passage through the 
neonate's stomach. Although the acidity in the stomach of an adult is normally high, 
and kills the majority of ingested bacteria, for the neonates this is not true. The 
gastric pH of neonate was 3.5 to 4.3 for the residual feeding regimes (Hurrell et al., 
2009b). 
In this study, all strains were able to survive on two types of infant formula (whey 
and casein) after adjusting to pH 3.5 for two hours at 37ºC, (Figures 4.12-4.19). 
Gastric juice is reported to play a pivotal role in controlling the food-borne infections 
and this research also backs up this point. The competence of bacteria in enduring the 
acidic conditions of the stomach implies that the bacteria might be pathogenic, which 
may result in disease. Earlier studies have shown that the survival rates of a few 
common food-borne infections were increased when the gastric acidity fell (Peterson, 
1989) accompanied by the decrease in the infective dose (Cash et al., 1974; Schlech 
et al., 1993). 
The next part of study determined the virulence potential of strains isolated from 
MBM and EFT using tissue culture techniques and identified the presence of 
virulence factors. Mammalian cell lines Caco-2 (colon) are used as representatives of 
the human intestinal tract whereas HBMEC and rBCEC4 are used as representatives 
of the human brain. Forty three Enterobacteriaceae including Ent. ludwigii, Ent. 
hormaechei, Ent. aerogenes, Ent. cloacae, Ent. cancerogenus and K. oxytoca strains 
were chosen to determine their  attachment and invasion of Caco-2 tissue culture 
cells. Fourteen organisms were checked for the ability to attach and invade through 
the surface of rBECE4 and HBMEC cells. Moreover, the ability of 23 strains to 
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survive inside the macrophage was investigated by using the U937 human monocyte 
cell line. 
All species exhibited the ability to attach to epithelial and endothelial cell lines 
(Caco-2, HBMEC and rBECE4 cells).  However, there were differences between 
species in their attachment to mammalian cell lines; (see Figures 5.1-5.4). For 
example, Ent. cancerogenus and K. oxytoca strains showed relatively high levels of 
attachment to Caco-2 cells compared with Ent. ludwigii, Ent. hormaechei, Ent. 
aerogenes and Ent. cloacae strains, (Figure 5.2). While, Ent. ludwigii and Ent. 
hormaechei strains showed higher levels of attachment to rBECE4 cells compared to 
their ability to attach to HBMEC cells (Figures 5.5 and  5.7). This finding is a clear 
indication of the potential of these bacteria to cause disease. 
When the pathogen attaches firmly with the host surface, it then starts to penetrate 
deep into the host. As it infects the host, the cycle goes on. Although a pathogen 
might possess an enhanced attachment rate, this may not be the case for invasion. 
Similar results were obtained in this study. Initially, all Ent. hormaechei were found 
to invade Caco-2 cells. Whereas Ent. cancerogenus strains 1350, 1077, 1037, 806 
and 1360 and K. oxytoca strains 1356 and 1079 which were observed to have highest 
attachment rates, did not imply the same in invasion rate. The invasion rate was 
found to be maximum for strain 1053 (Figures 5.1 and 5.3).  
In earlier study, the organism K. oxytoca has been linked with various conditions 
such as septicaemia, meningitis, gastrointestinal disease, soft tissue and even in the 
intravenous region where the host was either immuno-compromised or with 
conditions that favour pathogen infection conditions (Green et al., 2009). Virulent 
Ent. hormaechei, which has the ability to invade into innermost tissues, resulting in 
systemic infection has been reported by Townsend et al. (2008a).  This invasive 
process by Ent. hormaechei also includes gut epithelial cells. Therefore, the 
pathogenicity and virulence of strains can be determined by the ability of the strain to 
invade through the gut barrier. 
Moreover, in addition to determine the potential pathogenicity of strains, the ability 
of certain strains to survive inside human macrophages was measured and this 
included Ent. ludwigii, Ent. hormaechei, Ent. aerogenes, Ent. cloacae and K. 
oxytoca. Five strains, including three of Ent. hormaechei (790, 1038 and 798) and 
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two of Ent. cloacae (779 and 789), were able to survive inside macrophages up to 48 
hours. Among the investigated strains, Ent. cloacae 779 strain showed signs of  a 
decrease in persistence after 24 hours, whereas Ent. hormaechei 798 strain showed 
the maximum persistence of 48 hours in macrophages after which later on they were 
killed (Figure 5.9). The remaining three organisms, namely Ent. ludwigii, Ent. 
aerogenes and K. oxytoca, were destroyed by macrophages.    
In this study, there was a wide variation between strains in intra-macrophage survival 
data, which is plausibly reflective of the levels of pathogenicity in neonates. 
According to a previous study, the Sal. Enteritidis and Sal. Typhimurium, commonly 
causing localized infections in humans, such as mild gastroenteritis, were not able to 
survive well in human macrophages when tested in vitro (Schwan et al., 2000). 
To determine the pathogenicity, the invasive capability through epithelial or brain 
endothelia and persistence of the bacteria inside macrophages were compared for 
Ent. hormaechei strains 790, 798 and 1038. The mentioned strains could survive in 
macrophages for extended periods and also had the capability to invade the 
monolayer of three cell lines (Caco-2, HBMEC and rBECE4 cells) (Table 5.1, 
Figures. 5.3, 5.6, 5.8 and 5.9). These results substantiate the initial claim. This could 
also be the factor that aids the bacteria to penetrate the nearly unbreakable barrier, 
that is, the blood-brain barrier and escape from the host’s immune response, and to 
disseminate. 
The aforementioned results corroborate the previous study of Townsend et al. 
(2008a), which investigated the Cronobacter spp. outbreak in NICUs in France. That 
study highlighted the ability of the Cronobacter spp., to attach and invade the Caco-2 
human epithelial cell barrier. They were found to cross the rat brain capillary 
endothelial cells and persist inside macrophages for 48 hours. Half of the neonates 
exhibited clinical symptoms. This places more emphasis on the features which are 
used to evade the host’s immune response and are able to spread inside hosts.  
Enterobacteriaceae were also examined to establish any pattern in adherece 
to the surface of Caco-2 cells. The strains Ent. ludwigii, Ent. hormaechei,  
Ent. aerogenes, Ent. cloacae and K. oxytoca were found to adhere to the Caco-2 
cells, whereas no definite pattern could be observed. Therefore, it can be concluded 
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that the bacteria did not adhere with a definite pattern with the Caco-2 human 
epithelial cells and do nevertheless invade (Table 5.2, Figure 5.10 A, B and C). 
The other virulence factors which were studied were the ability to produce 
haemolysins and siderophores, serum sensitivity and antimicrobial susceptibility. 
Haemolysin is a toxin produced by the bacteria which also determines its 
pathogenicity. According to the previous study, α-haemolysin is more virulent among 
the three and it is expressed by various extra-intestinal pathogenic bacteria including 
E. coli (Balsalobre et al., 2006). Among the bacteria studied, except K. oxytoca strain 
832, all the other strains were found to be α-haemolytic on sheep blood and 17 strains 
were β-haemolytic on horse blood.  
Similarly, Ring et al. (2002) have shown that β-hemolysin is an important factor for 
the sepsis induced by group B Streptococcus spp., resulting in liver failure and death 
in serious cases. Therefore, these results imply that the strains have ability to produce 
both α-haemolysin and β-hemolysin, which may lysis the RBC cell membranes and 
cause disease in the neonates. 
Another virulence trait of bacterial sensitivity to normal human serum was 
investigated. Serum resistance was observed in all the strains of Ent. ludwigii, Ent. 
hormaechei, Ent. aerogenes, Ent. cloacae, and K. oxytoca, whereas Ent. ludwigii 
strains 1351 and 1439 and Ent. hormaechei strains 1053 and 1075 showed 
intermediate resistance to human serum. This is in agreement with the previous 
reports which claim that the most common trait of meningococci isolated from blood 
or cerebrospinal fluid is serum resistance (Figueroa and Densen, 1991). Clinical 
isolates of V. vulnificus showed serum resistance (Bogard and Oliver, 2007). Ent. 
hormaechei strains isolated from different neonates during a nosocomial outbreak in 
a California hospital were able to survive in human serum (Townsend et al., 2008b). 
Next on the list of virulence factors is the requirement for the element iron, which is 
important for the growth and development of the bacteria that cause the infection 
(Braun and Winkelman, 1987). This can be identified based on the ability of the 
bacteria to produce siderophores, a protein which helps in the uptake of iron into the 
bacteria. In this study, all the bacteria were observed to produce active siderophores. 
Apart from siderophore production, in the present scenario, molecular 
characterization was also performed to confirm the pathogenicity of the infecting 
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strains (Wilson et al., 2002). Genes that are responsible for the uptake of iron, viz. the 
irp1, irp2, fyuA were detected in HPI, the genetic and structure organiation of HPI are 
presented in section 1.11 Figure 1.3. Yersiniabactin, a siderophore produced by 
Yersinia  spp., is also a factor which confers virulence to it (Schubert et al., 2000). 
Johnson and Stell (2000) have shown that the genes for urosepsis, fyuA, is highly 
prevalent in virulent E. coli.  Moreover, Yersinia HPI can be used as a marker for the 
detection of E. coli and other Enterobacteriaceae which cause extra-intestinal 
infection (Schubert et al., 2002). In this study, the fyuA gene was identified in  
all Ent. aerogenes strains, Ent. cloacae strains, 4/6 Ent. ludwigii strains, 1/8  
Ent. hormaechei strains, 4/6  K. oxytoca strains, whereas the other two genes under 
investigation were not detected in any of the strains in the study. The fascinating 
aspect of this study is that some strains of Ent. ludwigii, Ent. hormaechei, and K. 
oxytoca were able to synthesize siderophores, where no genes previously reported for 
siderophore production (irp1, irp2 and fyuA) could be detected genetically. This 
shows that the organism has gained another siderophore systems such as pyochelin or 
anguibactin 
lack the hms locus and therefore are pigmentation negative but do carry a 45-kb 
stretch of chromosomal DNA comprising the irp1-irp2 and fyuA genes. 
In addition, all strains of Ent. ludwigii, Ent. hormaechei, Ent. aerogenes, Ent. 
cloacae, and K. oxytoca have acquired resistance to a broad spectrum of antibiotics. 
One of the noteworthy results found was that three strains of Ent. hormaechei (795, 
798 and 860) which exhibited resistance to aminoglycoside, penicillin, tetracycline, 
chloramphenicol, quinolones and cephalosporins 1, 2 and 3 and were found to be 
sensitive for carbapenems. Furthermore, most strains showed high levels of 
cephalosporins resistance in the absence of ESBLs producing genes, which may be 
because of the hyper production of chromosomal AMPC. AMPC β-lactamases are 
bacterial enzymes which are clinically important that hydrolyse 3
rd
 generation 
extended spectrum cephalosporins and cephamycins causing resistance to these types 
of antibiotic (Jacoby, 2009). 
These findings were in agreement with the previous study of Hurrell et al. (2009b), 
who reported the isolation of Ent. hormaechei from the surface of enteral feeding 
tubes at QMC and NCH. Most of the isolates were resistant to even the 3
rd
 generation 
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cephalosporins, ceftazidime and cefotaxime and were also found to be ESBL-
positive. This shows that the neonates were exposed to the strains which were highly 
resistant to antibiotics. 
Hemolysin production may also be associated with the other factors of virulence such 
as serum resistance and siderophore secretions which may result in neonatal 
infection. 
Finally, in accordance with table 5.1, six isolates can be categorized as high risk as 
they enhance the chance of infecting the neonates through the contaminated EFT 
administered infant formula. Those are Ent. hormaechei strains 790, 798, 1038, 1053 
and 1075 and Ent. ludwigii strain 1439. 
The risk factor in this analysis was ascertained based on the capacity of the strains 
under investigation to invade through various mammalian cell lines (Caco-2, 
HBMEC and rBECE4 cells) and their persistence in the human macrophages. The 
Ent. hormaechei strain 1053 exhibited a relatively high invasive capability in 
comparison with the other strains, Ent. hormaechei strains 790, 798, 1038 and 1075 
and Ent. ludwigii strain 1439, which exhibited less invasive capability in Caco-2 
cells. 
HBMEC and rBECE4 cells were used as model systems to investigate the potential 
of the strains to cross the brain capillary endothelial cell barrier. For three strains of  
Ent. hormaechei, (789, 1053 and 1075), a similar invasive rate was observed in both 
the cell lines, yet this was not the case of Ent. ludwigii strain 1439. The Ent. ludwigii 
strain 1439 exhibited higher levels of invasion in rBECE4 cells rather than HBMEC 
cell line. The strain was isolated from a neonatal meningitis case at QMC, 
Nottingham. 
There is also a chance that the strain could have infected the neonate as the skull was 
opened for a brain surgery. However, since this study aimed at evaluating the 
virulence of the bacteria that cause the disease with the clinical symptoms in vitro, it 
may be a better indication that the bacteria is potentially virulent and can potentially 
cause meningitis, because of the ability of the strains Ent. hormaechei to invade 
through the HBMEC and rBECE4 cell line barrier. 
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7.1 CONCLUSION 
The present study indicates the potential exposure of neonates to particular genotypes 
of strains due to heat tolerance, biofilm formation and acidic pH survival. The study 
also attempted to describe whether those genotypes have a greater propensity to 
invade neonatal intestines and invade the brain blood barrier and to evade the 
immature immune system. The key findings of this project are listed below. 
   
• Twenty-one EFT and 3 MBM pulsotypes of Enterobacteriaceae were 
associated with contaminated neonatal enteral feeding tubes and mastic 
human breast milk, respectively. This indicates that infants are susceptible to 
colonisation by Enterobacteriaceae. 
• The same pulsotypes were spread among the enteral feeding tubes of infants 
in the same NICUs, indicating the same origins, such as: environment, milk,  
carers or healthcare equipment. 
• Genotypic identification of bacterial strains is more accurate than the 
phenotypic technique and the profiling of bacteria by PFGE used in this study 
is a suitable technique for studying strain relatedness. 
• Most strains were able to survive at 55ºC for >30 minutes and this indicated 
that neonates might have been exposed to these organisms either from breast 
milk or from reconstituted infant formula. 
• Strains belonging to the same pulsotypes (Enc1, Enc2, Enc3, Ebh6 and Kc3 
pulsotypes) by PFGE analysis showed the same death rate at 55ºC.  These 
clonal strains may have the same source of origin which possibly 
contaminated different feeding tubes. Similarly, the MBM strains probably 
were isolated from the same mother or breast pomp. There is also a possibility 
of ingestion of these strains by neonates where they could have been exposed 
to the contaminated milk or the infant formula.  
• Biofilm formation on plastic materials was influenced by incubation 
temperature and type of formula in all tested strains. 
•  The quantity of biofilm was high in casein-based infant formula compared 
with whey- and soya-based infant formula in all strains. These observations 
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may indicate the importance of the nutrient type present in PIF for biofilm 
formation. 
• Most strains produced capsule material at 37ºC. This result is strong evidence 
that body temperature may play an important role in producing capsule 
material. 
• The ability of organisms to survive at pH 3.5 is an indicator that these 
organisms may pass through the stomach and colonise the intestine which 
may cause human illness. 
• All strains showed an ability to attach Caco-2, HBMEC and rBCEC4 cell 
lines. 
• Many strains invaded Caco-2, HBMEC and rBCEC4 cell lines and persisted 
and replicated within macrophages which may play a significant role towards 
morbidity and mortality in NICUs. 
• Most Ent. hormaechei strains were able to invade HBMEC cell lines at high 
rates compared to Ent. ludwigii strains. 
• Many of the Ent. hormaechei strains were able to survive within macrophages 
compared to the rest of the strains.  
• The adhesion of bacteria is significant for its ability to cause infection in 
neonates. All strains did adhere to Caco-2 cells and they showed three 
different adhesion patterns; aggregative, diffused and localized adhesions. 
Some strains belonging to the same pulsotype showed the same adhesion 
patterns. This is an indicator that the neonate was exposed by the same clone 
which could be from the same source.  
• The detection of haemolytic activity, serum resistance and siderophore 
production in all strains in this study indicate an increased risk to neonates. 
• Three of Ent. hormaechei strains showed resistance to even the 3rd generation 
cephalosporins, ceftazidime and cefotaxime and were ESBL-positive. This 
illustrates the fact that the neonates were exposed to strains which were highly 
resistant to antibiotics.  
 
Chapter7 
 
200 
 
7.2 Suggested preventive measures for the transmission of bacteria among 
neonates in NICU 
 Hand hygiene is considered the most important procedures in the prevention 
of cross contamination and cross infection by bacteria. Social hand washing 
should be before starting work in NICU, also after changing the gloves.    
 
 Change gloves during neonate care if moving from patient to patient. If the 
gloves contaminated body site to either another body site (including nonintact 
skin, mucous membrane, or medical device) within the same patient or the 
environment you should remove it. 
 
 The health care should use sterile disposal coat in NICU.  
 For the waste, do not touch bin lid with hands and dispose of the waste 
without de-contaminating hands.  
 
 The EFT should be placed in the neonates less than 24 hours to avoid bacteria 
colonisation. 
 
 Sterile medical equipment (thermometer or stethoscope)  should be use in 
NICU between potions.  
 
 Sterile breast pump should be used in NICU, nipple and mammary areola 
should be cleaned with soap and sterile water and then express the milk using 
sterile-gloves.  
 
 Holding different neonates with same coat and gloves should be avoided.  
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7.3 Limitations and recommendations for future research 
It is important to note the methodological limitations of this study. The limitations 
include poor information about source of MBM strains because we did not know 
which was obtained from which mother.  
In this study all the isolates from EFT were analysed. However, for comparative 
isolates should have been obtained from diverse sources in NICU such as nurse, 
breast pump, powder infant formula, water, surface of preparation area, and medical 
equipment to determine source of contamination in NICU, as described in Figure 1.1.    
Also, there was no clinical infection reported for the infants and also it was a long 
time (from 2007) between collection of strains and this study.  
The potentially of risk to neonatal health from Enterobacteriaceae strains for EFT 
strains and MBM strains should be studied in UK and Spain separately, as 
comparative study in each country. 
Another important limitation of this study is Ent. aerogenes and Ent. cloacae were 
not to test their ability to attach and invest HBMEC and rBCEC4 cell lines because, 
at the time this study was initiated, these strains were considered as K. oxytoca. 
On the another hand, there was one cluster, Kp2 pulsotype (Figure 3.6, section 
3.3.1.3 was determined in two different hospitals (the KAH and PRH Jordan), this is 
an unexpected result. Thus this hypothesis needs verification by using a different 
restriction enzyme in the PFGE. Furthermore, more isolates should have been 
collected from different source as described in Figure 1.1. 
The current study did not examine responsible genes for biofilm formation, It is 
important to determine the expression of several biofilm genes affected by 
temperature on biofilm formation on plastic material. Such as, csgABCDEFG operon 
and mlrA. Moreover, responsible genes to form biofilms on plastic surfaces as well as 
alfalfa sprouts and Caco-2 cell lines, such as genes pgaC, yhjN and wcaD should be 
determined. 
Accordind to current study results for the synthesis of the capsular material should 
determine that if the glucose more importand for producing capsular material than 
galactose or are they equal sorces to support bacterial capsular formation? 
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Determination of survival curve of strains a range of at pH 2.5, 3.5 and 4.3 (HCl 
acidified formula) as this is representative of the neonatal stomach conditions on 
ingestion (Hurrell et al., 2009b). Besides, evaluated intragastric pH changes and acid 
reflux in response to feeding in infants with normal gastric emptying (Omari, 2003). 
Test the ability of organisms to metabolise sialic acid after passing through the 
blood–brain barrier, as this could be an important virulence factor. 
Study an apoptosis due to Ent. hormaechei, as this is an important mechanism 
contributing to the development of diseases.  
Finally, molecular methods for detecting of carbapenem resistance genes such as 
blaKPC gene. Carbapenem resistance among Enterobacteriaceae, in particular 
among Klebsiella pneumoniae and Escherichia coli, is an emerging problem 
worldwide. 
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APPENDICES 
 
Appendix 1: Salmonella serotype Braenderup reference standard (H9812), 
approximate band sizes in kilobases shown restricted with XbaI and run under the 
PFGE standardized conditions (Hunter et al., 2005). 
 
 
 
 
APPENDIX  2: 100 bp PCR sizer ladder. 
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     Appendix 3: PFGE cluster analysis of Ent. hormaechei isolated from EFT (UK). 
 
QMC: Queen’s  Medical Centre. NCH: Nottingham City Hospital. Ebh - Ebh7 indicates PFGE cluster groups,  
U: Unique. 
 
 
Strain no. Source Date of isolation Neonate PFGE cluster
790 16/01/2007 4 U
795 17
797 17
798 18
799 18
800 19
801 20
802 21
803 22
979 36
980 36
981 36
983 36
986 36
987 36
993 36
997 36
856 50
859 51
860 52
861 52
862 52
863 52
960 23/05/2007 83 U
1044 115 Ebh7
1052 117
1033 110
1034 110
1035 110
1074 117
1032 110
1053 117
1075 117
1027 108 Ebh5
1038 113
1039 113
1040 113
1066 126
1067 126
1081 126
1084 126
1068 128
1069 128
1089 128
Ebh1
12/11/2007
19/11/2007
Ebh4
22/10/2007
NCH
QMC
Ebh2
Ebh3
Ebh7
Ebh5
16/10/2007
30/01/2007
16/02/2007
17/04/2007
Ebh6
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Appendix 4: PFGE cluster analysis of Ent. cancerogenus isolated from EFT(UK).                        
 
QMC: Queen’s Medical Centre. NCH: Nottingham City Hospital. Ebc1- Ebc6 indicates PFGE cluster groups,  
U:Unique. 
 
Strain no. Source Date of isolation Neonate PFGE cluster
782 7
783 8
781 17/01/2007 6
784 23/01/2007 9
806 24 U
807 24
808 24
810 26
814 27
815 27
816 27
817 27
818 13/02/2007 28
824 36
982 36
985 36
988 36
989 36
992 36
994 36
996 36
998 36
990 37
991 37
825 37
826 37
827 33
828 33
829 33
831 33
834 35
957 81
966 86
969 87
972 87
842 20/03/2007 42 Ebc3
845 45
847 45
848 48
850 48
851 48
907 58
908 58
909 58
1059 119
1071 108
1037 112 Ebc6
1042 128
1054 118
1077 31/10/2007 118 U
1088 19/11/2007 120 Ebc6
16/01/2007
NCH
22/05/2007
16/10/2007
QMC
Ebc3
06/02/2007
Ebc3
11/02/2007
16/02/2007
Ebc2
17/02/2007
Ebc3
20/02/2007
Ebc4
22/10/2007 Ebc4
Ebc5
02/04/2007
Ebc1
10/04/2007
24/04/2007 Ebc2
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Appendix 5: PFGE cluster analysis of Klebsiella  spp. isolated from EFT (UK). 
 
QMC: Queen’s Medical Centre. NCH: Nottingham City Hospital. Kc1- Kc6 indicates PFGE cluster  
groups, U: Unique.  
 
 
 
Strain no. Source Date of isolation Neonate PFGE cluster
778 1
785 9
787 10
788 11
792 13
794 14
832 36
833 36
830 20/02/2007 33
839 39
841 39
976 89
977 89
999 94
1004 94
1006 94
1000 95
1002 95
1005 95
1001 96
1003 96
1012 103
1013 103
1014 103
1046 116
1048 116
1049 116
1078 120
1079 121
1090 129
1091 129
1092 129
1093 129 U
Kc1
16/02/2007
23/01/2007
Kc5
NCH
QMC
Kc2
Kc4
Kc6
Kc3
Kc1
30/05/2007
05/06/2007
12/06/2007
22/10/2007
31/10/2007
28/02/2007
19/11/2007
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Appendix 6: PFGE cluster analysis of Ent. cloacae and Ent. aerogenes isolated from 
EFT (UK). 
 
QMC: Queen’s Medical Centre. NCH: Nottingham City Hospital. Ebl1 and Eba1 indicate PFGE cluster groups, 
U: Unique. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Species Strain no. Source Date of isolation Neonate PFGE cluster
Ent. cloacae 779 16/01/2007 2
Ent. cloacae 789 23/01/2007 12
Ent. aerogenes 1058 16/10/2007 119
Ent. aerogenes 1056 22/10/2007 118
NCH Ebl1
Eba1QMC
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Appendix 7: PFGE cluster analysis of Klebsiella spp. isolated from EFT (Jordan). 
 
KAH: King Abdulla Hospital. PRH: Princesses Rahma Hospital. Kp1-Kp10: indicates PFGE cluster groups; U: 
Unique. 
 
1727, 1728 22/05/2011 16 Kp2 bebelac
1701, 1702 8 Kp7
1703 8
1705, 1706, 1707, 1708 9 S26
1704 8 U
1699, 1700 7 Kp7
1689 3 Kp2
1686, 1687, 1688 3 Kp3
1691, 1692 4 Kp9
1690 4 U
1725, 1726 15
1722, 1723, 1724 KAH 14
1709,1710, 1711, 1712 10 Kp6 bebelac/ S26
1717 07/07/2011 12 Kp2
1730, 1731, 1732, 1733 18 Kp5
1693, 1694, 1695, 1696 5
1697, 1698 6
1729 15/07/2011 17 Kp5
1718, 1719, 1720, 1721 13
1681, 1682 1
1716 11
1715 11
1713, 1714 2
1683, 1684, 1685 2 Kp3
1736 19 Kp2
1734, 1735 KAH 19 Kp10
1740 21
1741, 1742, 1743 22
1737, 1739 21
1738 20
1752, 1753 12/12/2011 27 Kp1
1750 26 Kp2
1744, 1745 23
1746, 1747 24
1748, 1749 25
1751 26
1754 28
1756 28 Kp2
Kp8
31/05/2011
04/07//2013
06/07/2011
PRH
bebelac
neosure
KAH
neosure
09/07/2011
PRH
PRH
Kp1
Kp4
Kp2
10/12/2011
15/12/2011
Kp6
Kp2
Kp9
S26
23/07/2011
07/12/2011
20/12/2011
neosure
bebelac
Strain no. Date of isolation Source Neonate PFGE cluster Formula milk
Kp2
